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Abstract 
The objective of my research was to generate novel information concerning the 
epidemiology, diagnosis and prevention of bovine respiratory disease complex (BRDC), a 
common pre-weaning and post-weaning beef calf disease.  To reach my objective, I conducted 
three prospective field trials within post-weaned calf populations, and one retrospective study of 
pre-weaned calves utilizing survey data. 
I evaluated differences in behavior, health and performance in calves receiving multiple 
component health programs.  Calves in a minimally invasive program, which included primarily 
non-injectable products, displayed less aversion to initial product administration but experienced 
higher BRDC morbidity (P = 0.02) and poorer performance  (P = 0.04) compared to calves in a 
more invasive (all injectable products) program. 
Secondly, in a study of Mannheimia haemolytica inoculated calves, I found that no 
parameter included in physical examinations, or common blood component evaluations could 
discern health from disease.  However, disease recognition was aided by the measurement of the 
number of steps taken by a calf in a 24 hour period.  None of the parameters that were evaluated 
predicted the severity of lung pathology. 
Thirdly, I conducted a study in post-weaned feeder calves that determined prevalence 
estimates for Mollicutes in general, and Mycoplasma bovis specifically, and their respective 
associations with health and performance.  Nasal Mollicutes prevalence was high on arrival, and 
differences in calf performance were associated with (P < 0.01) nasal prevalence.  More than 
half of the calves seroconverted to M. bovis; calves not seroconverting gained more weight (0.49 
kg/head/day) during the study than those calves that did seroconvert (0.35 kg/head/day). 
 Finally, I conducted a retrospective analysis of national U. S. cow-calf survey data to 
identify herd level management practices associated with pre-weaned calf BRDC.  I found 
feeding antibiotics to pre-weaned calves, importing cattle, the number of outside visitors, 
economic purpose of the cow-calf operation, and breeding management of the herd were 
associated with herd-level pre-weaning BRDC rates. 
My research projects generated unique information concerning the epidemiology of 
important pathogens, differences among preventive health programs, objective BRDC diagnostic 
parameters, and pre-weaning BRDC risk factors.  These research studies reinforce the 
complexity of BRDC and demonstrate the pathogen, animal and management factors affecting 
BRDC risk in pre- and post-weaned beef calves. 
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Preface 
Bovine respiratory disease complex (BRDC) commonly afflicts both pre- and post-
weaned beef calves.  This disease syndrome epitomizes the term multifactorial with calf, 
pathogen, and management practices each playing intricate and connected roles in the 
epidemiologic triad.  Recently, new management practices (e.g. metaphylaxis) have decreased 
BRDC incidence in some populations.  Although multiple-component preventive health 
programs, including biologics, antimicrobials, parasiticides, and nutraceuticals have been 
developed, BRDC continues to be a health issue.  Due to the complexity of this disease, research 
investigating the success differences among preventive health programs, and identifying novel 
BRDC recognition tools is important.  Additionally, because the pathogens associated with this 
disease complex are similar in both pre- and post- weaning populations, further research into the 
pathogen dynamics within calf populations and their association with health and performance 
will help us better understand this disease complex.  An important component of preventive 
medicine is the identification of risk factors that can be modified to improve health.  Identifying 
those risk factors that have the largest potential impact on calf health is important information for 
the beef industry. 
Most research has focused on comparing single products of a health program, (e.g., two 
types of viral vaccines), and not two programs with different combinations of products (e.g., 
viral-bacterial-parasiticide combinations).  The difficulty, and perhaps the reason this type of 
research is not often undertaken, is the inability to identify the individual products within these 
programs that may be responsible for observed differences in health or performance.  However, 
xxi 
 
combinations of products are often used; therefore, comparing combinations would be an 
important step in comparing the success between BRDC preventive health programs.  To 
investigate this issue, I completed a study comparing the health, performance and behavior of 
calves that received two different post-weaned calf preventive health programs (Chapter 2).   
No BRDC preventive health program is completely effective, and similar to other 
diseases, the success of medical intervention is predicated by early disease recognition.  Early 
identification of BRDC continues to be a major challenge in the control of this disease syndrome.  
Presently in the beef industry, subjective observation of subtle changes in calf physical 
appearance, activity and apparent appetite are commonly used for BRDC recognition.  
Discovering objective recognition tools as indicators of early BRDC would allow more timely 
medical intervention and increase the probability of positive outcomes.  Validated ante-mortem 
lung disease severity assessment tools are also lacking within the beef industry.  Discovering 
objective measurements that could predict the severity of BRDC lung lesions would allow an 
objective assessment of the effectiveness of treatment regimens and could prevent suffering by 
improving disease outcome prognostication.  The objective of my research into this topic was to 
investigate metabolic parameters and physical behaviors as indicators of early BRDC and the 
severity of lung pathology (Chapter 3).   
A key to understanding the pathology and epidemiology of an organism lies in 
understanding its frequency and distribution.  Some organisms were identified many years ago as 
important BRDC pathogens; therefore, many prevalence studies have been completed and 
associations with BRDC are well documented.  Other organisms have only recently been 
associated with BRDC; therefore, little is known about these organisms’ epidemiology as it 
relates to BRDC.  One such group of pathogens belong the bacterial class Mollicutes (bacteria 
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lacking a cell wall, of which Mycoplasma sp. are the most dominant).  The objective of my third 
study was to measure Mycoplasma nasal and serological prevalence at multiple time points 
(Chapter 4) and to evaluate associations with cattle health and performance indices.  Both upon 
arrival and temporal changes of Mycoplasma nasal and serological prevalence would be 
important to understanding the epidemiology of this organism and would assist veterinarians and 
producers when designing preventive health programs such as those described in Chapter 2.  
Another important issue for better understanding and managing BRDC in beef calves is 
the characterization of associated risk factors.  Management practices as risk factors for BRDC 
in post-weaned beef calves and pre-weaned dairy calves are widely published.  Despite many 
cow-calf operators considering pre-weaning BRDC an important disease, little research has been 
completed on risk factors in pre-weaned U. S. beef calves.  For the purpose of disease control, 
extrapolating risk factors from one bovine production system to another may seem logical, but 
given the differences in calf age (pre-weaned calves vs. post-weaned calves) and animal 
management (dairy-calf hutches vs. cow-calf pairs), such an extrapolation may be inappropriate.  
There are likely management practices which are unique to the cow-calf industry that impact 
post-weaning BRDC.  During the post-weaning period, this disease is difficult both to prevent, 
and diagnose, so being able to identify risk factors at the pre-weaning level may be an important 
step in preventing this disease.  Discovering the management practices that enhance or reduce 
BRDC risk will be important to veterinarians when designing BRDC prevention programs or 
when assessing present cow-calf management practices.  To meet my objective of evaluating 
cow-calf management practices as risk factors for pre-weaning BRDC, I analyzed data gathered 
from a national survey of U.S. cow-calf operations (Chapter 5).   
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My objectives in the BRDC research described here are multifaceted.  First I wanted to 
quantify differences, based on health, performance and behavior between post-weaning 
preventive health programs.  I also wanted to identify behavioral changes and metabolic 
parameters as possible accurate BRDC diagnostic tools.  Additionally, I desired to investigate the 
population dynamics, and associated effects with health and performance of an important but 
only recently identified BRDC associated pathogen.  Lastly, I wanted to identify those 
management practices that are associated with pre-weaning BRDC in a unique study utilizing 
data from a U.S. national survey. 
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CHAPTER 1 - Literature review: epidemiology, diagnosis, and 
prevention of bovine respiratory disease complex 
 
G.A.Hanzlicek
a
, D.G. Renter
a
, B.J. White
b 
 
 
 
a
Department of Diagnostic Medicine and Pathobiology, Kansas State University, 
Manhattan, Kansas 
b
Department of Clinical Sciences, Kansas State University, Manhattan, Kansas 
 
Introduction 
Beef calf life cycles can be divided into two distinct time periods: pre- and post-weaning.  
Weaning is the management practice where mother and offspring are physically separated and 
milk feeding is terminated.  This stage is a critical period in beef cattle production systems.  In 
beef production, these two time periods share some common diseases and disease risk factors, 
but the primary diseases, disease timing, and risk factors of importance differ between the two 
periods. 
Regardless of the specific disease or timing, causes of calf diseases are multi-factorial.  
The calf, pathogen, and environment are intimately associated arms of the epidemiological 
disease triad.  The disease triad and the synergy that exists between each arm are important 
concepts that form the foundation for calf disease control and prevention programs (Radostits, 
2001).  Incorporating the triad concept into the decision-making process for herd disease 
management can significantly increase efficiency, reduce cost of production, and increase 
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production unit profitability (Wikse et al., 1994; Griffin, 1997).  The objective of this review is 
to discuss the BRDC disease epidemiology for the pre-weaning and post-weaning periods.  
Specifically, the focus of this manuscript is on BRDC and the associated risk factors, economic 
ramifications, and prevention and management programs for pre-weaning and post-weaning time 
periods. 
Pre-weaning health and disease 
Disease epidemiology 
Several studies have estimated the prevalence of beef calf pre-weaning morbidity and 
mortality (USDA, 1998a; USDA, 2009c).  Morbidity risk for pre-weaned calves was 3.8% for 
respiratory disease, 3.5% for diarrhea/digestive, and 2.2% for pinkeye (USDA, 1998b).  
Although not the most often listed, diarrhea and pneumonia are important with regard to pre-
weaning morbidity and mortality.  The 1997 National Animal Health Monitoring System 
(NAHMS) survey reported that 5.1% of herds had at least a 2% incidence of diarrhea and 14.1% 
of herds had at least a 2% incidence of pneumonia (USDA, 1998a).  A South Dakota study 
reported the following prevalence of morbidity: diarrhea (21.4%) and respiratory disease 
(15.5%).  The NAHMS survey reported that 3.6% of all calves born alive were lost or died 
before weaning (USDA, 2009c).  This survey also reported as the percentage of total death loss 
of calves less than 3 weeks of age by several perceived causes: weather (25.6%), unknown 
(18.6%), respiratory (8.2%), digestive (14.0%), calving problems (25.7%), predators (4.7%), and 
poisoning (0.0%) (USDA, 2009c).  These findings differ slightly from those of the 1997 
NAHMS study, which showed that calving problems was the most frequent (33.0%) cause of 
calf death, followed by digestive and respiratory deaths at 16.4% and 8.8%, respectively (USDA, 
1998b).  Also in the NAHMS Beef 2007-2008 survey, the percentage of total deaths of calves 
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greater than three weeks of age were listed as: weather (10.0%), unknown (19.4%), respiratory 
(31.4%), digestive (22.6%), calving problems (2.3%), predators (4.7%), and poisoning (0.1%) 
(USDA, 2009c).  In 73 Colorado herds, diarrhea and respiratory infections were responsible for 
11.5% and 7.6%, respectively, of total pre-weaned calf mortality (Wittum et al., 1993).  These 
studies indicate that although multiple health issues are associated with pre-weaning morbidity 
and mortality, BRDC plays an important role. 
Although diarrhea and BRDC are both important pre-weaning health issues, the age-
associated incidence risk of neonatal diarrhea and pre-weaning pneumonia differs.  
Gastrointestinal infections from Escherichia coli, rotavirus, and coronavirus occur most 
commonly in calves less than 3 weeks of age, and  Saif et al. 1985 suggested that age of 
susceptibility varies by pathogen and estimated age ranges for several common pathogens 
including E. coli (< 7 d), rotavirus (7 to > 30 d), coronavirus (7 to > 30 d), and Cryptosporidia (7 
to 21 d) (Saif, 1985).  Because diarrhea incidence occurs over a relatively narrow time period, 
labor and management focus on the disease triad needs to occur soon after birth.  This may allow 
cow-calf producers to concentrate labor but may also be challenging if the disease demands 
overwhelm the available labor.  In contrast, pneumonic infections associated with bovine herpes 
virus-1 (IBR), bovine respiratory syncytial virus (BRSV), bovine viral diarrhea virus (BVDV), 
and Mannheimia haemolytica may occur at any age.  However,  research on a single, large herd 
over a 20-year period illustrated that the highest BRDC incidence rates occurred between calf 
ages of 70 and 170 days (Snowder, 2005).  Because respiratory disease onset can occur over a 
long range of calf age, management focus on respiratory disease control needs to occur over the 
entire period from birth to post-weaning.  This is a challenge for cow-calf producers, because 
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calves usually spend most of this phase in pasture or range environments where early disease 
detection and intervention are difficult. 
Pre-weaning bovine respiratory disease 
Risk factors 
Bovine respiratory disease risk factors are complex and varied.  A study that followed 
more than 10,000 beef calves from birth to harvest revealed that dam age was a risk factor for 
calf BRDC incidence (Muggli-Cockett, 1992).  In that study, calves born to 2-year-old dams had 
an increased risk for pre-weaning pneumonia, but a decreased post-weaning BRDC risk 
compared with calves from older dams (Muggli-Cockett, 1992).  If younger dams transferred 
lower levels of passive immunity to their calves, the calves could be at a higher risk for 
pneumonia.  Conversely, relatively low levels of passive immunity may have allowed for 
development of active immunity when vaccinated, thus decreasing the disease risk in the feeding 
phase.  Several factors could account for differences between calf health and dam age including 
dystocia levels, colostrum quality and mothering ability.  Future research into the association 
between dam age and BRDC risk is warranted. 
Prior disease experience also may be a risk factor for subsequent BRDC.  Calves 
diagnosed with scours early in their lives were found to have an increased risk of subsequent pre-
weaning pneumonia (Sivula, 1996).  This may indicate that previous illness can negatively affect 
immunity directly by overwhelming the immune system or secondarily through disease-
associated anorexia and malnutrition.  Additionally, calves with poor immunity may be more 
susceptible to many diseases.  Regardless of the mechanism, it appears that general management 
practices that decrease disease risk for early pre-weaning diarrhea could serve to decrease future 
disease incidence risk (e.g., for BRDC) later in the pre-weaning period.  More research is needed 
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to investigate interactions between health history, present immune status and pre-weaning 
BRDC. 
Population dynamics play an important role in pre-weaning pneumonia risk.  A positive 
association between calving season length and pre-weaning pneumonia mortality risk had been 
found in Canadian cow-calf herds (Dutil et al., 1999).  In the same study, owners of larger herds 
(>40 cows) reported a higher incidence of respiratory disease (Dutil et al., 1999).  The increased 
risk for pre-weaning pneumonia associated with higher population density and longer calving 
season length may be partly explained by the fact that older animals serve as common carriers of 
many respiratory pathogens (i.e., bovine herpes virus-1) and potentially spread the virus through 
saliva (Akermann, 2006).  This increased risk of population density and dynamics may be 
explained by the concept of ―herd immunity‖.  For example, as the calving season progresses, 
herd population dynamics change because disease-susceptible animals (calves) continually make 
up a larger percentage of the population; as the percentage of susceptible animals increases, the 
risk of disease outbreaks also increases.  Management practices that reduce the level of exposure 
to BRDC pathogens will continue to be important to disease control programs.  
Genetics also may play a role in pre-weaning BRDC risk.  Pre-weaning BRDC resistance 
heritability has been estimated to be 0.07 to 0.20 (Muggli-Cockett, 1992; Snowder, 2006).  In a 
more recent study, heritability for pre-weaning BRDC resistance was estimated to be 0.11 (+/- 
0.06)  in a population of 1,519 calves (Schnieder et al., 2009).  Another study noted significant 
differences in pre-weaning BRDC resistance heritability between breeds of cattle (Snowder, 
2006).  In this study pre-weaning BRDC incidence was 17.8% for Hereford calves and 7.8% for 
Angus calves.  Recently a quantitative trait loci identifying resistance to BRDC has been 
elucidated (Casas and Snowder, 2008).  Although the heritability of BRDC resistance appears to 
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be low, concentrating on selecting those seedstock animals possessing inherent resistance or 
tolerance to BRDC or substituting more resistant breeds for susceptible breeds may be useful 
BRDC control strategies. 
Prevention and management 
Disease prevention in a population is based on the ability to incorporate all components 
of the standard epidemiological triad (i.e., host, environment, and pathogen) into herd health 
management regimes (Martin et al., 1987).  Incorporating the triad concept into the decision-
making process for herd disease management can significantly increase efficiency, reduce cost of 
production, and increase herd profitability (Wikse et al., 1994). 
One of the major challenges in pre-weaning BRDC management is the timing of 
vaccination in the presence of maternal antibodies.  For each calf, there is a unique period of 
time after birth during which maternal IgG is waning but immunocompetence is not complete 
(Chase, 2008).  Susceptibility to calfhood diseases is elevated during this phase, which lasts until 
active immunity has reached protective levels for the current disease challenge.  Traditional 
studies investigating passive transfer interference typically measure antibody changes after 
vaccination (Ridpath et al., 2003).  More recent studies have evaluated innate and active 
immunity responses in the presence or absence of maternal antibodies (Fulton and Burge, 2000).  
Cell-mediated and B-cell memory responses have been demonstrated by using attenuated 
vaccines in the presence of maternal antibodies (Ellis, 1996).
 
  These findings may provide 
support for the development of novel attenuated vaccination products for use in very young 
calves to provide a primary memory response.
 
  Potential differences between vaccine types were 
evaluated in a bovine viral diarrhea study in which calves with circulating maternal antibodies 
were vaccinated at seven weeks of age.  Calves vaccinated with modified-live BVDV mounted a 
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T-cell response, whereas calves given killed vaccine did not develop a T-cell response (Endsley 
et al., 2003).  This suggests that memory cells were stimulated during a primary immune 
response in the presence of maternal antibodies; thus, the long-held belief that maternal 
antibodies interfere with parenteral vaccinations when given to young calves needs to be 
revisited. 
Different routes of vaccination administration in young calves have been investigated for 
their effectiveness as components of BRDC preventive health programs.  Vaccines delivered 
intranasally have been more protective against a clinical BHV-1 challenge than parenterally 
administered products in BHV-1 seronegative calves and in calves possessing maternal 
antibodies (Castrucci, 2002).  Calves that received the intranasal vaccination did not become 
febrile, were not dyspnic, did not have nasal discharge, and were not observed coughing, 
whereas some of the calves vaccinated with the parenteral product had at least one of these 
clinical signs.  In another study, 2-week-old Holstein-Hereford cross calves with evidence of 
maternal antibodies were given a single intranasal BHV-1 vaccination and challenged 16 weeks 
later with live BHV-1 (Patel, 2005).  Although no rise in virus-neutralizing antibodies to BHV-1 
was observed in any calf, all intranasally vaccinated calves were protected against pyrexia and 
nasal viral shedding was decreased in this group.  If intranasal vaccines targeting other BRDC 
pathogens are effective in the presences of maternal antibodies requires more research. 
Very few studies have provided vaccination timing guidelines for immunizing young 
calves against BRDC agents in the presence of maternally derived antibodies.  If maternal 
antibodies block a primary immune response to vaccination, one might conclude that 
administration of respiratory vaccines should be delayed until passive immunity to common 
bovine respiratory viruses has waned.  In one study, the average time for passively acquired 
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BVDV titers to decay to negative status (<16) was 192 days of age (Fulton et al., 2004).  Other 
studies have shown that passive immunity to Mannheimia haemolytica and Pasteurella 
multocida was lowest at 60 to 90 days of age (Prado et al., 2006).  Using estimations of 
seronegativity as guidelines for vaccination program timing disregards the distribution of 
seronegative and seropositive calves.  Some calves will reach seronegativity earlier than the 
population mean, and if the mean is used, this group of calves may be left unprotected.  If novel 
attenuated vaccines can be invented for widespread use in pre-weaned calves, then the 
uncertainty concerning vaccine timing or vaccine method of administration would be less 
important.  Much more research investigating the interaction between maternal antibody 
presence and immune response to vaccination is badly needed. 
Because BRDC is complex, prevention programs in the pre-weaning period may not be 
effective if concentrating on a risk factor, but may require the assessment of simultaneous risk 
factors such as herd age, the incidence of other diseases, genetics and vaccine management.   
Weaning 
As mentioned earlier, weaning is the process when mother and offspring are separated by 
the cow-calf producer and suckling is terminated.  In addition to the cessation of milk 
consumption, the calf also experiences a change in living environment and solid diet components 
(Price et al., 2003).  These weaning events are believed to be stressful to the calf, as measured by 
behavior changes such as increased vocalization, pacing and low feed consumption (Haley, 
2006).  Additionally, more subjective measures of stress such as calf serum catecholamine levels 
have indicated that weaning is a stressful event (Lefcourt and Elsasser, 1995; Hickey et al., 
2003). 
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Stress is important in the immediate post-weaning period because it negatively impacts 
the immune system (Blecha, 1984).  This occurs at a time when the exposure to viral and 
bacterial pathogens are increased (Duff and Galyean, 2006).  The most important post-weaning 
disease is BRDC, and it has been shown that stress enhances the viral-bacterial synergy that 
occurs between BRDC pathogens (Hodgson et al., 2005).  To reduce the level of stress 
experienced by beef calves, several weaning strategies have been developed. 
The most common weaning method is an abrupt separation of the calf and cow (Haley et 
al., 2005).  Separating cows and calves by the greatest land distance is an important component 
of this weaning method, but distance separation does not appear to diminish the level of stress 
(Haley et al., 2005).  Recently a two-stage system where nursing is first prevented, by a device 
placed in the calf’s nose, followed later by calf-dam separation was investigated as an alternative 
weaning method (Haley, 2006).  In this study, on the first day after separation, the two-stage 
weaned calves walked less distance (5.2 ± 0.5 km/d) compared to abruptly weaned calves (16.7 ± 
3.1 km/d).  Based on the distance difference, the authors concluded the two-stage weaned calves 
were less stressful.  Several studies have investigated the utility of fence-line contact between 
calf and cow at weaning (Stookey et al., 1997; Price et al., 2003).  Observers recorded the 
amount of time spent walking and lying down for a random sample of calves within each 
treatment.  The fence-line contact calves spent less time walking and more time lying down 
compared to the abruptly weaned calves.  These studies suggest that weaning methods differ 
with respect to the amount of stress experienced by calves.  From these results, future studies 
investigating the association between weaning method and subsequent calf health would be a 
logical next step. 
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Post-weaning health and disease 
Disease epidemiology 
After weaning, calves may be moved to feedlots, backgrounding or stocker facilities.  
Although differences in business methods and management goals may differ between these 
animal production entities, they are similar in that they report BRDC as the greatest disease of 
concern. 
According to the NAHMS Feedlot 99 survey, cumulative disease incidence risks during 
the feedlot phase are approximately 14.4% for BRDC, 3.1% for atypical interstitial pneumonia 
(AIP), 1.9% for digestive disorders, 2.2% for bullers, 1.9% for lameness, and 0.4% for central 
nervous system (CNS) (USDA, 2000b).  Several other studies have indicated that BRDC is the 
most common feedlot disease (Ribble et al., 1995b; Edwards, 1996; Smith, 1998a; Loneragan et 
al., 2001b).  In North America, BRDC accounts for 70% to 80% of morbidity and 40% to 50% of 
mortality (Smith, 1998b).  Reported values for BRDC morbidity risk range from 0 to 86% (Kelly 
and Janzen, 1986; Gardner et al., 1999; Snowder et al., 2007; Step et al., 2008; Babcock, 2009; 
Garcia et al., 2009; Schneider et al., 2009b).  Additionally, NAHMS reported that a larger 
percentage of calves experienced BRDC in feedlots with >8,000 capacity (15.5%) than in 
feedlots with smaller capacities (8.7%) (USDA, 2000a).  Loneragan et al. found that most death 
loss was attributed to BRDC and that mortality incidence increased by 20% to 35% for each 
hundredweight decrease in cattle arrival weight (Loneragan, 2004).  Reported values for the 
mortality risk associated with BRDC range from 0% to 8% (Step et al., 2008; Holland et al., 
2010).  Although other diseases are reported during the post-weaning period, and BRDC 
morbidity and mortality incidence differences by facility capacity or animal size, BRDC 
continues to plague the beef industry. 
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Peak BRDC incidence reportedly occurs relatively early in the feeding period.  A 
Canadian study found BRDC morbidity peaked at 7 to 14 days and then declined toward zero by 
day 28 (Martin and Meek, 1986).  In a South African study, peak initial BRDC incidence 
occurred on day 18 and 87% of all cases occurred by day 35 (Thompson et al., 2006).  In a large 
retrospective study of 31,131 BRDC morbidities, the average days on feed to initial treatment 
was calculated at thirty (Babcock, 2009).  In a 3-year study across 10 feedyards, the average days 
to first treatment was 40 days and 75% of cases occurred by day 55 (Schnieder et al., 2009).  
These studies suggest that days to peak morbidity increased over the study years.  A need for 
future research to investigate the possibility for predicting temporal patterns in groups of calves 
is needed.  This would allow feedlot personnel to concentrate labor and materials at specific 
times to specific groups of calves. 
Several researchers have reported a seasonal pattern for BRDC.  For example, two 
studies showed that BRDC morbidity and mortality peak in early autumn and winter (Irwin et al., 
1979; Ribble et al., 1995a).  And in a multiple-year, single-feedlot study, the highest risk of 
BRDC mortality occurred in the fall (Ribble et al., 1995a).  Authors of those studies noted that 
the coldest temperatures and greatest amounts of precipitation occurred during this time.  These 
findings may indicate that fall weather patterns negatively affect calf health.  It is also possible 
that non-weather-related risk factors are present (Babcock, 2010).  Most calves enter the 
feedyard during the fall (USDA, 2000a).  This sudden influx of calves may negatively affect 
health through an increase in commingling stress and pathogen exposure.  According to the 
NAHMS Feedlot 99 study, in feedlots of 8,000 head or more, the average pen observer is 
charged with watching 2,000 head of calves (USDA, 2000b).  According to the same survey, the 
majority of feedlots observe each pen twice daily during the first 15 days after arrival (USDA, 
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2000b).  Additionally, only 27.6% of feedlots require formal training with written guidelines for 
disease diagnosis, 45.4% offer formal non-written but not written guidelines, and 18.3% require 
no formal training (USDA, 2000b).  Therefore, it is also possible during the fall when many 
groups of calves are arriving that a feedlot health system may be overwhelmed by the number of 
new cattle and pens that require multiple daily observations by employees who may lack 
adequate BRDC observational training. 
Atypical interstitial pneumonia is a respiratory disease with distinctly different causes 
and temporal distributions.  The cause of AIP is unknown, but it is believed that a synergistic 
event occurs between toxic rumen product production, 3-methyleneindolenine, and BRSV 
presence (Loneragan et al., 2001a).  In a 2-year study, the mean days from feedlot arrival to AIP 
experience was 114 days (Ayroud et al., 2000).  Mortality from this disease ranges from 0.03%  
to 0.05% of cattle placed (Hjerpe, 1983).  Even at the low mortality risk stated here, the 
economic impact of this disease could be substantial when multiplied over large groups of cattle.  
Additionally, it has been shown that calves that become morbid closer to scheduled harvest have 
reduced carcass weight, presumably because they had less time to completely recover (Babcock, 
2010).  There may be an additional economic cost due to delayed slaughter due to treatment 
withholds and reduced finishing weight.  Because little is known about the etiology, more 
research is needed in this area.  
Several diseases occur during the post-weaning period including lameness and digestive 
disorders.  Bovine respiratory disease complex continues to be the most common disease during 
this time.  The temporal distribution of this disease may have changed over time.  Whether is due 
to calf type changes or management changes are unknown.  Future research investigating 
temporal pattern differences between calf groups is needed.   
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Post-weaning bovine respiratory disease complex 
Economics 
The economic effects of BRDC are estimated at $750 million to $1 billion dollars and 
include prevention, treatment, and production costs (Griffin, 1997).  Preventive health program 
components include vaccinations and metaphylaxis; expenses for the latter have been estimated 
to range from $5.00 to $12.92 per calf (Guichon et al., 2000; Booker et al., 2007). 
Some economic loss due to BRDC is realized through a reduction in the number of 
marketable animals due to mortalities, and morbidity treatment costs.  One researcher estimated 
for every one percent increase in BRDC pen morbidity, death loss increased by 0.14% (Irsik et 
al., 2006).  Estimates for a single BRDC treatment, realized through pharmaceuticals and 
supplies,  ranged from $15.57 to $16.64 per animal, and average BRDC treatment cost was 
$12.59 with a range of $11.09 to $16.26 (Faber et al., 1999; USDA, 2000a).  With newer 
antimicrobials, the costs of treatment may be greater than those listed above. 
Production effects of BRDC in the post-weaning phase have been extensively studied.  In 
one study, the carcass value for untreated calves was $23.32 dollars more than calves treated 
once for BRDC and $30.15 and $54.01 more than calves treated twice or three times, 
respectively (Schneider et al., 2009a).  In another study, calves treated once for BRDC had lower 
yield grades, fat thickness, and kidney/pelvic/heart fat but did not differ in marbling or hot 
carcass weights (HCW) compared with non-treated calves (Garcia et al., 2009).  In a 15-year 
study, calves treated for BRDC had lower HCW and weight of retail cuts than non-treated 
calves, but there were no differences in average daily gain (ADG) (Snowder et al., 2007).  In 
another study by Snowder (2006), calves diagnosed with BRDC had lower ADG (0.95 kg/day) 
than healthy calves (0.99 kg/day) (Snowder, 2006).  Other studies have investigated feed 
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efficiency differences between pens of cattle at different BRDC mortality levels.  For example in 
one study, for each percentage increase in mortality for a pen of cattle, feed conversion 
decreased by 0.12 kg, which resulted in an added cost of $1.00 per head (Irsik et al., 2006).  In a 
recent study, BRDC affected calves gained 0.6 kg less than untreated calves over the entire 
feeding period (Schneider et al., 2009a).  In the same study, a higher percentage (71%) of calves 
that were never treated for BRDC graded as Choice or better compared with calves that were 
treated (57%) (Schneider et al., 2009a).  And Gardner et al. (1999) reported that calves never 
treated (1.53 kg/day) for BRDC had higher ADG over the entire period than calves treated once 
(1.49 kg/day) for BRDC (Gardner et al., 1999). 
Most studies on the performance effect of BRDC reported differences between healthy 
and sick cattle over an entire feeding period.  However, one study demonstrated that the effect of 
BRDC on performance differed based days from arrival and slaughter (Babcock, 2009).  In that 
study, calves that were treated closer to slaughter had higher ADG than similar calves treated 
earlier in the feeding period.  This may indicate that production costs from BRDC episodes are 
not uniform across all phases of the feeding period and that BRDC prevention and interventions 
that occur earlier in the feeding period may have a larger positive effect.  
The economic effects of BRDC appears to differ by the timing of the event in relation to 
day before slaughter, and are realized through prevention and treatment costs, reduced feed 
performance and final product value.  Further research into this area is needed. 
Post-weaning bovine respiratory disease complex risk  factors 
Important to the management of BRDC is the identification of risk factors.  Risk factors 
for post-weaning BRDC include arrival weight, transportation stress, gender, commingling, 
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receiving period management such as dehorning and castration, and dietary provisions, and 
pathogen exposure (Duff and Galyean, 2006; Fike and Spire, 2006). 
Arrival weight often appears to be negatively associated with calf health. Lightweight 
calves (< 318 kg) had a higher incidence of BRDC than heavyweight calves (Alexander et al., 
1989; Sanderson et al., 2008).  But in a case-control study, no association between arrival weight 
and BRDC morbidity was found (Booker et al., 1999).  The discrepancies between studies may 
be explained by the lack of a standard BRDC case definition in the Sanderson study, and a strict 
BRDC case definition in the Booker study.  Additionally, the Sanderson study had a large 
sample size (20,136 calves), was evaluated at the pen level compared with the Booker (200 
calves) and on an individual calf level, which may have allowed for more precise group 
estimates.  If weight is a proxy for age, lighter calves may be more immunologically naïve 
because they have been exposed to fewer pathogens over time than heavier calves.  Additionally, 
it is possible that lighter calves still possess maternal antibodies that interfere with some arrival 
respiratory vaccines and, therefore, do not become immunized.  If the studies reported in the 
early segments of this paper suggesting MLV may not be affected by maternal antibodies this 
last explanation may not be valid given the majority of feedlot calves are administered MLV 
upon arrival (NAHMS, 2000b). 
Long transport times, defined as longer than 24 hours, have been associated with 
increased BRDC morbidity (Cole et al., 1988).  Sanderson et al.(2008) observed a 10% increase 
in morbidity risk for each 160 km increase in travel distance (Sanderson et al., 2008).  In 
contrast, another study conducted over a four year period showed no difference in BRDC 
mortality in calves hauled over long distances (Ribble et al., 1995c).  This difference in study 
outcomes may be a reflection of calf population differences, or it is possible that travel distance 
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affects BRDC morbidity risk without a subsequent associated increase in mortality.  It is also 
possible that feedlot health providers are cognizant of transport times and concentrate 
observations of or administer treatments (metaphylaxis) to pens of long-haul cattle, therefore 
reducing mortality risk.  
Gender and pen gender distribution have been associated with BRDC morbidity 
(Alexander et al., 1989; Snowder et al., 2006).  One study found that heifers were at an increased 
risk of BRDC mortality compared with steers (Loneragan et al., 2001b).  Additionally, heifer 
calves not selected by cow-calf producers for replacements are typically lighter weight, and 
visually of lesser quality, which suggests they are younger in age and, in turn, may have an 
increased pathogen exposure naivety, or may have other health issues.  Additionally, heifers may 
experience additional stresses such as estrus or pregnancy (Smith et al., 2001). Pens with a 
mixture of steers and heifers had an increased risk of BRDC, compared to non-mixed pens 
(Sanderson et al., 2008).  It should be noted that in this study a direct comparison between steer 
and heifer pens was not completed.  The mechanisms to explain the difference between pen-
gender-composition is unknown and needs further research. 
Commingling has been associated with BRDC risk.  Calves from multiple sources housed 
in the same pens had a higher BRDC risk than calves in single-source pens (Ribble et al., 1995a; 
Sanderson et al., 2008).  In the Bruce County project, mixing calf groups after arrival was 
associated with increased BRDC morbidity (Martin et al., 1981).  In another study, calves from a 
single source that were not commingled at the feedyard had less BRDC morbidity than calves 
from auction barns or calves that were commingled upon arrival (Step et al., 2008).  Comingled 
calves presumably experience increased stress levels and pathogen exposure compared with non-
commingled calves.  This provides a management option for reducing BRDC risk, but for many 
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large feedyards, feeding only non-commingled calves will be logistically impossible.  According 
to the NAHMS Beef 2007-2008 study, 80% of U.S. herds have 50 or fewer cows (USDA, 
2009c).  Because semi truckloads of cattle are typically 23,000 kg loads and transportation costs 
prohibit partial truckloads, commingling during transport will continue to be a risk factor.  
Additionally feedlot pen sizes routinely house 150-350 or more animals, which again 
necessitates cattle be commingled upon arrival (USDA, 2000b). 
Post-arrival management procedures such as castration and dehorning are risk factors for 
BRDC.  Mortality was significantly higher in calves castrated upon arrival than in calves that 
arrived at the feedlot as steers (Martin et al., 1980).  In a more recent study, BRDC morbidity 
risk was higher for beef stocker calves that were castrated (60%) upon arrival than for those that 
arrived as steers (28%) (Pinchak et al., 2004).  In another study, calves dehorned after arrival 
were at a higher risk of BRDC morbidity than those that were not dehorned (Daniels, 2000).  The 
majority of feedlots reported placing at least some intact males and calves with horns (USDA-
2000a).  Additionally, 6.3% of cow-calf operations marketed calves with horns and 23% as intact 
males (USDA, 2000a).  This suggests that efforts to reduce the effects of these two procedures 
may depend on additional cow-calf operator-education and research investigating newer methods 
for managing castrated and dehorned calves. 
Concentrate levels and dietary source may be associated with BRDC.  High concentrate 
receiving diets were associated with increased BRDC morbidity (Galyean et al., 1999).  Calves 
fed a 75% concentrate diet experienced more morbidity (57%) than calves fed a 25% concentrate 
diet (47%) (Lofgreen, 1983b).  In contrast, no BRDC morbidity difference was found between 
calves fed 70%, 75%, and 85% concentrate diets (Fluharty and Loerch, 1996).  The difference 
between the Lofgren and Fluharty studies may be related to the concentrate levels fed.  It is 
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possible that morbidity risk is not different between high levels of concentrate feeding but 
between low concentrate and extremely high concentrate arrival diets.  In the Bruce County 
project, calves fed a diet consisting of large amounts of corn silage during the first week after 
arrival were five times more likely than calves fed only grass hay to die from BRDC (Martin et 
al., 1980).  The difference in diets in this study could still be said to be a difference in 
concentrate levels. In contrast, feeding only grass hay for the first three 3 days after arrival 
decreased BRDC morbidity risk (Lofgreen, 1983b).  The differences in studies mentioned above 
may be more related to the effects of abrupt dietary changes than in the source of nutrients.  
Almost one-half of cow-calf operations report selling calves immediately upon weaning (USDA-
APHIS:VS, 2009b).  Presumably calves sold at weaning most likely are exposed to high forage 
diets, and an exposure to high concentrate diets upon feedlot arrival constitutes an abrupt dietary 
change. 
Arrival protein levels and protein sources have also been associated with BRD incidence.  
In one study, morbidity risk increased linearly for diets containing 12%, 14%, 16%, and 18% 
crude protein although source of protein was not associated with morbidity (Fluharty and Loerch, 
1995).  In two subsequent trials, the same researchers found no difference in morbidity between 
protein levels or sources and concluded that high levels of protein were necessary in receiving 
diets because of low dry matter intakes (Fluharty and Loerch, 1995).  In a randomized trial, 
Galyean, et al. (1993) found that BRDC morbidity risk was higher in calves fed a 16% crude 
protein diet than in calves fed a 14% crude protein diet (Galyean et al., 1993).  Martin (1982) 
reported that calves fed high levels of non-protein nitrogen during the early feeding period were 
at a higher risk of BRDC mortality compared to calves receiving natural protein (Martin, 1982).  
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Studies investigating the association between BRDC and dietary protein levels are conflicting. 
This suggests that future research into this area is warranted.  
Bovine respiratory disease complex risk factors are numerous and complex.  Given the 
different management skills and business needs that are present in the cow-calf industry, certain 
risk factors (light arrival weights, intact bulls, and calves with horns) will continue to be a part of 
post-weaning calf health.  Also that a large percentage of calves are born and raised in distant 
areas from feeding operations, transport times will continue to affect BRDC rates (USDA, 
2009b).   Finally, commingling will continue to be a risk factor given the cow-calf herds sizes, 
transport truck sizes, and large feedlot pen capacity (USDA 2000a; USDA, 2008a).  
Concentrating on evaluating and discovering other more manageable risk factors such as nutrient 
density may be warranted.  Additionally, the invention of novel interventions designed to lessen 
the effects of the aforementioned risk factors may become important to the feedlot industry.   
Pathogens 
Understanding pathogens are important to BRDC management because they are 
intimately associated with other arms of the epidemiological triangle.  Although the risk factors 
between pre-weaning post-weaning BRDC may differ, the pathogens associated with this disease 
are similar.  The list of BRDC associated pathogens is extensive and includes viruses: infectious 
bovine rhinotracheitis virus (IBR), bovine viral diarrhea virus (BVDV), parainfluenza-3 virus 
(PI-3), bovine respiratory syncytial virus (BRSV), and bacteria: Mannheimia haemolytica, 
Pasteurella multocida, Mycoplasma bovis, and Histophilus somni (Wikse, 1985; Smith, 1996; 
Griffin, 1998; Radostits, 2000; Apley, 2006).   
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Viral pathogens 
Viral pathogens are important contributors to BRDC pathology.  Although much research 
has already been completed investigating the pathological mechanisms of each BRDC associated 
virus, more research is needed to understand the immunosuppressive and synergistic nature of 
these organisms.  
Infectious bovine rhinotracheitis virus 
Infectious bovine rhinotracheitis (IBR) is caused by Bovine herpes virus-1 (BHV-1) and  
is transmitted by aerosol or close contact with infected animals, including indirect transfer 
through contaminated food and water (Engels and Akerman, 1996; Fulton, 2009).  Portals of 
entry include the nasal cavity, eyes, and oropharynx.  As a result of BHV-1 infection, the 
mucociliary elevator is compromised, and this reduces the clearance of bacteria pathogens from 
the respiratory tract (Kapil and Basarab, 1997).  This virus is immunosuppressive in the lower 
respiratory tract because it impairs macrophage, neutrophil, and lymphocyte functions.  
Ultimately, this impairment can lead to increased respiratory tract infections (Kapil and Basarab, 
1997). 
Infectious bovine rhinotracheitis is associated with BRDC in calves entering the feedlot 
at less than 1 year of age (Patel, 2005; van Drunen Littel-van den Hurk, 2006).  Infectious bovine 
rhinotracheitis naïve calves are exposed to the virus by a carrier that harbors the virus either in 
the upper respiratory tract or within the trigeminal nerve (Kapil and Basarab, 1997).  Trigeminal 
nerve infections are considered latent, and reactivation occurs after stresses such as transport, 
commingling, and environmental conditions (Kapil and Basarab, 1997). 
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Martin et al. reported that approximately 10% of calves were IBR seropositive on arrival 
and approximately 2% to 3% seroconverted over a 30-day period (Martin et al., 1989).  In a 
group of stocker calves, 7.5% had positive IBR titers upon arrival (Fulton et al., 2000).  In a 
different study, 18.3% of calves were positive for IBR upon arrival, and calves that became 
BRDC cases had significantly lower arrival titers compared with controls (Martin and Bohac, 
1986).  There were no differences between cases and controls in arrival IBR titers, but IBR 
arrival titers were positively associated with a higher risk of BRDC mortality (Booker et al., 
1999).  It appears that calves can be exposed to IBR before entry into the feedlot, and exposure 
may continue through the early feeding period.  Additionally, this organism may not be 
associated with BRDC morbidity but may be associated with mortality.  More research into the 
mechanism of disease for this organism is warranted. 
Bovine viral diarrhea virus  
Bovine viral diarrhea virus (BVDV)is an important BRDC pathogen (Campbell, 2004).  
This virus is thought to be transmitted through close contact with carrier animals, with aerosol 
exposure considered a secondary mode of transmission (Pellerin et al., 1994; Ridpath et al., 
1994; Fulton and Burge, 2000; Fulton et al., 2005; Ridpath, 2005).  Bovine viral diarrhea virus 
reduces the effectiveness of the mucociliary apparatus and is considered immunosuppressive 
(Fulton and Burge, 2000).  Bovine viral diarrhea virus is believed to have a synergistic 
relationship with Mannheimia haemolytica, PI-3 virus, BRSV, and Mycoplasma bovis (Potgieter 
et al., 1984; Fulton et al., 2000; Haines et al., 2001). 
One study found that 56% of calves had positive BVDV titers upon arrival and 24% of 
the calves seroconverted to BVDV during the first 28 days of the feeding period (Martin and 
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Bohac, 1986).  In that same study, seroconversion was positively associated with BRDC 
morbidity. In a similar study, 81.7% of calves purchased through auction markets were 
seronegative to BVD type  I and 86.7% were seronegative to type II  upon arrival, and 38.5% 
seroconverted to type I and 27.9% seroconverted to type II during the first 5 weeks on feed 
(Fulton et al., 2000).  Large differences in BVDV sero-prevalence at feedlot arrival suggests that 
clustering of this virus among certain cattle populations occurs.  Another study showed BVDV 
seroconversion had a sparing effect on BRDC incidence (Allen et al., 1992).  Similarly, Booker 
et al. showed that BVDV seroconversion was not associated with BRDC but higher arrival 
BVDV titers were associated with increased BRDC risk (Booker et al., 1999).  In contrast, 
O’Connor et al. (2000) found that at arrival, BVDV seropositive calves were at lower risk of 
BRDC morbidity than seronegative calves (O'Connor, 2000).  This may suggest that 
seroconversion across BVDV species is not similar, and conversion to exposure to one species 
may be more protective that conversion to another.  Additionally, these results suggest that 
serostatus is a measurement of blood antibody levels which do not necessarily infer protection.  
Parainfluenza virus  
Parainfluenza virus type 3 (PI-3) is ubiquitous in cattle populations (Kapil and Basarab, 
1997).  Like BHV-1, PI-3 affects the upper respiratory ciliated apparatus and predisposes calves 
to secondary bacterial infections.  Additionally, it is believed that this virus is 
immunosuppressive through its negative effects on macrophage and lymphocyte function (Kapil 
and Basarab, 1997). 
In one study 16.2% of calves were serologically positive to PI-3 upon arrival with 24.2%  
positive by 30 days after arrival to a feedlot (Yates et al., 1983).  In a 2-year study, 11% of calves 
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were PI-3 seropositive upon arrival and 67% had seroconverted by day 28; in the same study, 
seroconversion to PI-3 was associated with an increased risk of BRDC (Martin et al., 1989).  In 
contrast,  Allen et al. (1992) found seroconversion to PI-3 viruses to be protective against BRDC 
morbidity (Allen et al., 1992).  This studies suggest that exposure to PI-3 is common in some 
populations and that the effects of seroconversion may be different across different calf 
populations.   
Bovine respiratory syncytial virus  
Bovine respiratory syncytial virus (BRSV) is considered a primary BRDC pathogen and a 
component of the respiratory complex (Gershwin, 2007).  Infection usually occurs through 
contact with nasal secretions, and with aerosols over short distances (De Jong and Kimman, 
1994).  As with the other BRDC viral pathogens, BRSV reduces the effectiveness of the 
mucociliary apparatus, allowing secondary lung bacterial infections (Ellis, 2009).  Unlike BVDV 
and BHV-1,  BRSV is not considered immunosuppressive (Baker, 1985).  There appears to be a 
synergistic relationship between BRSV and rumen-derived pneumo-toxicants such as 3-
methylindole (Gershwin, 2007).  From this relationship, BRSV has been associated with AIP, a 
less common form of pneumonia in feedlot calves (Ellis, 2009).  A unique feature of BRSV, 
similar to that observed with respiratory syncytial virus in humans, is the enhanced pathological 
reaction observed in previously vaccinated calves prior to natural BRSV exposure (Gershwin et 
al., 1998). 
Booker et al. (1999) reported that less than 25% of calves were seropositive for BRSV at 
feedlot arrival and more than 50% seroconverted to BRSV within 30 days (Booker et al., 1999).  
In a 2-year study, only 4% of calves were BRSV positive upon arrival and 61% had 
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seroconverted by day 28 (Martin et al., 1989).  In that same study, seroconversion to BRSV was 
associated with BRDC morbidity. In another sero-epidemiological study, 72.2% of calves 
purchased through auction markets were seronegative to BRSV upon arrival and 77.9% 
seroconverted during the first 5 weeks on feed (Fulton et al., 2000).  In one study, higher BRSV 
titers upon arrival were associated with reduced risk of BRDC (Martin et al., 1999).  In another 
study arrival BRSV serostatus was not associated with BRDC morbidity risk (Collins et al., 
1988).  From these studies, exposure to BRSV differs greatly both in pre-weaning and post-
weaning calf populations, and that higher titers may be protective, seronegativity is not 
necessarily a risk factor.  Although BRSV is considered to be a primary BRDC pathogen, more 
epidemiologic research is needed to establish this organism role in calf pneumonia. 
Corona virus  
Corona virus (BRCoV) has recently been associated with BRDC, but its role in this 
disease is unknown.  This organism was first isolated from pneumonic calves in 1993 (Storz et 
al., 2000).  Later BRCoV was isolated from calves experiencing  diarrhea and respiratory disease 
(Boileau and Kapil, 2010).  The pneumonic viral strains are referred to as bovine respiratory 
corona virus (BRCoV), and it is unknown whether the pneumonic and enteric forms are 
antigenically different (Boileau and Kapil, 2010).  Infection is usually by fecal-oral, and aerosol 
routes are secondary (Boileau and Kapil, 2010).   
In a recent study  20% of calves from a single source were seropositive upon arrival and 
41% had seroconverted by day 35 (Thomas et al., 2006).  In the same study, 14% of multi-source 
calves purchased from sale barns were seropositive upon arrival and 89.9% seroconverted by 35.  
In another study, 58% of the calves seroconverted to BRCoV during the initial 28 days of feed, 
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and calves that seroconverted were 1.6 times more likely to require treatment for BRDC 
(Lathrop et al., 2000).  O’Connor et al. (2001) reported that 90% of the calves were seropositive 
to BRCoV upon arrival (O'Connor et al., 2001).  In a Canadian study, 83% of calves were 
seropositive upon arrival and BRCoV serostatus was not associated with BRDC risk (Martin et 
al., 1998).  Calves that seroconvert to BRCoV within the first month on feed are at an increased 
risk of BRDC and are more likely to require multiple treatments (Lathrop et al., 2000; Plummer 
et al., 2004).  Exposure to this organism appears to be common, but given the conflicting studies 
a need to define this organism’s role in BRDC is very much needed.   
The information discussed above suggests that virus exposure clusters within 
populations.  Additionally, the importance of serostatus or seroconversion to BRDC control for 
all the mentioned viruses is conflicting.  Perhaps the conflict can be explained by these 
parameters not measuring protection but other unassociated, unknown factors.  Future research is 
needed to investigate the calf-pathogen reaction concentrating on identifying parameters that can 
be associated with protection. 
Bacterial pathogens 
Mannheimia haemolytica 
Mannheimia haemolytica is considered the most important BRDC bacterial pathogen 
(Griffin, 2010).  It is a commensal organism that resides in the upper respiratory tract and 
nasopharynx and becomes pathogenic after gaining access to the lower respiratory tract (Rice et 
al., 2007a).  Although considered highly infectious, M. haemolytica is not considered highly 
contagious (Rice et al., 2007b).  Griffin (2010) noted that this lack of contagiousness did not 
hold true when experimentally inoculated calves were mixed with non-inoculated calves (Griffin, 
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2010).  The contagiousness Griffin noted may be more of a result of the inoculation procedure or 
bacterial dose, and not necessarily the contagiousness of the organism.  Mannheimia haemolytica 
is a unique BRDC pathogen because of the number of virulence factors it possesses.  These 
include ahdesins, polysaccharides, leukotoxin, iron-binding proteins, and lipopolysaccharides 
(Confer, 2009).  Leukotoxin is the most important virulence factor (Czuprynski et al., 2004).  
There is a synergistic relationship between BRDC viral pathogens as immunosuppresors and M. 
haemolytica (Rice et al., 2007a). 
Upon arrival to a feedlot 95.4% of calves were M. haemolytica seropositive and all had 
seroconverted by day 30 (Yates et al., 1983).  In another study, 50% of calves were seropositive 
upon arrival and 40% seroconverted over next 30 days (Booker et al., 1999).  Additionally, 
calves that seroconverted to M. haemolytica were 2.83 times more likely than seronegative 
calves to experience BRDC (Booker et al., 1999).  In a 3-year study, 70% of incoming calves 
were M. haemolytica seropositive and 45% had seroconverted by day 28 (Martin et al., 1989).  In 
that same study, risk of BRDC was positively associated with M. haemolytica seroconversion.  It 
is apparent that exposure to this organism is common in some pre-weaning calf populations and 
that exposure can continue in the feedyard.  What is less clear is whether M. haemolytica is a 
primary or opportunistic pathogen and if primary, how infectious this organism may be.  
Pasteurella multocida 
Pasteurella multocida is an upper airway commensal and can be found in clinically 
normal and sick calves (Dabo et al., 2007).  In an eight year (1994-2002) randomized study, 
utilizing the same bacterial isolation procedure, a decrease in the M. haemolytica: P. multocida 
ratio isolated from fatal BRDC cases was observed (Welsh et al., 2004).  Co-infections with 
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other pathogens are common, and P. multocida is believed to have a synergistic relationship with 
Mycoplasma organisms (Dabo et al., 2007).  Like other BRDC-associated bacterial pathogens, P. 
multocida is considered an opportunist; thought not to be able to produce disease on its own 
(Autio et al., 2007).  Virulence factors possessed by P. multocida have not been well described 
but include adherence and colonization factors, lipopolysaccharides, iron-regulating proteins, and 
proteases (Dabo et al., 2007). 
In a group of 62 beef calves, 36.4% were positive to P. multocida upon arrival and 60.4% 
had seroconverted by day 30 (Yates et al., 1983).  In a case-control study  P. multocida was the 
most prevalent organism found in the cases (Allen et al., 1991).  Seroconversion to P. multocida 
was found not to be predictive of the probability of a future BRDC episode (Virtala et al., 2000).  
Although  P. multocida’s role in BRDC has been studied for many years, understanding 
of its role in BRDC is not well described.  There is not enough research to say if this organism is 
becoming more or less prevalent, and future research is needed in this area, and more research 
into the association between prevalence, seroconversion and subsequent BRDC risk is needed.   
Mycoplasma bovis 
The causal role of Mycoplasma bovis in BRDC is not clear (Rosendal and Martin, 1986; 
Maunsell, 2009).  However, some European researchers believe M. bovis is a major cause of 
BRDC, mastitis, and arthritis (Nicholas and Ayling, 2003).  In Europe, M. bovis is thought to be 
responsible for 25% to 33% of all BRDC cases (Gevaert, 2006).  Mycoplasma bovis infection 
usually occurs through the respiratory tract, and transmission can occur by direct contact with 
carriers or fomites (Confer, 2009).  In addition, M. bovis is transferred in milk, a characteristic 
unique to potential BRDC pathogens, and nursing calves can become infected through exposure 
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to contaminated milk (Maunsell, 2009).  A unique clinical feature of M. bovis is the appearance 
of arthritis in calves post- infection (Confer, 2009). 
In a prevalence study at multiple stocker production units, 2% of calves were nasal PCR 
positive for M. bovis upon arrival.  At the stocker unit level, 0% to 4% of farms were positive 
according to nasal PCR and 0% to 6% were positive according to nasal culture (Wiggins et al., 
2007a).  Another study revealed that 50% of calves were M. bovis seropositive at arrival and 
40% of the negative calves had seroconverted by day 28 (Martin et al., 1989).  This indicates that 
exposure to M. bovis continues after arrival and that stressed calves are able to mount an immune 
response.  Calves that experienced BRDC had higher M. bovis titers on day 28 than calves that 
had not experienced BRDC (Rosendal and Martin, 1986).  In the same study, there was no 
association between BRDC risk and M. bovis seroconversion status.  In two other studies, there 
was no difference between BRDC cases and controls with respect to serostatus or seroconversion 
(Rosendal and Martin, 1986; Martin et al., 1989).  In a more recent study,  stocker calves that 
were nasal PCR positive were more likely (OR 10.6) to experience fever during a background 
period than negative calves (Wiggins et al., 2007b). 
Difficulties in assessing the role of M. bovis in BRDC occur because this organism is 
more difficult to culture compared to other BRDC associated pathogens.  Additionally, the 
frequent use of metaphylaxis products that are ineffective against M. bovis may have confused 
the true BRDC role of this organism.  More research is needed to assess the role of this 
organism, and as newer antibiotics targeting M. bovis become available the role of this organism 
may change.  
Furthering our understanding of BRDC requires additional research to determine the 
specific mechanisms of pathogenicity and virulence of bacteria as pathogens.  Similar to issues 
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mentioned with BRDC viruses, conflicting conclusions of the importance of serostatus or 
seroconversion would be beneficial to future BRDC control methods. 
Disease recognition 
Observation of pens of calves by humans continues to be the primary method of BRDC 
recognition.  Observation of clinical signs such as anorexia, nasal discharge, lack of rumen fill, 
lethargy, and ocular discharge are subjective, and the criteria for categorizing cattle as sick vary 
between feedlots (Duff and Galyean, 2006).  In addition, personnel who conduct the observations 
have various biases and observational abilities.  Because of the subjective nature of observation, 
and the observational skill and experience variability between observers, diagnosis is not always 
accurate (Duff and Galyean, 2006).  Once an animal has been observed to have one or more of 
the clinical signs mentioned above, it is usually taken to a treatment facility, where a rectal 
temperature is taken.  Abnormal rectal temperature definitions vary between production units 
and range from temperatures > 103.0 º F to > 104.5 º F.  Clinical illness scoring systems have 
been devised for BRDC recognition (Apley, 1997; Fajt et al., 2003).  In these systems, calves are 
given a score of 1 to 4 (1 = normal, and 4 = moribund).  Typically, calves with a score greater 
than 1 are removed from the pen, and a rectal temperature is taken.  If the rectal temperature is 
above the normal defined range for that production unit, the animal is treated for BRDC (Apley, 
1997). 
Several studies have confirmed the lack of sensitivity of subjective observational 
measures.  A study of 5,976 calves in a Midwestern feedlot revealed a BRDC morbidity 
incidence of 8.17%, but at harvest 61.9% of the animals had lung lesions suggestive of a 
previous BRDC episode (Schneider et al., 2009b).  In an earlier study, 68% of calves that were 
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not observed to be ill from birth to slaughter had lung lesions suggestive of at least one BRDC 
episode (Wittum et al., 1996).  In another study using Bayesian statistical methods, the 
sensitivity and specificity for clinical signs plus rectal temperature, was only 61.8% and 62.8%  
(White and Renter, 2009).  It is clear that because visual observations are the first ―diagnostic 
test‖ used in BRDC diagnosis the low sensitivity of this test is problematic.  High sensitivity 
tests are ideal when used as disease screening tools (Dohoo et al., 2003).  Because BRDC 
observation as a tool has low sensitivity and accuracy, disease recognition will continue to be a 
struggle. 
Subjective measures of normal and diseased-animal behavior have been practiced, but 
quantifiable measures of animal behavior have been put forth only recently (Weary et al., 2009).  
For example, differences in watering and feeding behavior between healthy and sick calves have 
been investigated as an early BRDC recognition tool.  One investigator, using remote activity 
monitors, found that number of daily feeding times predicted BRDC morbidity better than 
watering behavior, and that morbid calves spent less time at the feed bunk than healthy calves 
(Sowell et al., 1999).  In another study, calves that became ill 11 to 27 days after arrival spent 
more time drinking and took more frequent drinks during the first 5 days after feedlot arrival 
than calves that remained healthy (Buhman et al., 2000).  Other detailed quantitative measures 
have also been investigated.  A Mannheimia haemolytica challenge study found that total steps 
taken in a 24-hour period decreased significantly immediately post-inoculation and remained 
lower than pre-inoculation levels for up to 9 days (Hanzlicek et al., 2010).  Objective measures 
to accurately recognize BRDC can be accomplished using mechanical devises that measure 
behavior parameters. 
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Blood metabolites have been investigated as means of diagnosing BRDC or predicting 
BRDC survival.  Of these metabolites, acute phase proteins such as haptoglobin, fibrinogen, and 
serum amyloid-A have been the most intensely investigated (Arthington et al., 2003; Ganheim et 
al., 2003; Ganheim et al., 2004; Humblet et al., 2004; Nikunen et al., 2007).  Haptoglobin was a 
sensitive indicator of future BRDC morbidity, but another study showed that haptoglobin 
concentration was unassociated with the number of BRDC treatments and was a poor predictor 
of disease outcome (Wittum et al., 1996; Carter et al., 2002).  In another study, fibrinogen was 
higher in calves with early BRDC than in normal calves (Berry et al., 2004).  A combination of 
fibrinogen and haptoglobin had a sensitivity of 71% and a specificity of 83% for BRDC 
diagnosis based on a gold standard of calf history, clinical examination and either 
bronchoalveolar lavage and paired serology or necropsy (Humblet et al., 2004).  In the same 
study, sensitivity increased to 80% when four acute phase proteins were used concurrently.  
Other blood metabolites have been investigated with respect to BRDC recognition.  Coghe et al. 
(1999) found that oxygen saturation and blood lactate were not sensitive indicators of early 
BRDC (Coghe et al., 1999).  In a challenge study, no blood metabolites measured by complete 
blood count, blood gas, or serum chemistries were accurate at recognizing early BRDC or 
predicting the severity of the lung lesions (Hanzlicek et al., 2010).  Whether blood metabolites 
are usual indicators of BRDC has not been decided.  Given these tests are confirmatory tests 
used after the insensitive test of calf observation, the utility of their use is guarded. 
Infrared pictures have been investigated to determine if skin or ocular temperature are 
early indicators of BRDC.  In two separate BVDV induction studies, cranial and ocular-
thermography were found to be sensitive indicators of infection (Schaefer, 2004; Stewart et al., 
2005).  In another study, sensitivity and specificity were 67.6% and 86.8%, respectively, for 
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ocular infrared thermography, used as an early BRDC recognition tool, when compared to the 
gold standard of a core temperature ≥104.0ºF, presence of nasal discharge or cough, a white cell 
count <7 or >11,000 µL
-1
 and a neutrophil: lymphocyte ratio of <0.1 (Schaefer et al., 2007).  
This tool was compared with the already low sensitivity realized in BRDC recognition; therefore, 
the usefulness of this tool requires further research.  The objective nature of the BRDC screening 
test is a difficult problem in the diagnosis of BRDC.  Other recognition tools are confirmatory 
tools and more research is needed to assess their specificity. 
Prevention and management 
Post-weaning disease prevention programs can be initiated during the pre-weaning or 
post-weaning phases of beef production.  Pre-weaning programs include preconditioning and 
pre-sale vaccinations, dietary management, and post-weaning programs include arrival 
vaccinations, dietary management, biosecurity, and metaphylaxis. 
In 1965, Dr. John Herrick coined the term ―preconditioning‖ (Miksch, 1984).  Since that 
time, no standardized definition as it applies to pre-weaned calves has been established (Lalman 
and Smith, 2000).  Nonetheless, the term usually infers on-farm weaning, castration, dehorning, 
acclimation to bunk feeding, and vaccination.  A study that compared preconditioned calves with 
control calves found that the preconditioned calves had a lower BRDC morbidity risk than the 
controls (Macartney et al., 2003).  Morbidity risk was lower in calves vaccinated with a killed 
vaccine twice, 2 to 4 weeks before sale and again when commingled at the sale barn, than in 
calves vaccinated with a modified live respiratory vaccine either at the sale barn or upon arrival 
at the feedlot (Kreikemeier et al., 1996).  In another study, preconditioned calves (vaccinated 
against viral pathogens 3 weeks prior to weaning and held at the farm for 25 to 30 days before 
33 
 
shipment to the feedyard) did not have fewer BRDC episodes than non-preconditioned calves 
(Pritchard and Mendez, 1990).  Although preconditioning is believed to be an effective BRDC 
control practice, deficiencies in research to assess their effectiveness are present.  Much of this is 
due to no strict definition of preconditioning.  The studies listed above all were considered 
preconditioning studies but differed greatly in component parts, so drawing conclusions is 
difficult.  Even the ―best‖ preventive health program cannot be expected to be effective if not 
practiced.  A high percentage of cow-calf producers sell calves at weaning (USDA-APHIS:VS, 
2008).  If preconditioning programs can be shown to be effective through proper research, then 
the task of communicating to producers and lenders will be an important next step. 
Pre-sale vaccination programs are becoming more popular in North America (Macartney 
et al., 2003).  The difference between pre-sale and preconditioning programs is that the former 
requires vaccination, castration, and dehorning prior to shipment but not source housing for 30 to 
45 days.  A study followed preconditioned calves, pre-sale-vaccinated calves, and auction-barn-
purchased calves for 28 days after arrival to a feedlot and found that  compared with auction-
barn-purchased calves, preconditioned calves were 0.22 times as likely and pre-sale-vaccinated 
calves were 0.68 times as likely to be treated for BRDC (Macartney et al., 2003).  Difficulties in 
assessing the effectiveness of this practice remains because of sparse published research.  It is 
possible that pre-sale vaccination has risen because cow-calf operators have recognized the 
importance of preconditioning for BRDC control but they (and their lenders) many times have 
high risk aversion.  Vaccinating prior to sale is therefore a method used to reduce risk and 
simultaneously ―do something‖ to prevent BRDC.  
In addition to preconditioning and pre-sale vaccination programs, feedlot arrival 
vaccination programs are also widely used.  Although arrival vaccination programs are common, 
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and hundreds of BRDC vaccines are marketed, very few direct comparison BRDC multi-
pathogen vaccine field studies have been published in referred journals (USDA, 2000a; 
Bowland, 2000).  In a  review of published BRDC vaccine field efficacy studies , few were 
found not to contain major design flaws (Perino and Hunsaker, 1997).  The authors concluded 
that the effects of BRDC vaccination at arrival are equivocal.  Despite the paucity of vaccine 
field studies, 98% of all feedlot-processed cattle are vaccinated against respiratory disease upon 
arrival or shortly after (USDA, 2000a).  Many studies have been conducted to compare single 
pathogen vaccines or compare single and double pathogen vaccines with multi-pathogen 
vaccines, but few studies have included a negative vaccine control group (Jericho, 1982; 
Castrucci, 2002; Schunicht et al., 2003; Wildman et al., 2008).  One exception is a Canadian 
study in which increased BRDC risk in calves vaccinated against respiratory pathogens upon 
arrival was noted (Martin et al., 1981).  In that study, a multitude of vaccines were used and 
many different pathogens were targeted; the final model vaccine variable contained all vaccines 
and all pathogens, so direct comparison with non-vaccinated herds is difficult.  To accurately 
assess the effectiveness of BRDC vaccines, more negative control vaccine studies are needed in 
the beef industry.  Given the large amount of faith in vaccines, it is understandable that cattle 
producers or biologic companies will be reluctant to participate in these studies. 
Metaphylaxis, another common practice, is the mass administration of parenteral 
antibiotics at arrival to groups of calves considered to be at high risk of BRDC.  In the NAHMS 
99 Feedlot study, the most common reason for initiating metaphylaxis was the appearance of the 
group of cattle upon arrival; the second most common reason was prior poor health outcomes in 
cattle from the same source (USDA, 2000b).  According to the NAHMS 99 feedlot survey, 
56.4% of the surveyed feedlots administered metaphylaxis, and a higher percentage of large 
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feedlots (82.1%) used metaphylaxis compared with smaller feedlots (46.2%) (USDA, 2000a).  
The difference in metaphylaxis use between feedlots of different sizes may indicate that larger 
feedlots receive more high-risk (long transported calves from multiple sources) than small 
feedlots, which may feed their own cattle or locally-raised cattle, or may indicate a difference in 
the priority of preventive health program funds. 
One of the first studies that investigated the utility of metaphylaxis occurred in 1983 
(Lofgreen, 1983a).  In that study, groups of calves given parenteral oxytetracycline for 3 days 
after arrival had fewer treatment days per calf purchased (2.9 days) than non-medicated calves 
(3.7 days).  A meta-analysis of 107 randomized field trials indicated that parenteral mass 
antibiotic administration to calves upon feedlot arrival reduced BRDC morbidity risk (Van 
Donkersgoed, 1992).  In a Canadian study, calves given tilmicosin metaphylaxis had reduced 
BRDC morbidity compared with a control group (Schumann et al., 1990).  In another study by 
the same authors three treatment groups were randomly assigned:(tilmicosin upon arrival, 
tilmicosin 72 hours after arrival, and control), metaphylaxis-given calves experienced less BRDC 
morbidity than the controls during the first month after arrival (Schumann et al., 1991).  In a 
study of 57 stressed beef calves, morbidity for calves given tilmicosin upon arrival was 0% and 
morbidity for a control group was 46.4% (Galyean et al., 1995).  In a follow-up study of 183 
calves, the tilmicosin metaphylaxis calves again experienced lower (11.9%) BRDC morbidity 
than control calves (43.6%) (Galyean et al., 1995).  In another tilmicosin metaphylaxis study, 
metaphylaxis calves had a lower morbidity risk (15.0%) than controls (54.0%); the mean days to 
morbidity was also higher for metaphylaxis calves than for controls (15.3 vs. 3.5 days, 
respectively)(McClary and Vogel, 1999).  The results of these studies suggest that metaphylaxis 
is an effective practice for reducing BRDC morbidity.  However, in a consumer survey study, 
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33% of participants said they would not purchase meat if they knew it came from an animal that 
had received antibiotics during the feeding phase (Brewer and Rojas, 2008).  Despite the 
apparent effectiveness of administering antibiotics upon feedlot arrival, other methods that are 
more acceptable to consumers need to be developed and evaluated.  
The prevention and management practices described above concentrate on improving calf 
immunity, reducing exposure to pathogens or controlling resident pathogen populations. 
Biosecurity on the other hand concentrates on reducing exposure to known and unknown 
pathogens.  Biosecurity (i.e., reducing pathogen exposure and transmission) has been suggested 
as a means to control BRDC (Callan and Garry, 2002; Brandt et al., 2008).  Strict biosecurity is 
difficult to accomplish in large feedlots because large numbers of cattle are purchased from 
multiple sources and subsequently housed together (Brandt et al., 2008).  Additionally, many 
BRDC pathogens are ubiquitous and cannot be eliminated from cattle populations.  However, 
some biosecurity measures seem appropriate and practical in the feedyard.  For example, 
preventing healthy calves from direct exposure to pathogens harbored by sick animals through 
isolation is a practical biosecurity method.  Brandt et al. (2008) surveyed Midwestern feedlot 
managers and reported that 36.8% allowed direct fence-line contact between sick and health 
calves (Brandt et al., 2008).  Because BRDC is multi-factorial and there is difficulty 
accomplishing suggested biosecurity practices in our modern beef production systems, it may be 
more effective to concentrate on other control methods in conjunction with biosecurity. 
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Conclusion 
Bovine respiratory disease complex is an important disease found in both pre-weaned and 
post-weaned calf populations.  This disease is multifactorial and differences in risk factors 
between the two populations do exist, although the associated pathogens are similar. 
Regardless of the population, BRDC research and control will be more effective if the 
multifactorial nature of this disease remains within focus.  Needed research in the pre-weaning 
phase relates to assessing proper immunization timing, identifying management practices as risk 
factors, and developing methods of BRDC recognition.  Research results conflict into the 
importance of vaccine timing or type of product used; more research is needed.  No published 
research investigating management practices as risk factors for pre-weaning BRDC has been 
published.  This information may an important first step in controlling this disease on cow-calf 
operations.  In the post-weaning phase many risk factors associated with BRDC have been 
recognized. Some risk factors are result of management practices that occur in the pre-weaning 
phase.  Unfortunately, some of these risk factors will continue to be difficult to manage because 
of demographic constraints, herd size, and long-standing traditions that exist in the U.S. beef 
production systems.  This necessitates research to discover objective, sensitive, and practical 
methods for early BRDC detection.  Treatment success requires early disease recognition, and 
only through accurate diagnosis will we be able to assess treatments successes and offer timely 
prognostications.  Additionally, research assessing BRDC preventive health programs will 
continue to be important because some risk factors will be difficult to manage.  Lastly, given 
some public aversion to antibiotic use in livestock and the possible interaction between antibiotic 
use and bacterial antibiotic resistance, research into other methods, such as diet modulation or 
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genetic manipulation will continue to be important.  Finally, bovine respiratory disease complex 
is aptly named, because of its multifactorial complexity.  Future research to reduce BRDC’s 
effects will require interdisciplinary efforts by researchers with common goals.  
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Abstract 
Bovine respiratory disease complex (BRDC) is the most important health issue in beef 
feeder calves.  Our study was a randomized, blinded field trial to evaluate potential differences in 
health, production and behavior in feeder calves administered two different preventive health 
programs.  Calves in two replicates (n=305 and n=308) were allocated to pens and then pens 
were randomly assigned a preventive health program.  One program (Prog1) consisted of 1 
injectable clostridial vaccine, 1 intranasal modified live respiratory vaccine, 1 topical and 1 oral 
parasiticide.  The other program (Prog2) consisted of 1 injectable clostridial vaccine, 1 modified 
live respiratory vaccine and 1 injectable parasiticide.  A greater percentage of calves in Prog1 
(59.7%) experienced BRDC morbidity compared to the Prog2 program (47.8%).  There were no 
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differences between programs in mortality, case-fatality, 1
st
 treatment success or chronicity risks.  
The average daily gain over the entire study period for the Prog2 calves (1.23 kg) was greater 
than the Prog1 calves (1.16 kg).  Calves administered Prog1 on average took more steps each day 
during the first 28 days of the study.  Additionally, Prog1 calves spent more time lying down on 
certain days during the last 14 days of the study.  During initial program administration, fewer 
Prog1 calves (39.8%) vocalized compared to Prog2 calves (47.8%).  In this study, calves 
administered a program with fewer injections indicated less aversion to program administration 
than those administered more injections, but experienced greater morbidity and poorer 
performance. 
Introduction 
Bovine respiratory disease complex (BRDC) continues to be the most economically 
important disease in post-weaned calves (Kelly and Janzen, 1986; NAHMS, 2000; Loneragan et 
al., 2001).  The negative economic effects include reduced performance, increased treatment and 
labor expense, and reduced carcass quality (Jim et al., 1993; Griffin, 1997; Snowder, 2006; Duff 
and Galyean, 2007).  This disease complex is believed to be multifactorial with components that 
include viruses, bacteria, stressors, environment and genetics (Edwards, 1996; Snowder et al., 
2005; Berghaus et al., 2006).  Primarily due to the complex nature of this disease complex, 
BRDC  has been shown to be increasing in frequency despite the creation of new immunization 
and metaphylaxis regimes (Loneragan, 2004).  One challenge for controlling BRDC is the few 
objective  clinical disease  recognition measures that exist (Hanzlicek et al., 2009).  Some studies 
have shown that the number of calves treated for BRDC is much lower than the number with 
pulmonary lesions at slaughter (Wittum et al., 1996).  This suggests that inadequacies in BRDC 
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identification exist, and have increased the need to find effective preventive programs, and 
numerous studies investigating the individual components of these control programs have been 
completed.   For example, various vaccine types including modified live and killed products, 
vaccine combinations and timing of vaccine administration, have been investigated as potential 
BRDC control program components (Martin et al., 1983; Van Donkersgoed et al., 1990; Perino 
and Hunsaker, 1997; Vangeel, 2007; White et al., 2008; Wildman et al., 2008).  In addition, 
dietary components such as roughage, concentrate, protein percentage and mineral/vitamin 
concentration have been investigated as possible control program components (Cole and 
Hutcheson, 1990; Gallo and Berg, 1995; Galyean et al., 1999; Salyer et al., 2004; Rivera, 2005). 
The objective of this study was to evaluate potential differences in health, performance 
and behavior between two feeder-calf arrival health programs differing based on products and 
number of injections: one program (Prog1; 1 oral, 1 intra nasal, 1 topical, 1 subcutaneous 
injection) and another program (Prog2; 2 subcutaneous and 1 intramuscular injection).  We 
hypothesized that calves administered the program with fewer injections may behave differently 
and outperform, both in health and performance, calves administered a more invasive program.  
This research is unique as it compares overall preventive health programs (including products 
and methods of administration) with respect to health, performance and behavioral outcomes. 
Materials and methods 
This experimental protocol was approved by the Kansas State University Animal Care and Use 
Committee. (Protocol #2571). 
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Animals 
This study was completed in two replicates using crossbred beef calves.  Calves were 
procured in the Southeast United States (Tennessee and Kentucky) through livestock order-
buyers, and transported (average distance 1223 kilometers) to the Kansas State University 
Stocker Unit (KSBSU), Manhattan, Kansas.  Each replicate consisted of three truckloads of 
cattle where one load of approximately 100 calves arrived each day for 3 consecutive days.  Each 
truckload was housed in a separate string consisting of 8 adjacent dry-lot pens. 
Preventive health programs 
All products contained in the health programs are commercially available and were 
administered according to labeled instructions. The minimally invasive program, hereafter 
referred to as Prog1, consisted of intranasal modified live vaccine including bovine viral diarrhea 
virus Type I and II, parainfluenza 3 virus, bovine respiratory syncytial virus, and infectious 
bovine rhinotracheitis virus, (Onset 5 IN
®
, Intervet/Schering Plough Animal Health, DeSoto, 
KS); an injectable clostridium bacterin, containing Clostridium chauvoei, Clostridium septicum, 
Clostridium novyii, Clostridium sordellii, Clostridium perfringens B, C & D (Vision 7® 
Intervet/Schering Plough Animal Health, DeSoto, KS); oral fendbendazole endo-parasiticide 
(Safeguard
®
 Intervet/Schering Plough Animal Health, DeSoto, KS) and a topical avermectin 
endo-ectoparasiticide (Ivomec Pour-On
®
, Merial, Duluth, GA) (Table 1).  The more invasive 
program, hereafter referred to as (Prog2), consisted of an injectable modified live vaccine 
including bovine viral diarrhea virus, parainfluenza 3 virus, bovine respiratory syncytial virus, 
and infectious bovine rhinotracheitis virus (Bovishield Gold 5
®
, Pfizer Animal Health, New 
York, NY); an injectable clostridium bacterin containing Clostridium chauvoei, Clostridium 
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septicum, Clostridium novyii, Clostridium sordellii, Clostridium perfringens C & D (Ultrabac 7
® 
Pfizer Animal Health, New York, NY) and an injectable doramectin endo- ectoparasiticide 
(Dectomax Injectable
®
 Pfizer Animal Health, New York, NY, (Table 1).  In addition on study 
day 28,  the Prog1 calves were administered the same clostridium vaccine as on arrival (study 
day 0), and the MOR calves were administered an injectable modified live vaccine containing 
bovine respiratory syncytial virus (BRSV) (Bovishield BRSV
®
, Pfizer Animal Health, New 
York, NY) and the same clostridium vaccine as they received on arrival.  The clostridium 
vaccines for both program groups and the BRSV vaccine for the Prog2 group were re-
administered as recommended by the vaccine product label.   
Preventive health program allocation 
Upon arrival to the study facility (study day 0), calves were individually weighed, 
determined to be a bull or steer, and given a unique ear-tag identifier. Calves were assigned pens 
using a random number generator in a commercially available software program (Excel
®
, 
Microsoft Corporation, Redmond, WA), and pens were balanced for weight and gender.  All pen 
assignments were done within load resulting in eight pens per load (24 pens in each replicate).  A 
coin flip at every other pen was used to allocate the preventive health program (Prog1 or Prog2); 
the coin indicated the program for the first pen with the subsequent pen receiving the alternate 
program.  Thus, one half the pens within each load were assigned to each program.  Four 
adjacent pens from a single load in each replicate (2 pens of each program) were selected to 
participate in the behavior monitoring portion of the study. The random number generator was 
used to assign calves in the behavior monitoring pens to wear both an accelerometer and 
pedometer (n=32 each replicate), or pedometer only (replicate 1, n= 20 and replicate 2, n= 21)   
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Equal numbers of accelerometer/pedometer and pedometer only calves were contained in each 
program group.  These numbers were chosen pre-trial considering the number of accelerometers 
that were available. 
Preventive health program administration 
The day after arrival (study day 0), calves in each load were administered their assigned 
program, administered metaphylaxis, ear tissue sampled and bulls were surgically castrated 
without the use of anesthesia.  Program details are listed in Table 1.  Programs were administered 
to all calves by the same individual according to labeled directions.  Modified live viral vaccines 
were administered either intranasally as a single dose (2ml) in the left nostril or intramuscularly 
(2ml) in the right cervical region for the Prog1 and Prog2 programs, respectively.  Clostridial 
vaccines were given subcutaneously in the left cervical region, to calves in Prog1 (2ml) and 
Prog2 (5ml) programs.  The Prog1 calves received both a topical (500 mcg/kg BW) and oral (5 
mg/kg BW) parasiticide.  Calves in the Prog2 program received a subcutaneous parasiticide (200 
mcg/kg BW).  Castrations for all calves were performed by the same experienced veterinarian 
using a Newberry knife (Jorgensen Lab, Loveland, Colorado) and White’s Double Crush 
emasculator (Jorgensen Lab, Loveland, Colorado).  All calves were given ceftiofur crystalline 
free acid (Excede
®
, Pfizer Animal Health, New York, New York) subcutaneously in the base of 
the right ear, with the dosage (6.6 mg/kg BW) calculated on average load weight.  Biopsies were 
collected from the right ear of each calf for bovine viral diarrhea virus antigen capture ELISA 
analysis.  Twenty-eight days after arrival, calves in both programs were re-vaccinated with 
clostridial vaccines, and Prog2 calves were also administered a modified live BRSV vaccine 
(Table 1). 
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Feeding program 
All ingredients are reported on a dry matter basis.  The arrival diet consisted of prairie 
hay containing 7.0% crude protein and 0.44 mcal/kg net energy gain (NEg) and ad libitum water.  
Beginning two days after arrival, the calves were fed  a total mixed ration (TMR) consisting of 
mixed grass hay, alfalfa hay, dry rolled corn, wet corn gluten feed, and a commercial premix 
pellet (Cargill Animal Nutrition, Minneapolis, Minnesota).  This ration was formulated to 
contain 15.2% crude protein and 1.09 mcal/kg NEg.  Beginning on post-arrival day 8 and 
continuing through day 18, calves were fed a TMR incorporating the same ingredients as above, 
but containing 15.2% crude protein and 1.14 mcal/kg NEg.  On day 19 and continuing through 
the study endpoint, calves were fed a TMR utilizing the same ingredients formulated to contain 
14.4% crude protein and 1.20 mcal/kg NEg.  Feed bunks were observed and scored twice daily, 
and the amount of feed not consumed was used as a basis for the amount delivered at the next 
feeding. 
Vocalization and chute exit score 
A single non-blinded evaluator determined whether each calf vocalized or not during 
program administration, including vaccine and parasiticides.  This determination was completed 
before metaphylaxis or castration processes were initiated, and any vocalization was considered 
a positive.  Additionally, each calf was assessed a chute exit score (1 walk, 2 trot, 3 run, 4 jump) 
after program administration by the same non-blinded individual. (Grandin, 1998) 
Health monitoring 
Calves were observed for health status twice a day by animal care givers employed by the 
production unit (KSBSU).  The care givers were blinded to the preventive health program 
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allocation of each pen.  Calves with clinical illness score (CIS) greater than 1 (1 normal; 2 mild 
depression, gaunt; 3 severe depression, labored breathing, ocular/nasal discharge;  4 moribund, 
near death, little response to human approach) were taken to the working facility for physical 
examination.  Animals with a CIS greater than 1 and a rectal temperature ≥ 40C and not 
presenting of signs indicating non-respiratory disease were given antibiotics according to the 
production unit’s standard operating procedure. The regimen for BRDC treatment was: first 
illness, florfenicol (Nuflor®) 40mg/kg; second illness, enrofloxacin (Baytril®) 10mg/kg, and 
third illness oxytetracycline (Biomycin® 200) 4 mg/kg.  In both replicates combined, ten total 
calves were treated for diseases other than respiratory disease, (n= 4 for scrotal infection, n = 2 
for lameness, n = 2 for diarrhea and n =2 for keratoconjunctivitis). No hospital pen was used in 
this study; all calves were returned to their original pen after physical examination and 
medication.  Calves observed to be ill, examined and administered antibiotics for the third time 
were designated as chronic and were not medicated again.  Health outcomes of interest included 
morbidity, first treatment success, chronicity, case-fatality, and mortality. (Table 2) 
Production parameters 
Calves were individually weighed on three occasions: arrival (day -1), revaccination (day 
28) and study completion (approximately day 42).  Average daily gain (ADG), was calculated 
for three time periods: arrival to day 28, day 28 to study completion, and from arrival to study 
completion.  These 3 time periods will be hereafter be known as arrival, revaccination, and entire 
study period, respectively.  Total as-fed feed delivered to each pen was recorded and used as a 
proxy for feed intake and to calculate pen-level feed to gain ratios from arrival to study 
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completion.  All production parameters, except feed delivered, were analyzed with mortalities 
removed from the data set and are defined in Table 2. 
Behavioral assessment 
Behavior was monitored for all calves within designated pens using pedometers and 
accelerometers.  The pedometers and accelerometers were applied to the right distal metatarsus 
using a padded self-adhesive neoprene strap.  The entire apparatus, including pedometer, 
accelerometer and batteries, weighed approximately 0.5 kg.  All calves within the behavior 
assessment pens were taken to the working facility once a week to download accelerometer and 
pedometer data.  Because of the time the calves spent away from their pens during the data 
download days, these data were removed from the data analysis.  Data were analyzed for two 
time periods:  1) arrival processing through study-day 13 and 2) revaccination (day 28) to study 
completion.  These 2 time periods will be referred to as ARR and REVAC, respectively, 
throughout the manuscript. 
Postural assessment (percent time spent standing and lying down) was completed using 
accelerometers (GP1 Programmable Accelerometer, Sensr, Elkader, Iowa).  The accelerometer 
recorded five variables at 100 readings per second: average acceleration in three axis (X, Y, Z), 
vector magnitude average, and vector magnitude maximum.  A commercial software program 
(Sensware, Sensr, Elkader, Iowa) was used to average the readings over a 5 second time period.  
The total time spent each day lying down or standing was calculated using a pre-established 
algorithm. (Robert et al., 2009)  Pedometers (NL-800 Activity Monitor, New Lifestyles, Lee’s 
Summit, Missouri) were used to measure total steps taken in a 24 hour period. 
58 
 
Statistical analysis 
Data were analyzed with a commercial software program (SAS v. 9.1). Logistic 
regression (generalized linear mixed) models were used to analyze vocalization, and health 
outcome data.  Vocalization models included chute-exit-score as a fixed effect to control for 
possible confounding (Dohoo et al., 2003).  Random effects in the logistic models evaluating 
potential associations between preventative health program and health outcomes included 
replicate, truckload within replicate and pen within truckload to account for lack of independence 
among calves (Dohoo et al., 2003).  General linear mixed models were used to evaluate potential 
associations between the preventative health programs and pen-level ADG, ratio of kilograms of 
feed fed to kilograms of weight gain, and kilograms of feed delivered.  Random effects in these 
models included, replicate, truckload and truckload within replicate.  For the cattle which had 
behavioral measures, only data from calves not becoming morbid during any portion of the trial 
were used in the analyses.  General linear mixed models were used to evaluate potential 
associations between health program and the total number of steps taken in a 24 hour period 
(pedometer), the study day relative to arrival or revaccination, and the potential interaction 
between step counts and study day; castration data were evaluated in this analysis as a potential 
confounder.  Each model accounted for repeated measurements on calf and the lack of 
independence between calves within pen and replicate (Dohoo et al., 2003).  Mixed effects 
logistic regression was used to evaluate associations between health programs and the effects of 
the daily percent of time spent lying (determined by accelerometers), castration, study day 
relative to arrival or revaccination, and the potential interaction between percent of time lying 
and study day.  The two time periods (13 days post-arrival and 14 days post-revaccination) were 
modeled separately and each model included adjustments for repeated measurements on calves 
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and random effects for pen and replicate. A P value of ≤ 0.05 was considered significant for all 
models. 
Results 
Study subjects 
The study population for both replicates combined consisted of 308 calves in Prog1 and 
305 in Prog2. The breakdown of calves within program by replicate was Prog1 154 and 154 and 
Prog2 152 and 153 for replicate 1 and 2, respectively.  Mean arrival weights were 207.9 kg and 
208.0 kg for Prog1 and Prog2 groups, respectively.  By program group within replicate 1 the 
arrival weights were 207.2 kg (Prog1) and 207.5 kg (Prog2) and for replicate two,  208.7 kg 
(Prog1) and 208.6 kg (Prog2).  The Prog1 group contained 65% bulls (202/308), 100 in the first 
replicate and 102 in the second replicate, and the Prog2 group contained 66% bulls (202/305), 
101 in the first replicate and 101 in the second replicate.  One calf in each replicate, both Prog2  
calves, was positive for BVDV persistent infection by antigen capture ELISA.  These calves 
were removed from the study and study site on day 2 and 7, for replicate 1 and 2, respectively. 
 Health 
Morbidity in replicate 1 was 65.5% (101/154) for Prog1 and 47.8% (84/152) for Prog2.  
In replicate 2 morbidity was 53.8% (83/154) and 40.5% (62/153) for Prog1 and Prog2, 
respectively.  Mortality for replicate 1 was 2.6% (4/154) and 3.2% (5/152) for Prog1 and Prog2, 
respectively.  Replicate 2 mortality was 4.5% (7/154) for Prog1 and 0.6% (1/53) for Prog2.  Case 
fatality for replicate 1 was Prog1: 3.9% (4/101) and Prog2: 5.9% (5/84).  For replicate 2 case 
fatality was 8.4% (7/83) and 1.6% (1/62), for Prog1 and Prog2, respectively. 
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There was no significant interaction between preventive health program and replicate; 
therefore, data from the replicates were combined for final analysis.  Morbidity for Prog1 was 
59.7% (184/308) and 47.8% (146/305) for Prog2. The percentage of all morbidity that occurred 
during the first 28 study days was 92.7% (306/330).   The percentage of mortal Prog1 program 
calves was 3.5% (11/308) and 1.9% (6/305) for Prog2 program calves. Case fatality for the 
Prog1 group was 5.9% (11/184) and for the Prog2 group 4.1% (6/146).  The percentage of calves 
defined as chronic was 16.8% (31/184) and 11.6% (17/146) for Prog1 and Prog2, respectively. 
First treatment success for Prog1 was 60.9% (72/184) and for Prog2 was 64.4% (52/146).  The 
multivariable model indicated that morbidity was lower (p =0.02) in Prog2 (47.8%) calves 
compared to Prog1 (59.7%). (Table 3) There were no significant differences between groups in 
first treatment success, chronicity, case fatality and mortality. (Table 3) 
Performance 
The ADG for ARR was 1.24 kg/day and 1.33 kg/day for Prog1 and Prog2, respectively.  
For REVAC the ADG for Prog1 was 0.98 kg/day and Prog2 was 1.03 kg/day. From arrival to 
study completion (ENTIRE) was 1.16 kg/day for Prog1 and 1.23 kg/day for Prog2. Average 
daily gain (kg/day), for ARR period was greater (p = 0.05) in Prog2 compared to Prog1. (Table 
4)  Average daily gain for the revaccination period was not different between programs.  For the 
period from arrival to study completion, average daily gain was greater for Prog2 (1.23 kg) 
compared to Prog1 (1.16 kg) (P = 0.04).  No differences were found in feed to gain ratio or feed 
delivered between programs.  Unadjusted feed to gain ratio was 3.32 kg/kg and 3.13 kg/kg for 
Prog1 and Prog2, respectively.  Feed delivered for Prog1 was 87.60 kg and 90.57 kg for Prog2  
(Table 4). 
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Behavior 
Pedometer data from 4 calves in replicate 1 for the ARR period, and 1 calf in replicate 1 
and 4 calves in replicate 2, for the REVAC period, were not used for analysis due to pedometer 
malfunction.  As previously mentioned, data from data downloading days (7, 14, 42) were 
removed from the analysis.  No interaction between program and study day or replicate was 
found for either time period.  Model estimated mean steps taken per 24 hour period during the 
ARR period, tended to be greater (p=0.07) for the Prog1 calves (2620) compared to the Prog2 
calves (2449).  There was no difference between mean steps taken during the REVAC period. 
For combined replicates, 64 calves wore accelerometers (n=32 in each replicate).  Data 
from calves wearing accelerometers that became morbid (Prog1: n=15, Prog2: n=18) during any 
portion of the study were removed from behavior analysis. Additionally, data from 2 calves 
within each program for the REVAC period were removed from the analysis due to 
accelerometer malfunction and incomplete data capture. For the first replicate 9 Prog1 and Prog2 
calves, and for second replicate 9 Prog1 and 9 Prog2 calves were included in the analysis.   
For the percentage of time spent lying down, a program by study-day interaction was 
found for both time periods examined: ARR (Figure 1) and REVAC (Figure 2). The Prog2 
program calves did spend more time lying down on days 32 and 34 compared to the Prog1 
calves. (Figure 2).  Figure 1 shows that the Prog2 calves spent more time lying down during the 
early study days within the ARR period, but lying down behavior for the programs became 
similar later in this period.  During the REVAC period, a similar pattern with Prog2 calves lying 
down more was observed until day 34, when the Prog2 calves time spent lying down decreased 
and the Prog1 group time spent lying down increased. (Figure 2) 
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Vocalization 
The percentage of calves vocalizing at initial program administration was less (P=0.05) 
in Prog1 (39.8%) compared to Prog2 (47.8%).  An association between exit score and the 
probability of vocalizing was found (P<0.01).  The percentage of calves vocalizing decreased as 
each exit score decreased from 1 to 3.  The percentage of calves that vocalized were 63.0% (CI 
52.8, 72.2), 52.2% (CI 42.7, 61.5) and 34.4% (CI 25.2, 44.8) for exit score 1, 2, and 3 
respectively. No difference in vocalization was found between exit score 3 and 4, 27.4% (CI 
17.2, 40.8). 
Discussion 
Calves entering feeder-calf production units are normally administered a combination of 
preventive health products comprised primarily of vaccines and parasiticide combinations. 
Although combinations of products are routinely administered, most research studies concentrate 
on comparing the efficacy of individual products.  Our study is unique because two combinations 
of products were compared, which we have designated ―programs‖.  Because we compared 
programs, the determination of which particular product(s) contributed to the health, 
performance, and behavioral differences identified in the current research is impossible to 
determine.   
The percentage of calves vocalizing during initial program administration was higher in 
Prog2 program calves compared to Prog1 calves.  The results from our study are similar to a 
study investigating aversion to injections between calves that were blinded or not-blinded to the 
presence of humans administering the treatments (Mitchell et al., 2004).   This study concluded 
the injection process is responsible for the aversion demonstrated by the calves and not the mere 
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presence of, or handling by, humans.  Other research has indicated that procedures involving the 
head and ears, such as ear tagging and metaphylaxis administration, result in more frequent 
vocalization compared to procedures involving only the cervical region (Grandin, 1998).  In our 
study, administration of the Prog1 program did require head manipulation for intranasal vaccine 
application, but not ear manipulation (vocalization assessment occurred before metaphylaxis was 
initiated), which may help explain the difference between the two studies. 
Neither program appeared to effectively prevent BRDC, but we did not have a negative 
control group and the level of morbidity was similar to that reported in other beef feeder cattle 
studies (Sowell et al., 1999; Richeson et al., 2008).  Other researchers have observed differences 
in BRDC incidence between vaccination combinations (Wildman et al., 2008).  The Prog1 
program calves did experience more BRDC morbidity compared to Prog2 calves.  Both 
programs contained vaccines and parasiticides that targeted the same organisms, but differences 
in route, dosage, and vaccine strains were present.  Bovine viral diarrhea virus (BVDV) vaccine 
strains for Prog1 were Type I: Singer, Type II :125A and for Prog2 were Type I: NADL, Type II 
: 53637 (Ridpath, 2005).  Cross reactivity between vaccine and field strains is an important 
consideration in vaccine selection (Ridpath, 2005).  In our study, a BVDV persistently infected 
animal was found in each of two replicates, and transiently BVDV infected animals may have 
also been present.   Although we did not attempt to isolate and characterize strains, it is possible 
that any BVDV field strains that may have been present were more genomically similar to the 
strains contained in the Prog2 vaccine and therefore more effective vaccine protection occurred.  
A difference also existed in the mode of viral vaccine delivery with the Prog1 calves receiving an 
intranasal vaccine and the Prog2 calves an intramuscular vaccine.  Shewen et al. suggest that 
antibodies to some pathogens produced by mucosal delivered vaccines are transient and do not 
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persist on the mucosal surface without constant antigenic stimulation (Shewen P. E. , 2009).  
Some calves in the Prog1 group may not have been able to maintain long-term mucosal 
immunity sufficiently to prevent infection. 
The parasiticide agents and route of administration also differed between programs, and 
this may have contributed to the morbidity differences. Internal parasites may negatively impact 
an animal’s ability to mount immune responses to bacterial infections, and studies in mice have 
demonstrated a negative impact on vaccine efficacy (Mulcahy et al., 2007; Urban et al., 2007).  
Although previously published information has shown the products used in both programs to be 
effective in reducing internal parasite populations, parasiticide efficacy in the present study was 
not evaluated (MacGregor et al., 2001; Reinhardt et al., 2006; Ives et al., 2007).  Differences in 
efficacy of parasiticides between programs may have contributed to our findings.     
Although a greater percentage of Prog1 calves became morbid from BRDC compared to 
Prog2 calves, treatment success outcomes (case fatality, first treatment success, chronicity) did 
not differ between groups.  This suggests the BRDC episodes in the Prog1 group, although more 
common, were not more severe than those experienced by the Prog2 group. 
Calves in the Prog1 program had lower ADG compared to Prog2 calves during the arrival 
period and over the entire study period.  This is not surprising given a greater percentage of 
Prog1calves became clinically ill during the trial, and our results are similar to other studies 
showing BRDC’s negative effect on ADG (Gardner et al., 1999; Waggoner et al., 2007).  
Although there was a difference between preventive health programs in ADG over the entire 
study period, there was no difference during the revaccination period.  Most initial BRDC 
episodes, and program morbidity differences, occurred during the first 28 study-days (arrival 
time period), and it would be expected that ADG would be impacted more during this time 
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period relative to the last 14 study days when morbidity was relatively low.  The difference in 
ADG between Prog2 and Prog1 over the entire study contrasts with no difference found for both 
feed intake and feed to gain ratio over the same time period.  In a different study, dry matter to 
gain ratio was less for morbid calves compared to non-morbid calves during the first 28 day 
study period (Jim et al., 1993).  This discrepancy may be explained by pen size and health-
observation intensity.  In our study, the pen population was low (11-14 calves) possibly resulting 
in early BRDC recognition and treatment, which may allow morbid calves’ feed intakes to return 
to normal levels early in the course of disease.  Feed conversion results from our study differ 
with Chirase et al. who showed that calves subcutaneously vaccinated with Vision 7
®
 had lower 
feed to gain ratio during the first 28 days after arrival to a feedlot compared to calves 
subcutaneously vaccinated with Ultrabac 7
®
 (Chiras, 2001).  In their study morbidity levels were 
not reported, and no other health products were administered.  In our study, morbidity was 
greater in calves in the program that contained Vision 7
® 
which may have reduced any feed 
conversion differences that may have existed because of clostridial vaccines.  Additionally, 
because our study compared total health programs and not a single vaccine, other program 
components may have affected the impact of the Clostridium vaccines in a manner differently 
than was observed in the Chirase study. 
Calves administered the more invasive program (Prog2), tended to take fewer steps 
during the ARRIV period.  Because we assessed behavior only in non-morbid calves, this 
difference is not likely due to the difference in morbidity between groups.  Our vocalization 
results indicated that the Prog2 program was more objectionable, through greater vocalization, 
and this aversion may have carried over as fewer steps taken into the early portion of the study.  
The difference in steps may have been an indication of covert lethargy or malaise from the 
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multiple invasive products given on arrival.  Because more Prog1 calves experienced morbidity, 
it is likely more human activity occurred within the Prog1 pens (additional human activity to 
remove morbid calves from the pen for treatment).  Therefore, it is possible that the Prog2 calves 
did not take fewer steps than expected, but instead the Prog1 calves took more steps due to the 
additional human activity.  This theory is supported by the evidence that no difference in step 
counts between programs was observed in the REVAC period, when morbidity in both groups 
was relatively low.  Alternatively, the low number of injections (1 or 2) received by each group 
at revaccination did not elicit a large enough behavioral response to be demonstrated using 
pedometer data. 
A program by study-day interaction for time spent lying down each day was observed in 
both time periods (ARRIV and REVAC) evaluated in our study.  In the ARRIV period, there was 
separation between the estimated time lying on days 3 through 5 post-arrival with the Prog2 
calves spending a numerically higher amount of time lying.  The Prog1 group experienced more 
morbidity; therefore, this discrepancy may be explained by a larger number of sub-clinical 
BRDC cases occurring in the Prog1 group during this time period or additional human 
interaction as mentioned above.  The subclinical theory is substantiated by the results from a 
study where induced Mannheimia pneumonia calves spent less time lying down per day after 
disease onset (Hanzlicek et al., 2009).  Evaluation of 14 days following revaccination (day 28) 
revealed that calves in the Prog2 program spent more time lying down on days 5 and 7 post-
revaccination compared to Prog1 calves. The effect appeared to be transient and no differences 
were identified after 8 days post-revaccination.  Lying behavior in the Prog2 calves may have 
been due to a transient lethargic response to the higher dose clostridium vaccine and / or the 
MLV BRSV vaccine. Apley, et al. showed an increase in post-vaccination subcutaneous lesion 
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size when comparing 2ml and 5ml clostridium vaccines (Apley M, 1994).  If lesion size is an 
indication of inflammatory response, it is possible the Prog2 calves were indicating, by spending 
more time recumbent, the greater inflammation response to the 5cc dose clostridium vaccination.  
The BRSV vaccine may have also played a role in this behavioral response, but previous 
research did not demonstrate behavioral changes (depression) post-BRSV vaccination (Patel J, 
2004).  However, our study used an objective measure of behavior that may have detected 
smaller behavioral differences than could be identified through subjective measures. 
Conclusion 
To the authors’ knowledge this is the first controlled study comparing two complete 
feeder-calf health programs and demonstrating differences in some health, production, and 
behavior outcomes between programs.  Fewer calves in the Prog1 program vocalized during 
initial program administration suggesting programs that incorporate primarily non-injectable 
products into preventive health regimes are less aversive to calves.  Calves in the Prog1 program 
experienced higher morbidity and lower average daily gain during the early portion of the study 
and over the entire study period.  Calves administered the (Prog1) program tended to take more 
steps during the early portion of the study.  On days after revaccination, the calves administered 
the more invasive program (Prog2) spent more time lying down.  Future research using 
objective, constant postural monitoring technology, such as accelerometers and pedometers, is 
needed to gain understanding into calf behavior.  Because we compared complete health 
programs, it is impossible to say which product(s) within each program were responsible for the 
outcome differences.  Because these programs typically contain several components, our study 
also illustrates the challenges in designing and evaluating new feeder calf health programs, and 
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the value in utilizing objective measures to evaluate calf behavior as it is affected by these 
programs. 
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Table 2-1 Animal health products, by program and study period, used in a study to 
compare health, performance and behavior between crossbred beef calves 
Arrival 
Program 
Clostridial Respiratory/Viral Parasiticides 
Product Dose/route Product Dose/route Product Dose/route 
Prog1
a
 Vision
®
 7
c
 2ml/SQ Onset 5IM
®c
 2ml/IN 
IvomecPouron
®d
 + 
Safeguard
®c
 
25ml/topica
l 
11 ml/oral 
Prog2
b
 Ultrabac
®
 7
e
 5ml/SQ 
Bovishield
®
 Gold 
5
e
 
2ml/IM 
Dectomax
®
 
injectable
e
 
25ml/SQ 
Revaccination 
Program 
Clostridial Respiratory/Viral Parasiticides 
Product 
Dose/rout
e 
Product Dose/route  
Prog1
a
 Vision
®
 7
c
 2ml/SQ None -- None 
Prog2
b
 Ultrabac
®
 7
e
 5ml/SQ Bovishield
®
 BRSV
e
 2ml/IM None 
 
a
 Prog1= minimally invasive program containing 1 injectable component at both arrival and 
revaccination 
b
 Prog2= more invasive program containing 3 injectable components on arrival and 2 injectable 
components at revaccination 
c
Intervet/Schering Plough Animal Health, Omaha, NE 
d
Merial, Duluth, GA 
e
Pfizer Animal Health, New York, NY 
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Table 2-2 Definition of pen-level health and performance variables used in comparing two 
preventive health programs for crossbred beef feeder calves 
Variable Definition 
Morbidity 
number of 1st BRDC
a
 treatments in each pen  ÷  number of animals 
allocated to each pen 
Mortality 
number of  BRDC mortalities in each pen   ÷ number of animals 
allocated to each pen 
Case fatality 
number of  BRDC mortalities that occurred in calves previously 
designated as BRDC morbid in each pen  ÷ number of calves with first 
treatments occurring in each pen 
Chronicity 
number animals treated 3 times  ÷ number of animals allocated to each 
pen 
1
st
 Treatment Success 
1-(number of calves treated for the 2
nd
 time ÷ number of calves treated 1 
time) occurring in each pen 
Average daily gain (arrival) 
(total weight at day 28 - total arrival weight (day ) for all animals that 
survived to closeout)  ÷  28 (days)  
Average daily gain 
(revaccination) 
(total weight at study completion - total weight of all animals that were 
alive on day 28)  ÷  total days  post-day 28  
Average daily gain (study) 
(total weight at arrival for all calves that were alive at study completion - 
total arrival weight of all animals)  ÷ total number of  days  
Feed intake to gain ratio (pen 
level) 
total feed (as-fed) delivered ÷ (total closeout weight – total arrival weight 
of survivors) 
Feed delivered (per pen/day) 
total feed (as-fed) delivered ÷ number of animals allocated to each 
treatment 
a
BRDC = bovine respiratory disease complex 
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Table 2-3  Model
a
 adjusted percentages, standard errors, and P-values of health outcomes 
in combined replicates comparing two crossbred beef feeder-calf preventive health 
programs 
Health Outcomes Program
b
 
P value 
 
Prog1 Prog2 
Morbidity 60.0% (7.0)
c 
47.8% (7.3) 0.02 
Mortality 1.5% (1.3) 0.8% (0.7) 0.25 
Case fatality 2.7% (2.2) 1.9% (1.7) 0.53 
Chronic 15.0% (4.0) 10.7% (3.4) 0.24 
1
st
 Treatment Success 60.9% (5.3) 64.4% (5.4) 0.58 
 
a
Model included replicate, load and pen as random effects 
b
 Prog1 = 1 injectable clostridial vaccine, 1 intra nasal modified live respiratory vaccine, 
1 topical parasiticide, 1 oral parasticide: Prog2 = 1 injectable clostridial vaccine, 1 
injectable modified live respiratory vaccine, 1 injectable parasiticide 
c
 number experiencing health outcome / number at risk (SE) 
 
 
76 
 
Table 2-4 Model
a
 adjusted average daily gain (ADG) and P-values in combined replicates 
comparing two crossbred beef feeder-calf preventive health programs 
Performance Outcome 
Program
b
  
Prog1 Prog2 P value 
ADG: arrival to revaccination (ARR) 1.24 (0.06)
c
 1.33 (0.06) 0.04 
ADG: revaccination to study completion 
(REVAC) 0.98 (0.05) 1.03 (0.05) 0.46 
ADG: arrival to study completion (ENTIRE) 
1.16 (0.04) 1.23 (0.04) 0.04 
Feed to gain ratio (kg) 3.32 (0.62)
d
 3.13 (0.62) 0.72 
Feed delivered (kg) 87.60 (1.54)
e
 90.57 (1.54) 0.17 
 
a
Model included load, replicate as random effects 
b
 Prog1 = 1 injectable clostridial vaccine, 1 intra nasal modified live respiratory vaccine, 
1 topical parasiticide, 1 oral parasticide: Prog2 = 1 injectable clostridial vaccine, 1 
injectable modified live respiratory vaccine, 1 injectable parasiticide 
c
 kg/day (SE) 
d
Feed delivered/ADG (SE) 
e
Feed delivered per pen (SE) 
77 
 
Figure 2-1    Model
 
adjusted
a
 mean percentage of time spent lying down for the minimally 
invasive program (Prog1) and more invasive program (Prog2) preventive health programs 
for the first 13 days of the study. Prog1 contained 1 injectable vaccination and Prog2 
contained 2 injectable vaccines and 1 injectable parasiticide.   
  
 
a
Model contained gender, program, studyday, and interactions terms for program by study-day 
and gender by study-day, and accounted for repeated measurements on calves and random 
effects of pen (n= )and study replicate (n = 2).  
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Figure 2-2    Model
 
adjusted
a
 mean percentage of time spent lying down for the minimally 
invasive program (Prog1) and more invasive program (Prog2) preventive health programs 
from study 28 to study completion.  Prog1 contained 1 injectable vaccination and Prog2 
contained 2 injectable vaccines and 1 injectable parasiticide.    
 
 
 
a
Model contained gender, program, studyday, and interactions terms for program by study-day 
and gender by study-day, and accounted for repeated measurements on calves and random 
effects of pen (n= )and study replicate (n = 2).  
*Differences at the p =0.05 level for % time lying down by program and study-day.
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Abstract 
Bovine respiratory disease complex (BRDC) continues to plague the U.S. beef industry.  
One of the difficulties in managing this disease is the unavailability of sensitive BRDC 
recognition tools. Our goal was to determine the utility of physiologic, behavioral and 
pathological changes as objective indicators of early respiratory disease in crossbred beef calves 
with Mannheimia haemolytica pneumonia.  The disease was experimentally induced in clinically 
healthy calves through endoscopic pulmonary inoculation of Mannheimia haemolytica. Calves 
were necropsied on days 1, 2,3,4,7, and 9 after inoculation.  Physical examination (temperature, 
pulse, and respiration), clinical illness score, activity level and respiratory character were 
assessed three times daily beginning 4 days prior to challenge and continued throughout the 
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study.  Twice before inoculation and on days 1, 2, 3, 5, 7, and 9, arterial blood gas, blood 
chemistry and complete blood counts were assessed.  Pedometers and accelerometers were used 
to monitor cattle behavior and activity throughout the trial.  All calves became clinically ill after 
challenge and exhibited gross and histopathological signs of bronchopneumonia.  No parameter 
was a reliable indicator of disease progression as judged by percent pulmonary involvement.  
However, activity as measured by total steps taken in a 24 hour period did accurately identify 
changes in health status. This single pathogen challenge model successfully produced clinical 
signs and pathology consistent with field respiratory disease.  Routine laboratory parameters and 
subjective measures were not reliable indicators of progression of pneumonia.  However activity, 
objectively measured with pedometers and accelerometers, appears to be a promising tool for 
early recognition of bovine respiratory disease.  
Introduction 
Bovine respiratory disease complex (BRDC) is the most common and costly health 
problem in beef cattle today (Loneragan et al., 2001; Snowder et al., 2007).  By some accounts, 
feedlot deaths associated with BRDC are increasing (Loneragan et al., 2001; Thompson et al., 
2006; Snowder et al., 2007).  Economic losses associated with BRDC primarily occur during the 
feeding phase and include lower average daily gain, decreased carcass quality and increased days 
on feed (Wittum et al., 1996; Gardner et al., 1999).  If prevention and treatment costs are 
included, the estimated cost to the United States cattle industry is over $3 billion annually 
(Griffin, 1997).  Additionally, the impact on animal well-being is significant since BRDC is 
clearly the most common cause of morbidity and mortality in post-weaned beef cattle 
(Longeragan et al., 2001; Griffin, 1997).   
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BRDC is a multifactorial disease impacted by both pre- and post-weaning factors (Duff 
and Galyean, 2006).  Some causative agents associated with BRDC are considered to be 
ubiquitous commensal organisms in cattle.  The most commonly isolated organism from BRDC 
affected lungs, Mannheimia haemolytica (MH), is considered commensal in cattle.(Radostits, 
2000).  Successful treatment outcomes require early disease recognition, accurate 
prognostication and application of appropriate therapeutics.  Treatment failures affect animal 
welfare and increase economic losses through decreased performance and increased mortality 
(Terhune Terry N., 2005).  Therefore an accurate and timely diagnosis is critical to allow more 
positive economic and animal welfare decisions to be made.   
Currently, subjective measures such as attitude, appetite and activity level are used to 
determine if calves require further examination or treatment for BRDC (Griffin, 1996).  These 
observations are performed on individual animals; yet commercial beef production systems 
manage cattle in populations or herds.  Since herd animals tend to mask clinical signs, overt 
signs of illness are often absent early in the disease process.   
Objective measures to identify early clinical stages of BRDC currently do not exist.   
Improvements in diagnosis could be made through identification of repeatable, accurate 
measures associated with early stages of BRDC. We hypothesized changes in hematologic, 
behavioral, and physical exam parameters would be helpful for diagnosis and monitoring of 
BRDC.  The purpose of this study was to evaluate changes in physiological, pathological and 
behavioral variables in beef calves at multiple time points following inoculation with MH.   
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Materials and methods 
 This study was approved by the Kansas State University Institutional Animal Care and 
Use Committee.   
Calves 
Calves (n=14) were selected from a population of 34 crossbred beef steers that 
participated in a previous 14 day observational trial during which calves were observed for 
clinical signs of BRD.  Calves were observed for clinical illness for a total of 21 days prior to 
experimental MH inoculation.  All calves were tested for bovine viral diarrhea persistent 
infection by antigen capture ELISA.
a
  Additionally, a serum sample was collected from each calf 
to determine relative MH antibody  levels.  Nine calves of the initial 34 were not eligible for the 
study for the following reasons: 3 participated in another study, 1 poor temperament, 1 missing 
MH serology sample, 3 respiratory disease, and 1 with keratoconjunctivitis.  The seven 
remaining calves with the highest MH optical density readings were eliminated from the 
potential study population to reduce challenge response variability.  On day 0, four calves were 
removed pre-challenge and replaced by 4 other calves for the following reasons: 1 
keratoconjunctivitis and 3 shoulder injuries.  The average weight upon study initiation of the 14 
enrolled calves was 199.2 kg.  Optical MH ELISA antibody density for the study calves ranged 
from 0.137 to 0.571.    Calves were housed in a 150 ft. by 150 ft. dry lot, fed commercial grain 
mix and grass hay and allowed free access to water.   
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Inoculation 
Mannheimia haemolytica serotype A1 (OSU strain) isolated from a field case of BRDC 
was used as the challenge bacterium.  The isolate was grown on brain heart infusion agar (BHI) 
containing 5% bovine blood in a CO2 incubator for 18-22 hours.  Colonies were then suspended 
in BHI broth and incubated at 37 C for 5.5 hours.  Bacteria were pelleted by centrifugation, 
washed 3 times in sterile phosphate buffer saline (PBS) and re-suspended in PBS.  The final 
concentration of approximately 1 X 10
9 
per milliliter
 
was based on a standard curve of colony 
forming units vs. optical density.  Plate counts were used to confirm bacterial concentration.  
Four days after trial initiation, each calf was individually restrained in a portable cattle chute 
without sedation.  The external nasal passage was cleaned and a fiberoptic endoscope
b
 (100cm 
length X 6.6 mm diameter) was passed through the nares into the trachea and then tracheal 
bronchus into the right cranial lung lobe.  Forty-milliliters of the 1 X 10
9
 per milliliter 
concentration of MH inoculant in PBS was injected through a polyethylene tube (160 cm X 1.95 
mm) into the bifurcation followed by a 40 ml PBS flush.   
Pathology 
Calves were randomly assigned to harvest day using a random number generator.
c 
  
Necropsy, lung culture, and histopathology were completed on calves harvested, by captive bolt 
and exsanguination, on days 1, 2,3,5,7 and 9 post-inoculation (Table 1). Percent lung 
involvement was determined by palpation, visual observation and measurement of lesion cubic 
area by a board certified pathologist (DM).  In each lobe the percentage of total lung 
consolidation was calculated using the percent of each lobe determined to be pneumonic and a 
reported formula: (0.53 x left cranial apical%) + (0.049 x left caudal apical lobe%)+ (0.319 x left 
84 
 
diaphragmatic%) + (0.043 x accessory lobe%) + (0.352 x right diaphragmatic%) + (0.061 x right 
middle lobe%) + (0.60 x right caudal apical lobe %) + (0.063 x right cranial apical lobe %).(Fajt 
et al., 2003)  In addition, histopathology and bacterial lung cultures of each set of lungs were 
completed.   
Data collection 
Rectal temperature, heart rate, respiratory rate, breathing type, behavior evaluation, 
activity assessment, and clinical illness scores (CIS) were completed three times daily beginning 
four days prior to inoculation until study completion.  Physical examinations and all other 
assessments were completed by the same experienced veterinarian at each time point.  Breathing 
type was subjectively assessed during restraint using the nominal scale; normal or rapid.  
Activity was recorded as normal (N) or decreased (D).  Clinical illness scores were recorded 
while calves were being walked to the working facility using the scoring system: 1= normal, 2 = 
slightly ill, 3 = moderately ill, 4 = severely ill.   
 Arterial blood gas, blood chemistry, and complete blood counts were conducted daily, 
four days prior to disease induction, on inoculation day and days 1, 2, 3, 5, 7, and 9 post-
challenge.  Blood gas and chemistry analysis were completed using a chute side portable 
analyzer.
d
  Blood gas parameters evaluated included: pH, partial carbon dioxide (PCO2), partial 
oxygen (PO2), base excess (BEecf), bicarbonate (HCO3), total carbon dioxide (TCO2), oxygen 
saturation (SO2) and lactate.  Arterial blood was collected from the medial branch of the caudal 
auricular artery in a non-hepranized syringe and immediately placed into 1.3 ml volume plastic 
lithium heparin tubes
e
 for blood gas analysis.  The time from blood collection to completed 
blood gas analysis was estimated at less than three minutes.  Venous blood was collected from 
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either the jugular or coccygeal vein into 1.3 ml lithium heparin tubes.  These samples were 
analyzed for standard serum biochemistry parameters including: sodium (Na), potassium (K), 
chloride (Cl), hematocrit (HCT), blood urea nitrogen (BUN), and glucose (Glu) analysis.  
Venous blood was collected into a 2 ml EDTA tube
f 
 and complete blood counts were 
completed.
g
 
Animal behavior was continuously measured using accelerometers and pedometers.  Four 
days before inoculation each calf was fitted with an accelerometer
h
 and pedometer
i
 on the right 
distal lateral metatarsus.  These devices were housed in a plastic container and attached to the leg 
with two self-adhesive straps.  Each calf wore the devices until harvest day.  The accelerometer 
measured acceleration (g) in the x, y, and z axes at the rate of 100 times per second.  Commercial 
software
j
 was used to calculate the mean force (g), along with maximum and average vector 
magnitude over each 2 second period of time.  Vector magnitude was calculated 100 times per 
second by Equation 1: 
 (1)    
The vector magnitude average and maximum were calculated based on all vector 
magnitude calculations for each 2 second period of time.  Accelerometers were removed and 
data downloaded on days 0, 1, 2, 3, 5, 7, and 9.  Data was not recorded between the time the 
accelerometers were removed for download and replaced on the metatarsus, (approximately 1 
minute per day).   
Approximately 0.5 hour of video of each calf, in a group setting within the pen, was 
collected over the 9 day trial period.  The video was analyzed and logged by an investigator 
(blinded to accelerometer data) to record animal behaviors as one of three categories: lying 
down, standing in place, or walking.  Video data was used to generate an algorithm to classify 
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accelerometer data in a manner previously reported.(White B. J., 2008)  The combined video and 
accelerometer data were partitioned into training (70%) and test (30%) sets. The training set was 
used to generate a behavior classification algorithm using a classification tree.  The test set was 
run through the classification algorithm and compared to actual video logged values to evaluate 
the accuracy of the classification algorithm by comparing Kappa values for each categorical 
behavior variable.  The classification algorithm was used to assign a predicted behavior for 
accelerometer readings at each time point for each calf.  
 Pedometers recorded the number of steps taken in a 24 hour period (midnight to 
midnight).  These data were collected for each day beginning 4 days before inoculation through 
harvest.     
Statistical analysis 
All data were imported into a statistical program for analysis.
k
 General linear mixed 
models were used to analyze continuous data for blood parameters, pedometers, temperature, 
weight, heart and respiratory rates while accounting for repeated measures on individual calves 
over time.  Fixed effects evaluated included trial day in all models, and examination time 
(morning, noon, or evening) for temperature, heart rate and respiratory rate data.  All 
measurements prior to pneumonia induction were grouped into a single time period (trial day -1) 
and mean values for pre-induction data were considered as the baseline for each calf. If 
significant differences (P<0.05) by trial day were detected, comparisons among days were made 
using model-generated least square mean values and corresponding standard errors (SEM).   
The agreement between video recorded behavior and the algorithm used to classify 
accelerometer data was tested by calculating an overall Kappa value.  The proportion of time 
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standing and lying was modeled using logistic models
m 
 with effects included to account for 
repeated measure on calves and trial day of the experiment.  To determine potential changes in 
behavior patterns over time, the interaction between the percent of time spent in each behavior 
was also tested relative to trial day. Results from the sampling period most proximal to the 
necropsy were used in models as described above to compare relationship between each 
parameter and the percentage of lung lesions displayed in each calf.   
 
Results 
All calves were negative for Bovine Viral Diarrhea Virus persistent infection by antigen 
capture ELISA.   
Pathology 
Two calves each were harvested on days 1, 2, 3, and 5 (inoculation day = 0).  On trial 
days 7 and 9, three calves each were harvested.   All lung sets exhibited gross lesions consistent 
with bronchopneumonia; the extent of total pulmonary involvement ranged from 1.2% to 23.4% 
(Table 1).   Gross lesions were described as fibrinous bronchopneumonia with pleuritis on days 1 
to 3.  Atelectasis with resolving pneumonia described the lungs harvested on days 5, 7 and 9.  
Thirteen of the fourteen calves exhibited lesions on the right side.  The overall mean percent lobe 
involvement for the target areas of the right cranial apical, right caudal apical and right middle 
lobes was 40%, 55.4%, and 26.1%, respectively.     
 Harvest day was associated with the overall percentage of pulmonary lesions (p = 
0.03).  The percentage of lung lesions was significantly higher on day 2 compared to days 3 and 
7 but not different from the other days (Figure 1).  The percent lung involvement on day 7 was 
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significantly lower compared to days 2 and five.  There was no apparent ascending or descending 
trends in percent lung involvement (Figure 1).  Mannheimia haemolytica was cultured from 10 
of 14 lung sets.  Of the four sets of lungs from calves where MH was not cultured, 
Arcanobacterium pyogenes was isolated from 2 and Histophilus somnus from another.  One lung 
set had no bacterial growth.   
Clinical illness scores 
All calves had normal CIS, during the four days prior to inoculation, but all were scored 
as ill post-inoculation.  Statistical analysis was not completed for CIS, respiratory character or 
activity level because the observer was not blinded to the time relative to disease induction.  All 
calves had CIS of 3 at the first post-inoculation observation.  On day 1 post-inoculation, 32 
measurements were CIS 2 and 6 were at level 3.  For the rest of the study, 151 measurements 
were CIS 2 and 28 CIS 3. No calves received a normal CIS (1) between inoculation and harvest.   
Respiratory type 
Respiratory type was normal for all calves prior to inoculation, and for 4 out of 14 calves 
for the first reading after inoculation. From day 1 through trial completion, 17 of 179 respiratory 
type evaluations were classified as normal.  Prior to inoculation all calves had normal activity.  
At the first reading post-inoculation until harvest, all calves had decreased activity.   
 Temperature 
Least square mean rectal temperatures for all pre- and post-challenge days (range 39.8C-
40.4C) were above published normal values (38.5C-39.5C).(Radostits, 2000)  Only the 
inoculation day rectal temperature differed (p<0.05) from all pre- and post-challenge days 
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(Figure 2).  Rectal temperature increased throughout the day. There were differences (p < 0.05) 
between measurements collected in the morning (39.6C ± 0.049), at noon (39.4C ± 0.056) and 
early evening (40.2C ± 0.056).   
 Respiratory rate 
Mean respiratory rate on inoculation day (day 0) was greater (p=0.05) compared to day 1, 
but not higher than any other day.  Respiratory rates were greater than published 
values(Radostits, 2000) (30-60 breaths/minute) on all trial days and significantly greater than 
baseline (day -1) values on days 5 through 8 (Figure 3).  Respiratory rates were less (p < 0.01) in 
the morning (58.0 ± 2.4) relative to noon (75.3 ± 2.7) or evening (76.7 ± 2.5).   
 Heart rate 
Heart rates were greater than reference values (60-80 per minute) on all trial days and 
were significantly greater on inoculation day relative to all other days in the trial.  Heart rates 
appeared to decrease throughout the trial (Figure 4).  Heart rates were greater (p < 0.05) at noon 
(112.7 ± 2.8).  Evening heart rates (106.0 ± 2.7) were less (p<.05) relative to noon and greater (p 
<.05) than the morning rates (101.1 ± 2.6).   
 Body weight 
Body weights were only recorded daily and trial day was not significantly associated with 
changes in calf body weight.   
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Hematology and blood gas 
Complete blood count parameters were evaluated independently to determine if they 
were associated with trial day (Table 2).  The effect of trial day was significant (p<0.05) for total 
leukocytes, segmented neutrophils, erythrocytes, hemoglobin, hematocrit (spun and calculated), 
mean cell hemoglobin concentration (MCHC), and plasma protein.  The effect of trial day tended 
(p= 0.06) to be associated with fibrinogen concentration.  There was no overall effect (p > 0.10) 
of trial day on the counts for band neutrophils, lymphocytes, monocytes, eosinophils, basophils, 
mean cell volume (MCV) or mean cell hemoglobin (MCH).  Erythrocytes, hemoglobin, and 
hematocrit displayed similar trends over time with the largest values occurring prior to initiation 
of pneumonia and the lower values later in the study period.  Plasma protein decreased on days 1 
and 2 compared to pre-trial readings, and days 7 and 9 were both greater than the pre-inoculation 
measurements.  Segmented neutrophils and total leukocyte counts displayed a different pattern 
with the greatest values observed on day 1.  Pre-inoculation fibrinogen concentrations were less 
(p<.05) compared to days 1, 3, and 9.   
Serum chemistry parameters over the trial period are shown in Table 3.  There was no 
effect (p>0.10) of trial day on sodium, glucose, or the anion gap, yet trial day was associated 
with all other chemistry parameters.  All values, except pH, Hct% and hemoglobin, remained 
within published normal ranges from 4 days prior to inoculation through harvest.  The pH value 
on day 5 (7.61) was outside the normal range (7.31-7.53)(Smith, 2002), and was greater 
compared to days 1, 2, 3, and 9.  Mean hemoglobin was below the normal range (8-15 
mg/dL)(Smith, 2002) on days 2 through 7, but  only days 3 and 7 were less (p<.05) than pre-
inoculation values.  Total carbon dioxide (TCO2) concentrations were less (p<.05) prior to 
induction compared to trial days 1, 2 and five.  Potassium and chloride concentrations were less 
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(p<.05) on trial day 1 compared to pre-challenge baseline concentrations (4.27 mmol/L, 103.12 
mmol/L, respectively).  On day 5, base excess was greater (p<0.01) compared to pre-inoculation 
and all post-inoculation days.   
All measured blood gas parameters except oxygen saturation (SO2) were associated (p < 
0.05) with trial day (Table 4).  Oxygen saturation tended (p =0.08) to be impacted by day of trial.  
Blood lactate concentration was greater pre-inoculation compared to all days except day 1.  
Arterial pH, bicarbonate (HCO3), total carbon dioxide (TCO2), and base excess (BEcf) were less 
(p<.05) prior to induction compared to all days post-inoculation.  Pre-inoculation oxygen (PO2) 
was less (p<0.01) compared to days 5, 7, and 9.  Pre-inoculation PCO2 was greater (p<.05) 
compared to days 1, 5 and 9. 
Activity 
Model-adjusted mean step counts were greater (p <0.01) for all days post-inoculation 
compared to pre-inoculation (Figure 5).  Mean step count pre-inoculation was 10,986 (±692.6), 
and on day 0 it was 6,280 (± 692.6).  At no time after inoculation did least square mean total 
steps within a 24 hour period exceed 7,137.   
 Video was obtained on the 14 study calves over 13 days (day -3 was not recorded) with a 
mean recording time of 2.2 minutes per day per calf.  The overall agreement between the 
classification tree algorithm and the video recorded data was high (Kappa 0.91, 95% CI 0.89 to 
0.92).  Therefore, the classification tree was used to generate behavior estimates for each data 
point from the accelerometer data.  Data from the first day the accelerometer was placed and 
each calf’s harvest day were eliminated from the analysis because these were not complete 24 
hour periods.  Trial day was a factor (p<.05) in the percent of time animals spent standing and 
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tended (p = 0.08) to be associated with the amount of time spent lying down (Table 5).  Mean 
time spent walking was not associated (p=0.86) with trial day.  An interaction (p<.05) was 
identified in the amount of time cattle spent either standing or lying based on day of the trial 
(Figure 6).  Prior to induction of pneumonia, cattle spent more time standing (53.0% ± 3.7%) 
compared to lying (42.3% ± 3.7%).  After the induction of pneumonia, there were few 
differences in the amount of time spent in each activity, and in fact on day 4 post-inoculation, 
cattle spent more time lying (56.0% ± 4.6%) compared to standing (39.6% ± 4.6%).     
 
Discussion 
The challenge model utilized in this study successfully produced clinical and pathological 
signs of respiratory disease consistent with that observed in BRDC due to MH.  The distribution 
of pulmonary lesions in our study was similar to a bronchoscopy study where MH lesions were 
restricted to 15%-17% of the right lung lobes.(Reeve-Johnson, 2001b)  Other researchers have 
reported difficulty reproducing MH pneumonia without pre-exposure to viral pathogens or 
stressors.(Thomson, 1974) The etiology of BRDC is multifactorial.(Wittum and Perino, 1995; 
Roeber et al., 2001; Fulton et al., 2002)  Pre-weaning factors including  colostrum intake, bovine 
viral diarrhea virus (BVDV) status and pre-shipment management.(Step et al., 2008)  Post-
weaning factors include transportation stress, castration and dehorning, gender and nutritional 
management.(Blecha, 1984; Wittum and Perino, 1995; Daniels, 2000; Roeber et al., 2001; Fulton 
et al., 2002; Rivera, 2005; Duff and Galyean, 2006)    In our study, transportation and viral stress 
were not present but other stressors such as heat stress and frequent restraint did occur.  These 
stressors may have contributed to the success of our challenge model.   
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All calves had predominately right side bronchopneumonia except one, which had lesions 
primarily on the left side.  Presumably this was due to the calf coughing and potentially 
modifying the placement of the endoscope during introduction of MH.  In a previous challenge 
study, contrast bronchography documented the dissemination of bacteria into other lung fields 
during coughing episodes (Vestweber et al., 1990).  Gross necropsy and histopathology revealed 
acute bronchopneumonia on the day after inoculation. However, by day 5 post-challenge, lung 
lesions appeared to be resolving grossly and histopathologically.  This was an unexpected 
finding given the extensive lung lesions observed within the first few days after inoculation.  
This may indicate that MH, as a single pathogen, is unable to sustain severe inflammatory 
responses for more than a few days (Ames et al., 1985).  Other parameters such as leukocyte and 
neutrophil total counts indicated a rapid but transient response to infection.  In addition, in our 
study, calves had elevated core temperatures at challenge (>39.7C) which may been protective 
against bacterial growth.(Reeve-Johnson, 2001b)  Mannheimia haemolytica was found in 10 of 
14 lung sets, which is consistent with a previous study  where 9 out of 16 lungs were found to 
contain Pasteurella multocida after inoculation.(Dowling et al., 2002)   
Clinical illness score, respiratory type and activity were normal for all calves prior to 
disease induction, but all measures were abnormal at the first evaluation post-inoculation.  This 
validates the success of our induction model, and indicates that these subjective measures may be 
used to recognize early pulmonary disease.  Pyrexia and lethargy due to MH endotoxin and 
leukotoxin  may precede measurable lung tissue damage.(Zecchinon, 2005)  Clinical illness 
scores remained abnormal from induction to harvest, yet necropsy and histopathology results 
indicated a resolving bronchopneumonia starting on trial day 3.  Because the observer was 
unblinded in our study we were unable to accurately use clinical illness score as a predictor of 
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lung pathology severity.  Our conclusion, which agrees with others(Reeve-Johnson, 2001a), was 
that clinical illness scores do not give an adequate assessment of disease progression.  
In our study, we found that common clinical measurements (temperature, pulse, and 
respiratory rate) may produce conflicting results and can vary by the time of day.  Rectal 
temperatures were above normal throughout our study.  This is likely related to the elevated 
environmental temperatures (>32.2C) during the trial period, and restraint of the calves three 
times a day for physical examination.  Least square mean rectal temperature was greater on 
inoculation day than any other study day, and this transient increase may have been a direct 
result of the synergistic relationship between endotoxin and leukotoxin.(Jeyaseelan, 2002)   
Rectal temperature varied by time of day.  This is likely an effect of daily changes in ambient 
temperature and  agrees with findings in another studies indicating maximum heat dissipation 
occurs overnight.(Hahn, 1999)  Mean rectal temperatures for the post-inoculation morning 
readings were less than cut-off values (≥40C) used to determine sickness on some production 
units.  However, evening rectal temperature readings were above 40C, suggesting that time of 
day should be taken into account when rectal temperature is used as a diagnostic tool.   
  Mean heart rates were above published normal values for all trial days.(Radostits, 2000)  
Interestingly, heart rate decreased and respiratory rate increased as the study progressed.  This 
may be a possible source of diagnostic conflict if respiratory rate and heart rate are used together 
as indicators of pulmonary disease.  The time of day the measurement was taken had a unique 
effect on heart rate relative to rectal temperature or respiratory rate with the maximum heart rate 
observed at the 1200 observation.   
Rectal temperature, respiratory rate and heart rate immediately prior to harvest were not 
associated with percent lung involvement.  This disagrees with a study where rectal temperature, 
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respiratory rate and clinical score were associated with percent lung involvement seven days 
post-inoculation.(Reeve-Johnson, 2001b)  This difference may be a reflection of two different 
lung scoring systems rather than a difference in study outcomes.  The difference may also be 
explained by differences in inoculation methods, subject age, breed, and environmental 
conditions.  
Complete blood counts illustrated a transient increase in total leukocytes and a decrease 
in red blood cell count, although overall findings revealed few days when CBC parameters were 
beyond established normal values.  Absolute neutrophil numbers were elevated above the normal 
range post-inoculation days 1 and 9, which conflicts with reports that neutropenia occurs with 
gram negative bacterial pneumonia.(Hodgson, 2006; Jones and Allison, 2007)    Our 
observations began early after bacterial insult, and our results may indicate that neutrophilia 
occurs initially before an influx of neutrophils into lung tissue is precipitated by leukotoxins and 
endotoxins in MH infections. (Vestweber et al., 1990; Soethout, 2002; Zecchinon, 2005; 
Hodgson, 2006; Stockham Steven, 2008)  This finding may be valuable in assessing MH disease 
progression if early in the course of disease neutrophilia exists.   Our total leukocyte results were 
consistent with a similar study where leukocyte counts increased the day after inoculation and 
remained elevated for one day.(Ganheim, 2004)  However,  in another study total leukocyte and 
absolute neutrophil counts were highest at the first measurement (72 hours) after a blind tracheal 
inoculation in two week old Holsteins.(Vestweber et al., 1990)  The conflicting evidence may 
indicate that multiple factors affect blood leukocyte numbers, and the usefulness of leukocyte 
counts to consistently identify early BRDC is marginal.   
Mean red blood cell counts were highest prior to inoculation and above normal laboratory 
range pre-inoculation and on days 1, 2 and 3.   Others have shown a consistent decrease in red 
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blood cells from inoculation throughout the rest of the trial (Corrigan et al., 2007).   In contrast, 
polycythemia has been observed in hypoxic calves with chronic pulmonary disease.  As 
expected, mean fibrinogen levels were elevated and statistically higher than baseline values on 
days 1, 3 and 9.   However, fibrinogen values were not consistently elevated beyond the normal 
range post-inoculation.  Therefore, it was not a reliable predictor of BRDC in our trial.  These 
collective findings suggest limited utility for complete blood counts as early, objective indicators 
of BRDC.     
Although blood chemistry values tended to vary by trial day, most indexes remained 
within normal ranges throughout the trial.  Glucose was the only blood chemistry parameter that 
elevated, but this parameter was also elevated prior to disease induction.  Elevated glucose is 
thought to be a stress indicator (Stockham, 2008).  In our study, stress may have been induced 
from restraining and examining calves three times a day.  In our trial, blood chemistry analysis 
illustrated few measures that could be useful for objective diagnosis of early BRDC.   
Hypoxemia can be a manifestation of severe respiratory disease when both decreased 
ventilation and decreased tissue perfusion are occurring (Slocombe et al., 1984; Smith, 2002).  
Alveolar hypoxia (decreased SO2), as an indicator of hypoxemia, was not observed in our study 
after pneumonia induction.  Although cranioventral lobes had large areas of pathology, the total 
lung involvement may not have been extensive enough to alter ventilation rates or reduce 
pulmonary gas exchange.  Arterial pH increased after induction.  This finding indicates 
respiratory alkalosis associated with increased respiratory rate coupled with low percent lung 
involvement.  However, blood pH results remained normal except on day 5 when alkalosis was 
detected.  This may be due to increased sensitivity of arterial blood to pulmonary or metabolic 
changes compared to venous blood (Stockham, 2008).  Increased respiratory rates and gram 
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negative septicemia, both present in our study, can contribute to increased blood pH (Smith, 
2002; Stockham, 2008).  Respiratory rates were elevated throughout our trial and gram negative 
septicemia also likely occurred.  Ambient temperatures during the trial were high, which 
potentially contributed to greater than normal respiratory rates in these calves with respiratory 
disease.  Decreased arterial blood pH values  (respiratory acidosis) have been reported in calves 
with chronic respiratory disease (Nagy, 2006). However, none of the calves in our study entered 
advanced stages of chronic pulmonary damage.    
Increased blood lactate has been considered  a reliable prognostic indicator for mortality 
in acute bronchopneumonia (Coghe, 2000).  However, we did not find lactate to be useful in 
identifying early BRDC possibly because anaerobic metabolism did not occur due to the low 
percentage lung involvement.  Changes in blood gas and chemical values are not unique to 
BRDC, but can be affected by many factors, and require extensive lung involvement before 
significant changes do occur.  The use of blood gas and chemical parameters to recognize BRDC 
early after infection had no value in this study.   
Accelerometers were not useful in determining disease progression, however these data 
provided evidence of a behavioral change after the disease challenge.(Figure 4)  Prior to 
pneumonia induction, calves spent more time standing than lying indicating the behavior pattern 
of healthy calves in this environment.   By day 4 post-inoculation, calves spent more time lying 
than standing.  These findings are consistent with the idea that one of the primary clinical signs 
of BRDC is depression, but the change in the relationship between the two variables was not 
present until two days after induction of pneumonia.  Other researchers previously suggested that 
animal health could be effectively monitored using accelerometer,(Schoenig et al., 2004) and 
these devices have been used to show calf behavior changes following a specific event such as 
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castration (Fajt, et al., 2003).  In this study accelerometers objectively documented behavior 
prior to disease induction and provided evidence of behavioral pattern changes in early cases of 
respiratory disease.  
  We believe that we are the first to demonstrate the utility of pedometers as an effective 
indicator of respiratory disease in cattle.  Previously, pedometers have been used for estrus 
detection, lameness and illness detection in dairy cattle (Moallem, 2002; Rorie et al., 2002; 
Roelofs et al., 2005; Mazrier, 2006).  We found that the total number of steps taken during a 24 
hour period decreased post-inoculation and remained lower than baseline levels throughout the 
trial.  MH toxins in the inoculant may have induced lethargy and thus may explain the immediate 
activity decrease.  Although activity was reduced following disease induction, the number of 
steps on the day prior to harvest was not associated with percent lung involvement at necropsy.  
This may be explained by a calf’s ability to mask disease in a herd setting.  Activity, as measured 
by total steps taken, may be an indicator of early respiratory disease but it does not appear to be a 
reliable indicator of the progression or severity of disease.   
In this study we used a challenge model to replicate clinical signs and pathology of early 
bronchopneumonia due to MH, and investigated several parameters as potential objective 
indicators of early BRDC.  None of the parameters predicted lung disease progression.  Although 
physical and physiological pattern changes from pre-inoculation through harvest were noted, 
many times the numerical changes were too subtle to rely upon for consistent, accurate field 
diagnosis.  Total lung involvement for most calves in our study was relatively low and that may 
have minimized the numerical differences; however, our focus was early respiratory disease 
recognition when total lung involvement would be expected to be low.  Activity measures 
(pedometers and accelerometers) documented behavioral changes associated with disease state. 
99 
 
Although it is widely believed that calves suffering from BRDC are less active, our research is 
the first to document this behavioral change. The other disease identification tools used in this 
study have been used historically for many years by the livestock industry.  Our research 
indicates these are of little value for early disease recognition.  To reduce the effects of BRDC in 
beef calves, it is important to continue to evaluate tools for early recognition of disease.  
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Footnotes 
a. Kansas State University Veterinary Diagnostic Laboratory, Manhattan, KS 
b. VetVu Flexible Endoscope, Swiss Precision Products, Spencer, MA.  
c. Excel, Microsoft Corporation, Redmond, WA. 
d. i-Stat Handheld Portable Analyzer, Heska Corporation, Loveland, CO. 
e. 1.3 ml lithium tube, Sarstedt, Numbrecht, Germany. 
f. 2 ml EDTA blood tube, BD, Franklin, TN. 
g. Clinical Pathology Laboratory, College of Veterinary Medicine, Kansas State University, 
Manhattan, KS. 
h. GP 1Progammable Accelerometer, Sensr, Elkader, IA. 
i. NL-800 Activity Monitor, New Lifestyles, Lee’s Summit, MO. 
j. Sensware, Sensr, Elkader, IA. 
k. JMP 7.0, SAS Institute, Cary NC. 
l. PEPI, Version 4.0, Sagebrush Press, Las Vegas, NV. 
m.  Proc Glimmix, SAS 9.1, SAS Institute, Cary, NC. 
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Figure 3-1 Calf lung one day post-Mannheimia haemolytica inoculation 
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Figure 3-2 Calf lung three days post-Mannheimia haemolytica inoculation 
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Figure 3-3 Calf lung seven days post-Mannheimia haemolytica inoculation 
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Table 3-1 Percent consolidation
1
 measured at necropsy for each calf by days post-
inoculation. 
 
 
Calf 
ID 
Harvest 
Day 
Rt crn 
apical 
Rt cd 
apical 
Rt 
mid 
Rt 
diaph Acc 
Lft crn 
apical 
Lft cd 
apical 
Lft 
diaph 
Total Lung 
Score²
 
27 1 20 90 0 0 0 0 0 3 7.6 
30 1 0 0 0 0 0 0 100 20 11.3 
21 2 80 90 30 10 30 50 30 7 23.4 
25 2 80 80 80 0 0 0 0 0 14.7 
16 3 50 100 0 0 0 0 3 0 9.3 
23 3 50 50 0 0 0 0 0 0 6.2 
14 5 90 50 80 0 100 0 10 10 21.5 
28 5 30 100 30 0 100 0 0 0 14.0 
18 7 20 5 0 0 0 0 0 0 1.6 
22 7 0 20 0 0 0 0 0 0 1.2 
32 7 10 100 20 0 0 0 0 0 7.9 
3 9 0 0 25 20 50 0 0 0 10.7 
5 9 100 0 0 0 20 0 0 0 7.2 
12 9 30 90 100 0 0 30 40 0 16.9 
Average 40.0 51.8 26.1 2.1 21.4 5.7 12.9 2.9 11.8 
 
¹Abreviations include:  Rt crn apical (Right cranial apical), Rt cd apical ( Right caudal apical), Rt 
mid ( Right middle), Rt diaph (Right diaphragmatic), Acc( Accessory), Lft crn apical (Left 
cranial apical), Lft cd ( Left caudal apical), Lft diaph ( Left diaphragmatic) 
2
 Total percentage lung consolidation = (0.053 x left cranial apical %) +  
(0.049 x left caudal apical %) + (0.319 x left diaphragmatic lobe %) +  
 (0.043 x accessory lobe %) + (0.352 x right caudal lobe %) + (0.061 x right middle lobe %) 
 + (0.060 x right caudal apical lobe %) + (0.063 x right cranial apical lobe %) (Fajt et al., 2003) 
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Table 3-2 Least square mean complete blood count parameters
1, 2, 3 
by trial day 
with (-1) = combine baseline and other numbers corresponding to days post-inoculation. 
Trial Day -1 1 2 3 5 7 9 
Ref 
Rng4 
Trial 
d p-
value 
Leuk 9.58
 b
 12.57
 a
 9.82
 b
 8.41
 b
 8.67
 b
 10.19
 ab
 11.24
 ab
 
7-14 
K/ul 
<0.01 
Seg neut 4.20
 b
 7.85
 a
 4.98
 b
 3.96
 b
 3.73
 b
 4.85
 ab
 6.66
a b
 1-5 K/ul <0.01 
Band 
neut 
0.03 0.11 0.02 0.00 0.02 0.06 0.07 
0-.2 
K/ul 
0.27 
Lym 4.89 4.07 4.41 3.99 4.55 4.71 3.95 
2.5-7.5 
K/ul 
0.2 
Mono 0.27 0.35 0.24 0.22 0.2 0.31 0.32 
0.25-.85 
K/ul 
0.51 
Eos 0.15 0.1 0.15 0.19 0.15 0.15 0.07 
0-1.6 
K/ul 
0.72 
Bas 0.06 0.04 0.02 0.06 0.03 0.04 0 
0-.2 
K/ul 
0.64 
Erthr 9.13
 a
 8.63
 b
 8.33
 bc
 8.04
 cd
 7.71
 de
 7.16
e
 7.53
de
 
5-8 
M/ul 
<0.01 
Hemog 11.25
a
 10.58
b
 10.24
bc
 9.87
cd
 9.49
de
 8.84
e
 9.49
cde
 
8.5-14 
g/dL 
<0.01 
Hemat 
(calc) 
31.60
a
 29.99
b
 28.95
bc
 28.19
cd
 27.01
de
 25.20
e
 26.66
cde
 26-42 % <0.01 
Hemat 
(spun) 
33.41
a
 32.13
a
 30.23
b
 29.52
bc
 28.12
bc
 27.23
c
 28.96
bc
 26-42 % <0.01 
MCV 34.94 34.91 35.08 35.2 34.88 35.16 35.08 
32-51 
fL 
0.78 
MCH 12.42 12.48 12.32 12.36 12.48 12.46 12.82 
11-18 
pg 
0.33 
MCHC 35.72
ab
 35.62
ab
 35.52
ab
 34.98
c
 35.71
ab
 35.34
bc
 36.16
a
 
33-37 
g/dL 
0.02 
Plasma 
Protein 
7.29
c
 7.08
d
 7.06
d
 7.34
bc
 7.22
cd
 7.54
b
 7.97
a
 
7-9 
g/dL 
<0.01 
Fibrinoge
n 
0.63
c
 0.77
ab
 0.67
bc
 0.87
a
 0.68
abc
 0.68
abc
 0.87
ab
 
.3-.7 
gdL 
0.06 
 
1
Day -1 represents all pre-inoculation readings; all calves inoculated with 
 Mannheimia haemolytica on Day 0. 
2
Superscripts that differ within the same column illustrate significant (p<0.05) 
 differences in least square means. 
3
Abbreviations include:  Seg Neut (segmented neutrophils), Band Neut (band neutrophils), 
 Lymph (lymphocytes), Mono (monocytes),  Eosin (eosinophils), Baso (basophils), 
 Erythro (erythrocytes), Hemoglob (hemoglobin) 
4
Kansas State University Clinical Pathology Laboratory 
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Table 3-3 Least square mean serum biochemistry parameters
3
 by days from induction. 
      
Trial Day
1
 
            
  -1 1 2 3 5 7 9 
Refer-
ence 
Range
4 
Trial Day 
p-value
2
 
pH 7.52
bc
 7.53
bc
 7.53
bc
 7.48
c
 7.61
a
 7.58
ab
 7.48
c
 
7.3-7.5 
mmol/L 
<0.01 
pCO2 32.81
bcd
 34.21
abc
 33.72
abcd
 37.89
ab
 30.36
cd
 28.83
d
 38.92
a
 
35-44 
mmHg 
0.01 
HCO3 26.72
c
 28.31
b
 28.33
b
 27.67
abc
 30.07
a
 26.93
bc
 28.43
abc
 
20-30 
mmol/L 
 
<0.01 
BEecf 3.83
b
 5.64
b
 5.71
b
 3.56
b
 8.74
a
 4.65
b
 4.99
b
 
 
<0.01 
AnGap 10.7 10.5 9.48 11.05 8.24 11.14 10.48 
 
0.14 
Hb 8.31
ab
 8.59
a
 7.88
bc
 7.41
c
 7.66
bc
 7.34
c
 8.23
abc
 8-15 g/dL 0.02 
Na 136.54 134.99 135.71 136.3 135.65 136.99 136.61 
132-152 
mmol/L 
0.39 
K 4.27
b
 3.70
c
 4.04
bc
 4.07
bc
 4.13
bc
 3.96
bc
 5.34
a
 
132-152 
mmol/L 
<0.01 
Cl 103.12
a
 99.61
c
 102.01
ab
 101.93
abc
 101.28
bc
 102.58
ab
 101.70
ac
 
132-152 
mmol/L 
<0.01 
TCO2 27.69
c
 29.32
ab
 29.23
b
 28.93
abc
 30.99
a
 28.01
bc
 29.76
abc
 
132-152 
mmol/L 
<0.01 
BUN 7.45
bc
 8.25
ab
 6.34
c
 7.53
abc
 8.53
ab
 8.26
ab
 9.78
a
 
6-27 
mg/dL 
<0.01 
Glu 84.57 77.51 76.54 76.39 80.32 77.28 70.7 
45-75 
mg/dL 
0.26 
HCT 24.44
ab
 25.31
ab
 23.17
bc
 21.72
bc
 22.57
c
 21.60
c
 24.26
abc
 24-46 % 0.02 
 
1
Day -1 represents all pre-inoculation readings; all calves inoculated with Mannheimia haemolytica on Day 0.  
2
Superscripts that differ within the same column illustrate significant (p<0.05) differences in least square means. 
3
Abbreviations include Na (sodium), K (potassium), Cl (chloride), TCO2 (total carbon dioxide), BUN (blood urea nitrogen), Glu (glucose),  
HCT%PCV (hematocrit, % packed cell volume), pCO2 (partial pressure of carbon dioxide), HCO3 (bicarbonate), BEecf (base excess), AnGap (anion gap), and 
Hb (hemoglobin)
4 
Large Animal Internal Medicine, Third Addition, Mosby Publishing
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Table 3-4  Least square mean arterial blood gas parameters
3
 by trial day. 
Trial day
1
 pH PCO2 PO2 BEcf HC03 TC02 SO2 Lac 
-1 7.54
d
 30.86
a
 75.43
d
 3.69
c
 26.15
b
 27.17
b
 92.35
b
 1.67
a
 
1 7.65
 b c
 26.90
b
 90.28
cd
 8.58
b
 29.32
a
 30.15
a
 97.80
a
 1.33
ab
 
2 7.64
c
 27.98
ab
 95.71
bcd
 8.55
b
 29.22
a
 30.33
a
 97.91
a
 0.71
c
 
3 7.63
c
 27.66
ab
 97.12
bcd
 8.09
b
 29.01
a
 29.90
a
 97.72
ab
 0.47
c
 
5 7.76
a
 20.99
c
 125.52
a
 11.94
a
 30.88
a
 31.45
a
 99.38
a
 0.49
c
 
7 7.66
bc
 28.07
ab
 120.74
ab
 9.26
ab
 30.02
a
 30.73
a
 99.01
ab
 0.57
c
 
9 7.79
ab
 20.91
bc
 153.57
a
 13.10
ab
 31.53
a
 32.48
a
 99.48
ab
 0.43
bc
 
Reference 
Range
4
 
7.31-7.53 
   
35-44 
mmHg 
75-100 
mmHg 
 
20-30 
mmol/L 
21-32 
mmol/L 
94-100%     5-20 
  mmol/L 
Trial Day p-value
2
 
<0.01 <0.01 <0.01 <0.01 <0.01 <0.01 0.08 <0.01 
 
1
Day -1 represents all pre-inoculation readings; all calves inoculated with Mannheimia 
haemolytica on Day 0. 
2
Superscripts that differ within the same column illustrate significant (p<0.05) differences in 
least square means. 
3
Abbreviations include:   PCO2 (partial pressure of carbon dioxide), PO2 (partial pressure of 
oxygen), BEcf (base excess), HCO3 (bicarbonate), TCO2 (total oxygen), SO2 (oxygen 
saturation), and Lac (lactate)  
4 
Large Animal Internal Medicine, Third Addition, Mosby Publishing 
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Table 3-5 Percent of time spent in each activity as categorized by accelerometer by trial 
day. 
Trial Day
1 
% Lying % Standing % Walking 
-1 41.1%
c
 54.2%
a
 4.7% 
0 43.3%
bc
 52.9%
a
 3.8% 
1 41.8%
c
 53.9%
a
 4.2% 
2 45.9%
bc
 50.2%
ab
 3.8% 
3 52.0%
ab
 43.1%
bc
 4.7% 
4 55.9%
a
 39.4%
c
 4.6% 
5 50.9%
abc
 45.1%
abc
 4.0% 
6 49.0%
abc
 46.3%
abc
 4.6% 
7 40.4%
bc
 55.9%
a
 3.8% 
8 49.7%
abc
 47.2%
abc
 3.1% 
Trial d  
p-value
2
 
0.08 0.02 0.86 
 
1
Day -1 represents all pre-inoculation readings; all calves inoculated with MH on Day 0. 
2
Superscripts that differ within the same column illustrate significant (p<0.05) differences in 
least square means 
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Figure 3-4  Mean
1 
percent lung involvement by day
 
after inoculation with Mannheimia 
haemolytica. 
 
 
1
Means are model adjusted values from a generalized linear mixed model. 
Columns with unique superscripts statistically differ (p < 0.05).  
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Figure 3-5 Least square mean rectal temperature (°C) by trial day.
1,2,3,4
  
 
1
All readings prior to inoculation are included in trial day -1. 
2
Measurements were taken in the morning (0630), at noon, and late afternoon (1630).   
3
Columns with unique superscripts statistically differ (p < 0.05) 
4
Model accounted for the time of day measurement was taken and the repeated measures on an 
on individual animal. 
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Figure 3-6 Least square mean respiratory rate (respirations / minute) by trial day
1,2,3 
 
 
1
All readings prior to inoculation are included in trial day -1. 
2
Columns with unique superscripts statistically differ (p < 0.05) 
3
Model included random effects accounting for the time of day measurement and the repeated 
measures on an on individual.  
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Figure 3-7 Least square mean heart rate (beats per minute) by trial day
1,2,3
  
 
1
All readings prior to inoculation are included in trial day -1 
2
Columns with unique superscripts statistically differ (p < 0.05) 
3
Model included random effects accounting for the time of day
2 
measurement and the repeated 
measures on an on individual.   
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Figure 3-8 Least square means step counts by trial day
1
 from a model including random 
effects. 
1,2,3
 
 
1
All readings prior to inoculation are included in trial day -1. 
2
Columns with unique superscripts statistically differ (p < 0.05) 
3
Day 9 not included because it was a partial day 
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Figure 3-9 Interactive model adjusted mean percent of time spent lying and standing by 
trial day
1 
for calves inoculated with Mannheimia haemolytica Day 0.
2,3
. 
 
 
1
All readings prior to inoculation are included in trial day -1. 
2
Trial day 9 not included because it was a partial day 
3
Model was a logistic regression model accounting for repeated measures on individual calves. 
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Summary 
The purpose of this longitudinal cross-sectional times series study was to determine 
prevalence of nasal mycoplasma, serostatus and seroconversion and evaluate associations with 
health and performance in weaned beef calves during a 42 day feeding period.  Nasal swabs were 
collected and serum was collected on days 0 (arrival), 10, 42 and at first bovine respiratory 
disease complex (BRDC) incidence and were evaluated for Mollicutes (culture), Mycoplasma 
bovis (PCR), and Mycoplasma bovis (serum antibody).  On day 0, 90.4% of the calves were 
Mollicutes nasal culture positive.  Mycoplasma bovis seroprevalence was 26.6% on day 0 and 
98.2% by day 42 (P < 0.05).  Seroconversion to M. bovis between days 0 and 42 was associated 
(P = 0.04) with lower weight gain. Weight gain was greater in calves that were PCR negative on 
 119 
day 10 (P = 0.01) for M. bovis.  The percent of calves seropositive to M. bovis increased 
throughout the study indicating exposure and an immunological response to the organism. 
Although associations with health outcomes were not identified, seroconversion to M. bovis was 
associated with a decreased rate of weight gain during study period. 
Introduction 
Mycoplasma organisms (class Mollicutes) are associated with some of the most 
economically important and severe diseases observed in cattle (Nicholas and Ayling, 2003; 
Gagea et al., 2006b).   In the United States, mycoplasma organisms are associated with bovine 
respiratory disease complex (BRDC), and in other parts of the world they are associated with 
chronic pneumonia polyarthritis syndrome (CPPS) (Nicholas and Ayling, 2003; Clark, 2005; 
Gagea et al., 2006a; Caswell and Archambault, 2007). 
Mycoplasma bovis, the most frequently identified pathogenic mycoplasma, is an upper 
airway commensal that is not ubiquitous, but is commonly isolated from nasal samples in 
diseased and non-diseased calves (Boothby et al., 1983; Allen JW, 1991; Nicholas and Ayling, 
2003; Maunsell, 2009).  Several studies have investigated the prevalence of Mollicutes and M. 
bovis in calf populations at single sampling periods, but few have explored the associations 
between prevalence and seroconversion in individual calves at multiple time points (Yates et al., 
1983; Marques et al., 2007; Wiggins et al., 2007).   Increased awareness of the association 
between the dynamics of Mollicutes and M. bovis and relevant health and production measures 
may be clinically important.    
A longitudinal cross sectional time series study was designed to investigate these 
associations with three objectives: 1) to determine the prevalence of M. bovis and other 
mycoplasmas in nasal samples and M. bovis antibody concentration in weaned beef stocker 
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calves on three sampling days—arrival (Day 0)  revaccination (Day 10), and study completion 
(Day 42), 2) to determine the changes in nasal Mollicutes and M. bovis serostatus over 3 time 
periods: arrival to day 10 (AR), day 10 to day 42 (RV), and arrival to day 42 (ENT), and 3) to 
examine associations of nasal Mollicutes status, and M. bovis nasal status, and M. bovis 
serostatus and seroconversion with growth performance (average daily gain) and morbidity, 
mortality and case fatality risk.    
Materials and methods 
 Calves and preventive health program 
The study was conducted at a Kansa dry-lot, commercial stocker operation with a 
onetime capacity of approximately 6,000 calves.  The study population consisted of male 
crossbred beef-calves purchased at a livestock auction market in Georgia.  Before leaving the 
auction market, calves were administered a modified live vaccine
  
(MLV) (Bovishield Gold 5, 
Pfizer) which included bovine viral diarrhea virus (BVDV) Type 1 and 2, bovine respiratory 
syncytial virus (BRSV), parainfluenza 3 (PI 3)
 
and infectious bovine rhinotracheitis virus (IBR).  
Additionally, calves were administered a Clostridium vaccine
 
(Ultrabac 7, Pfizer)
 
containing 
Clostridium chauvoei, Clostridium septicum, Clostridium novyii, Clostridium sordellii, 
Clostridium perfringens C and D.  
The calves arrived in two groups one week apart.  Each group was allocated to one pen 
and pens were fed and housed separately for the entire study period.  The two study pens were 
isolated from other calves housed at the facility.  Two days after arrival (day 0), calves were 
administered an intranasal MLV infectious IBR and PI3 vaccine
 
(TSV II; Pfizer), a doramectin 
parasiticide
 
(Dectomax; Pfizer) and ceftiofur, (Excede; Pfizer).  An ear tissue sample was taken 
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at this time for real-time PCR
 
(Enfer) BVDV status.   Additionally, all calves were weighed, and 
intact male calves were castrated using a scalpel and Whites Emasculator (Jorgenson).  Ten days 
after arrival, all calves were administered a MLV containing BVDV Type 1 and 2
 
, PI3, BRSV, 
and IBR, (Bovishield Gold 5, Pfizer)  a clostridium bacterin
 
containing Clostridium chauvoei, 
Clostridium septicum, Clostridium novyii, Clostridium sordellii, Clostridium perfringens C & D 
(Ultrabac 7, Pfizer) and tilmicosin phosphate
 
(Micotil, Elanco). 
Health and production performance 
 Experienced animal care-givers (n = 2), employed by the stocker operation, observed 
calves twice daily for signs of illness.  The BRDC case definition was based on each calf’s 
attitude, appetite, and clinical signs as defined by the stocker unit’s standard operating procedure 
manual.  Calves observed with clinical signs of BRDC were removed from the pen, taken to the 
working facility and administered an antibiotic (Draxxin; Pfizer).  Rectal temperatures were 
recorded at this time, but the antibiotic was administered based on presumptive diagnosis of 
BRDC regardless of the temperature reading.  After treatment, all calves were taken back to their 
original pen.  For production performance evaluation (ADG), calves were individually weighed 
on three occasions: day 0, day 10, and day 42.   
Culture and serology sampling 
Nasal cultures were used to isolate mycoplasma and acholeplasma organisms, referred 
throughout the manuscript as Mollicutes.  Nasal swab and blood samples were collected from 
each calf on three scheduled sampling days.  Additionally, a nasal culture and serum sample 
were collected from each calf at the first BRDC episode.  Nasal and lung culture samples were 
collected from mortalities.  Nasal cultures were collected in each calf using a sterile single-
 122 
sheath guarded swab (Jorgenson) that was advanced approximately 10 cm into the ventral nasal 
meatus; then the swab was advanced through the sheath tip another 15 cm and a sample was 
collected. The swab was placed into mycoplasma broth
 
(Hardy Diagnostics Cat. No. G212), and 
transported on ice to Kansas State University (KSU) for overnight shipment to a commercial 
microbiology laboratory
 
(EIDE).  Serum samples consisted of approximately 6 ml of blood 
collected and transported, on ice, to a laboratory at KSU.  All mortalities were necropsied by one 
of the investigators (GAH) or the unit’s trained personnel. Lung cultures were collected by 
inserting a sterile culture swab (Jorgensen Laboratory) into a stab incision made with a sterile 
scalpel blade, at the demarcation line between normal and diseased tissue.  
Mollicutes culture and identification  
Prior to inoculation, each broth tube (Hardy) containing the nasal swab was inverted 
several times. One hundred microliters of broth were transferred to one-half of a 15 by 100mm 
mycoplasma agar plate (Hardy Diagnostics); broth was then streaked across the remaining one-
half of the plate using a sterile, cotton-tipped swab.
  
 The remaining broth was then placed in an 
incubator. The inoculum was then allowed to absorb onto the media for fifteen minutes, then the 
plates were inverted and incubated at 35-37° C, in 5% CO2 for 14 days.   
A tissue culture 40X microscope was used to search each plate for the presence of 
Mollicutes organisms.  Plates were observed after 3, 7, and 14 days of incubation, and only if 
negative at all three observations were samples recorded as negative.  For samples negative on 
day 3, the original sample broth was removed from incubation and used to re-inoculate new 
plates which were reexamined for the presence of Mollicutes organisms as described above. 
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Serology 
All serology tests were completed over a 3 day period using a commercial M. bovis 
antibody ELISA kit
 
(Bio-X).   Single serum dilutions were tested in random order over the 
testing period.   Serum dilution and microwell incubation was performed as recommended by the 
manufacturer.    
To calculate antibody levels, each OD value was subtracted from the negative control test 
value, and then divided by the corresponding positive control test value.  As recommended by 
the kit manufacturer, a sample was considered to be positive if the result was greater than 13.73.  
Raw percentage signal values were categorized by magnitude into 6 groups (0, +, ++, +++, 
++++, +++++). The signal value numerical limits were: ( 0 < 13.73) ;  (13.73 <  +  < 50.60) ; 
(50.60 < ++ <87.47) ;  (87.47 < +++ <124.35) ; (124.35 < ++++ < 161.22) ; (161.22 < +++++) . 
Seroconversion was considered to have occurred if the signal from a serum sample increased by 
2 orders (i.e. ++ initially to ≥ ++++) from the previous serum sample.   
Polymerase chain reaction (PCR) 
Polymerase chain reaction analyses were completed at the Kansas Veterinary Diagnostic 
Laboratory, targeting Mycoplasma bovis and using techniques as described by Lauerman et 
al.(Lauerman, 1998a).    The primers used   were forward primer: MBV-F 5’ -
TGATAGCAATATCATAGCGGC-3’; reverse primer: MBV-R 5’-
GTAGCATCATTTCCTATGCTAC-3’ (Harasawa, 1993; Lauerman, 1998b).   
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Statistical analysis 
Data were recorded on site using a commercial spreadsheet program
 
(Microsoft Excel).  
Descriptive statistics
 
(STATA v. 10.1) and results from hypothesis testing
 
(SAS v. 9.1) were 
generated using commercial statistical software packages.  Individual animal was the unit of 
analysis.  Gonadal status was forced into each model as a fixed effect to account for possible 
confounding.  Arrival weights were categorized into quartiles: <136 kg , 136-182 kg, 183-227 kg 
and > 227 kg based on industry standard break points, and this variable was also forced into all 
models to account for potential confounding (Dohoo et al., 2003b).   Pen was entered into the 
model as a random effect to account for the lack of independence between calves within each 
pen (Dohoo et al., 2003a).  General linear mixed models
 
(Proc Glimmix) were used to analyze 
data on health and performance outcomes potentially associated with nasal prevalence and 
seroprevalence at multiple sampling points accounting for repeated measures.  Linear mixed 
models
 
(Proc Mixed) were used to evaluate potential associations between nasal and serology 
results and ADG. 
Results 
A total of 305 mixed-breed beef calves from two arrival groups (n = 134 and n = 171) 
comprised the study population.  One calf from the second group was positive for BVDV 
persistent infection and removed from the study location within one day of initial processing.  
The remaining 304 calves had an average arrival weight of 183.5 kg; (Standard Deviation 41.29 
kg) and consisted of 18.4% (n = 56) steers and 81.6% (n= 248) bulls.   
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Mollicutes culture 
A nasal sample was not collected from one calf on arrival due to premature release from 
the cattle working chute.  Prevalence results for all sample times and diagnostic tests are 
included in Table 1.  The Mollicutes culture status of calves was associated (P = 0.01) with 
sampling day.  The prevalence was lower (P < 0.01) at day 0 compared to day 42. No difference 
was found between the prevalence at day 10 and day 42 or day 0 and day 10 (Table 1).   
Mycoplasma bovis serostatus and seroconversion 
M. bovis seropositive calves at each sampling day were 26.6%, 62.7%, and 98.2%, for 
day 0, day 10, and day 42, respectively (Table 1), and  serostatus was associated with sampling 
day (P < 0.01).  Calves seropositive at day 42 tended to have lower morbidity risk over the entire 
study period (P = 0.08) compared to seronegative calves at day 42.  Seroconversion was 
associated with sampling period (P < 0.01); the percentage of calves seroconverting to M. bovis 
increased over each time interval (Table 1) .  
Mycoplasma bovis nasal PCR 
The prevalence estimates for M. bovis are reported in Table 1.   The prevalence of M. 
bovis by PCR was higher at day 10 (P < 0.05) compared to days 0 and 42 (Table 1).  M. bovis 
PCR status was associated with seroconversion over any time period.  Being PCR positive for M. 
bovis at any time point was not associated with morbidity and mortality risk (Table 2).  
Results for samples at first BRDC treatment and necropsy   
All morbidities and mortalities were attributed to BRDC and 14.4% (44/304) of the 
calves were treated during the trial, with 6.5% (20/ 304 calves) dying during the period.  Of the 
44 BRDC morbid calves, 37 were sampled at first treatment leaving missing data for 7 calves 
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due to unforeseen logistical issues.  All calves sampled at first BRDC treatment were Mollicutes 
nasal culture positive.  At first BRDC treatment, three calves were PCR positive for M. bovis 
(8.1%.)   In dead calves, Mollicutes was cultured from 94.7% (18/19) of the nasal samples and 
94.1% (16/17) of the lung samples.  Three out of 19 (15.7%) calves had nasal samples positive 
by PCR for M. bovis.   Only one calf (5.5%) was positive on PCR analysis of lung sample for M. 
bovis.   
Mollicutes, Mycoplasma species Mycoplasma bovis and average daily gain 
Average daily gain for all calves over the entire study was 0.44 kg (range of -1.57  kg to 
2.14  kg).   Calves Mollicutes culture negative on day 0 gained more weight (P =0.06) than 
positive calves (Table 3).  Calves that were Mollicutes negative on day 42 also gained more 
weight (P = <0.01) compared to positive calves (Table 3).  There was no association between 
ADG and serostatus at any single sampling time point.   However, calves that did not seroconvert 
during ENT period had a higher rate of weight gain (P = 0.04) compared to calves that did 
seroconvert during the same period (Table 3).  Calves M. bovis PCR negative at day 10 gained 
more weight per day (P = 0.01) compared to positive calves, and calves remaining negative to M.  
bovis PCR at all sampling days tended to gain more (P = 0.09) than calves with at least one 
positive PCR result (Table 3). 
Discussion 
Most calves were Mollicutes nasal culture positive upon arrival and at each subsequent 
sampling period.  Our culture results contrast with one study where only 15% of calves were 
found to be nasal Mollicutes culture positive when sampled within 10 days after arrival (Wiggins 
et al., 2007).  This difference may be explained by different culture techniques that were used in 
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each study, but this could also indicate a difference in prevalence among different groups of 
stocker calves.  Additionally, researchers have suggested that management practices such as 
commingling and long transport distances, both of which occurred in our study, can increase 
Mollicutes nasal prevalence (Boothby et al., 1983).  The Mollicutes populations may also be 
explained by the 2 metaphylactic antibiotics, used by the stocker operation in our trial, one 
(Excede, Pfizer) being ineffective against all Mollicutes and the other (Micotil, Elanco) having 
limited activity against Mollicutes (Rosenbusch et al., 2005; Gerchman et al., 2009).   It is 
possible other commensal bacterial populations were reduced by the antibiotics which allowed 
Mollicutes populations to flourish. 
Over 25% of all calves were M. bovis seropositive upon arrival, and by study completion 
almost all calves (98.2%) were seropositive.  The half-life of M. bovis antibodies has been 
estimated to be 20 days, and given the young age (based on arrival weight) of some of the calves 
in this study, it is plausible that maternal antibodies may have been present upon arrival 
(Tschopp, 2001).   However, an analysis of the data revealed no association between arrival 
weight and arrival serostatus.  If calf body weight is a proxy for age, then it is less likely that 
arrival seropositive status was a result of maternal antibodies and more likely that it was due to 
previous M bovis exposure and infection.  One study found measurable antibodies, in 
seronegative calves, within 7 days post-M. bovis inoculation (Vanden Bush and Rosenbusch, 
2003).  We found a high percentage of calves became seropositive during the first 10 days of our 
study, which suggests that calves were exposed to M. bovis immediately prior to arrival or early 
in the study period.   
By study completion 59.7% of the calves had seroconverted to M. bovis.  Our findings 
agree with a previous study where 55% of calves entering a feedlot seroconverted during the first 
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7 weeks after arrival (Tschopp and others 2001).  The relatively low percentage of calves that 
seroconverted during the study period may be explained by the percentage of calves that were 
seropositive upon arrival.  Seroconversion was defined as a 2 fold increase in serum signal 
between samples.  It seems plausible that seropositive animals (those with higher initial values) 
were less likely to seroconvert than seronegative animals (those with lower initial values). Our 
study indicates that commingled calves, hauled long distances, and stressed by dietary and social 
challenges, are capable of mounting an immune response to M. bovis within 2 weeks after 
arrival.  The arrival nasal M. bovis PCR status and seroconversion were not associated and may 
indicate that the PCR is not a good indicator of the presence of the organism or that the tests 
were performed at a time when the organism was not present. Seroconversion to M. bovis likely 
requires exposure, invasion, and infection of the lower respiratory.   Risk factors associated with 
M. bovis seroconversion have been reported to include mixing calves of different age groups, 
metaphylactic antibiotic use and contact with a seropositive animal. (Tschopp and others 2001) 
The arrival weight range in our study was wide (90.9 kg to 345.5 kg) and assuming calf weight is 
a proxy for age, all three risk factors were present in our study population.   
Morbidity risk tended (P = 0.08) to be lower in calves that were seropositive at study 
completion, versus those that were seronegative.  Other studies have failed to find an association 
between M. bovis serostatus and morbidity or mortality (Rosendal and Martin, 1986; Martin et 
al., 1989).   No association was found between M. bovis seroconversion status and health 
outcomes.  This contrasts with two published studies that found calves which seroconverted to 
M. bovis were more likely to experience respiratory disease compared to calves that did not 
seroconvert (Rosendal and Martin, 1986; Martin et al., 1990).  That only tendencies were 
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observed in our study may be explained by the relatively low number of morbidity and mortality 
cases that occurred.    
Several associations were identified between Mollicutes and M. bovis presence and ADG.  
The presence of Mollicutes by nasal culture at day 42 was associated with lower ADG.  There 
also tended to be an association between ADG and arrival Mollicutes culture prevalence.  This 
may indicate that Mollicutes negatively effects performance when present in the upper 
respiratory tract or Mollicutes were also present in other anatomical areas and their presence was 
manifested by subclinical disease.  Other studies found a high proportion of apparently healthy 
calves with lung lesions at slaughter suggesting subclinical BRDC infections are common 
(Wittum et al., 1996; Gardner et al., 1998).  Additionally, a Bayesian analysis of two studies 
found that clinical signs, as a test  for BRDC diagnosis,  have relatively low sensitivity and 
specificity (White and Renter, 2009).    In the study described here, seroprevalence at any single 
time point was not associated with ADG, although seroconversion to M. bovis over the entire 
study period was negatively associated with performance.  Previously, researchers have shown 
that calves that seroconverted to M. bovis experienced a 7.6% decrease in average daily gain 
over a 49 day period, compared to calves that did not seroconvert (Tschopp and others 2001).   
Our findings suggest interventions that reduce seroconversion after arrival, such as prior 
immunization, or a reduction in exposure to M. bovis just before or during the early feeding 
period, may be beneficial in reducing the negative impact of this organism in the stocker phase 
of production.   That few BRDC morbidities occurred in our study but seroconversion was 
common may indicate a performance expense in response to M. bovis subclinical infections.  
The study subjects were typical of high stressed calves that enter United States stocker 
units.  The study described here indicates that in some populations Mollicutes organisms are 
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nasal ubiquitous, dynamic populations, and exposure to this class of organism may be common 
in newly arrived stocker calves.  We found 26.5% of calves seropositive to M. bovis on arrival, 
which suggests exposure to this organism may occur sometime prior to entry into a stocker 
facility.  Additionally, our data indicate that highly stressed beef calves are able to mount an 
antibody response to M. bovis soon after arrival, but seroconversion, or associated subclinical 
disease, has a cost that is expressed through a decrease in weight gain. This production cost was 
observed even though BRDC morbidity and mortality risks were low, suggesting Mollicutes, 
Mycoplasma species and M. bovis organisms have important effects on beef calves even if 
disease events are not clinically apparent. That seroconversion and not serostatus was associated 
with weight gain indicates that longitudinal studies are important in assessing the role of 
mycoplasma organisms in stocker unit performance.  Further research is needed to define the 
epidemiology of these organisms in other production settings and their effects on beef calf health 
and production performance.  
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Table 4-1  Unadjusted data from beef stocker calves showing prevalence based on 
Mollicutes nasal culture, M. bovis serostatus, M. bovis nasal PCR by sampling time.   
 Sample Day 
 Day 0 Day 10 Day 42 
Mollicutes nasal culture* 
90.4% 
a 
(274/303) 
100.0%
 ab 
(298/298) 
96.4% 
b 
(271/281) 
M. bovis seropositive 
26.6% 
a 
(81/304) 
62.7% 
b 
(187/298) 
98.2% 
c 
(276/281) 
M. bovis nasal PCR 
6.6% 
a 
(20/303) 
11.4% 
b 
(34/298) 
4.2% 
a 
(12/280) 
 Sampling Interval** 
 AR RV ENT 
M. bovis seroconversion 
10.7%
  a 
(32/298) 
41.2% 
b 
(115/279) 
59.7% 
c 
(168/281) 
 
*Data with different superscripts in the same row are different (P <0.05) based on 
multivariable regression   model including effects of arrival group, morbidity, arrival 
weight and gonadal status. 
**Relative to arrival at  a stocker facility: AR = day 0 to day 10, RV = day 10 to day 42, 
ENT= day 0 to day 42 
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Table 4-2 Unadjusted calf  respiratory disease (BRDC) morbidity by Mollicutes culture 
status, M. bovis nasal PCR status, M. bovis serostatus, seroconversion and nasal PCR status 
by sampling day* or period.  
 BRDC Morbidity by Test Results 
 Test Negative Test Positive P-value**
 
Mollicutes culture 
Day 0 
3.4% 
(1/29) 
15.3% 
(42/274) 
0.11 
Day 10 
0% 
(0/0) 
14.0% 
(42/298) 
     ---*** 
Day 42 
0% 
(0/10) 
11.8% 
(32/271) 
0.97 
Negative at all sampling days
 ****
 
0% 
(0/279) 
11.4% 
(32/279) 
--- 
M.  bovis serostatus 
Day 0 
15.2% 
(34/223) 
12.3% 
(10/81) 
0.84 
Day 10 
13.5% 
(15/111) 
14.4% 
(27/187) 
0.70 
Day 42 
40.0% 
(2/5) 
10.8% 
(30/276) 
0.08 
Negative at all sampling days
 50.0% 
(1/2) 
11.1% 
(31/279) 
0.19 
M.  bovis seroconversion 
AR 
12.7% 
(34/266) 
25.0% 
(8/32) 
0.58 
RV 
10.9% 
(18/164) 
12.1% 
(14/115) 
0.58 
ENT 
8.8% 
(10/113) 
13.0% 
(22/168) 
0.39 
Negative for all sampling days
 8.4% 
(9/107) 
13.3% 
(23/172) 
0.33 
M.  bovis  PCR 
Day 0 
15.1% 
(43/283) 
0.0% 
(0/20) 
0.96 
Day 10 
14.7% 
(39/264) 
8.8% 
(3/34) 
0.51 
Day 42 
10.8% 
(29/268) 
25.0% 
(3/12) 
0.43 
Negative for all sampling days
 12.0% 
(26/216) 
9.6% 
(6/62) 
0.66 
 
*Sampling day  in relation to arrival to stocker facility: day 0, day 10, day 42, and 
sampling periods: AR = day 0 to day 10, RV = day 10 to day 42, ENT = day 0 to day 42 
**P-values based on comparisons of model-adjusted means from multivariable logistic 
regression models containing effects of group, gonadal status , and arrival weight.. 
*** Unable to assess significance due to 0% for one group 
**** Represents parallel interpretation of test results; i.e. negative animals tested 
negative at all sample days or periods, and positive calves were positive at least 1sample 
day or period. 
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Table 4-3 Model-adjusted* means for daily weight gains (kg/day) by Mollicutes nasal 
culture, M. bovis serostatus and seroconversion, and nasal sample polymerase chain 
reaction (PCR) testing for M. bovis .   
 
Average Daily Gain by Test 
Result            P-value* 
Negative Positive 
Mollicutes nasal culture 
Day 0** 
0.59 
n = 29 
0.40 
n = 274 
0.06 
Day 10 
-- 
n = 0 
0.41 
n = 298 
-- 
Day 42 
0.93 
n = 10 
0.41 
n = 271 
< 0.01 
Negative for all sampling days*** 
-- 
n = 0 
0.41 
n = 279 
-- 
M. bovis serostatus 
Day 0 
0.40 
n = 223 
0.45 
n = 81 
0.53 
Day 10 
0.38 
n = 111 
0.44 
n = 187 
0.38 
Day 42 
0.68 
n = 5 
0.40 
n = 276 
0.25 
Negative for all sampling days 
0.38 
n = 2 
0.41 
n = 279 
0.92 
M. bovis seroconversion 
AR 
0.40 
n = 266 
0.51 
n = 32 
0.34 
RV 
0.45 
n = 164 
0.35 
n =115 
0.17 
ENT 
0.49 
n = 113 
0.35 
n = 276 
0.04 
Negative for all sampling periods 
0.49 
n = 107 
0.36 
n = 279 
0.06 
M. bovis nasal PCR 
Day 0 
0.40 
n = 283 
0.55 
n = 20 
0.25 
Day 10 
0.44 
n = 264 
0.20 
n =34 
0.01 
Day 42 
0.43 
n = 268 
0.18 
n = 12 
0.12 
Negative for all sampling days 
0.45 
n = 216 
0.31 
n = 62 
0.09 
 
*From a multivariable regression model of average daily gain from arrival to day 42 (with 
mortalities removed), which included effects for arrival  weight, group, gonadal status , 
morbidity 
**Sampling day or period  in relation to arrival to stocker facility: AR =  day 2 to day 10, 
RV = day 10 to day 42, ENT = day 0 to day 42 
***Negative = negative test result for all testing days or periods: Positive = 1 or more 
positive test  
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CHAPTER 5 -  Management practices associated with the rate of 
pre-weaning disease from a national survey of U.S. cow-calf 
operations 
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Abstract 
National survey data representative of 79.6% of U.S. cow-calf operations and 87.8% of 
U.S. beef cows were used to investigate associations between herd management practices and 
bovine respiratory disease complex (BRDC) rates in pre-weaned beef calves.  Data from surveys 
on management practices and health outcomes were combined for this assessment.  
Multivariable negative binomial regression models and a platform specifically designed for 
assessing weighted survey data were used to evaluate factors associated with herd BRDC rates, 
as defined by counts of reported BRDC treatments and total calf-days at risk from birth to 
weaning.  The final multivariable model contained six variables associated with pre-weaning 
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BRDC rates.  Higher BRDC rates were found in operations that fed antibiotics to calves to 
prevent pre-weaning BRDC (incidence rate ratio (IRR) 3.46; 95% confidence interval (CI) 1.39, 
8.60) compared to herds that did not feed antibiotics.  Importing bred heifers was associated with 
lower BRDC rates (IRR 0.40; CI 0.19, 0.82), but operations that imported weaned steers (IRR 
2.62; CI 1.15, 5.97) had higher rates than operations that did not import this class of animal.  The 
number of reported visits by outsiders also was associated with herd-level BRDC rates; 
compared to 0 visits, IRRs were 2.06 (CI 0.59, 7.13), 0.57 (CI 0.19, 1.70), 0.46 (CI 0.16, 1.31), 
1.26 (CI 0.45, 3.51) for 1-2, 3-5, 6-30, and >30 visits per month, respectively.  Operations whose 
calves were from composite genetics (IRR 2.27; CI 1.00, 5.16), two breed crosses (IRR 2.36; CI 
1.30, 4.29) or three breed crosses (IRR 4.00; CI 1.93, 8.31) had higher BRDC rates than single 
breed herds.  Compared to respondents that considered the cow-calf operation to be the primary 
source of income, those that considered the operation as a supplemental source of income (IRR 
0.48; CI 0.26, 0.87) had lower BRDC rates.  Our study demonstrated unique associations 
between pre-weaning BRDC rates and cow-calf management practices, and identified several 
factors that may be useful indicators of pre-weaning BRDC rates in U.S. cow-calf production 
systems. 
Introduction 
Bovine respiratory disease complex (BRDC) continues to be a significant health issue in 
the beef industry (Edwards, 1996; Smith, 1996; Snowder, 2006; Duff and Galyean, 2007; Fulton, 
2009).  In a national survey, over 33% of cow-calf producers agreed or strongly agreed that 
BRDC is economically important to their operation (USDA-APHIS:VS, 2009b).  In the same 
study, respiratory disease was reported as the cause of death for 8.2% of the calves that died 
before weaning.  In two multi-year studies, pre-weaning BRDC cumulative incidence within 
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herds ranged from 3.3% to 23.5% and 8.5% to 65.4% of calves born into a herd (Muggli-
Cockett, 1992; Snowder et al., 2005, respectively).  Calves that experienced pre-weaning BRDC 
were on average 16.5 kg and 7.7 kg lighter than their cohorts at weaning (Wittum et al., 1996; 
Snowder et al., 2005).  Pre-weaning BRDC morbidity can negatively affect calf sale weight and 
can lead to pre-weaning mortalities, thereby reducing the weight and number of calves that cow-
calf operators sell and impacting herd profitability. 
Risk factors for BRDC have been well documented for feedlot cattle and pre-weaned 
dairy calves (Van Donkersgoed, 1993; Svensson et al., 2003; Lago et al., 2006; Svensson et al., 
2006; Sanderson et al., 2008).  However, pre-weaned beef calves are managed much differently 
from dairy calves; therefore, it cannot be assumed that pre-weaning BRDC risk factors would be 
similar to those in the dairy industry.  There are no large-scale studies documenting management 
factors associated with pre-weaning BRDC in cow-calf herds.   
The United States Department of Agriculture (USDA) National Animal Health 
Monitoring System’s  (NAHMS) 2007-08 Beef Survey generated data on management factors 
and disease occurrences for U.S. cow-calf herds (USDA-APHIS:VS, 2008).  Our objective was 
to utilize these data to assess potential associations between cow-calf herd management practices 
and the rate of BRDC in pre-weaned beef calves.  Documenting the cow-calf management 
factors that are associated with BRDC morbidity would allow further focus on management 
areas that are most likely to offer the largest positive impact on this important disease syndrome. 
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Material and methods 
Survey design 
Data for this study were collected in two parts, Phases I and II (described below), of the 
USDA , NAHMS 2007-08 Beef survey (USDA-APHIS:VS, 2008).  From a sampling frame 
obtained from the National Agricultural Statistics Service (NASS), which included all cow-calf 
operations in the 24 selected states, a stratified random sample of operations was selected.  The 
survey was a single-stage design with sampling across strata (based on state and herd size) 
without replacement.  Herd size on January 1, 2007 within state was the stratification variable.  
States included in this survey were Alabama, Arkansas, California, Colorado, Florida, Georgia, 
Idaho, Iowa, Kansas, Kentucky, Louisiana, Mississippi, Missouri, Montana, Nebraska, New 
Mexico, North Dakota, Oklahoma, Oregon, South Dakota, Tennessee, Texas, Virginia, and 
Wyoming.  States were chosen based on a goal that the survey represents at least 70% of the 
animals and cow-calf producers in the United States.  
Survey data 
A total of 4,001 operations were selected to participate in Phase I (General Beef 
Management Report) of the survey.  The Phase I questionnaire contained 110 questions and was 
administered by trained enumerators from NASS between October 22 and November 30, 2007.  
Phase II of the survey (Veterinary Services Initial Visit) contained 51 questions and was 
administered by veterinary medical officers representing USDA-Animal Plant Health 
Information Service (APHIS) in January of 2008. 
Of those selected during Phase I, 47.8% (1,033) provided complete information and were 
eligible to participate in subsequent studies.  Of those eligible operations, 54.9% (567) consented 
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to participate in Phase II of the survey.  Reasons for not participating in Phase II included: 
refused to participate (35.3%), were not contacted (7.8%), and had no beef cows on hand (2.0%).  
The dataset used for our study contains answers given by the 567 participants who completed 
both Phase I and II.  Twenty four states (listed above) were included and these states include 
87.8% (28.6 million) of the beef cows and 79.6% (603,000) of the cow-calf operations in the 
United States (USDA-APHIS:VS, 2009a). 
Data validation for Phase I was performed by each state’s NASS personnel, and 
validation for  Phase II was performed by USDA’s Center for Epidemiology and Animal Health 
staff (USDA-APHIS:VS, 2008).  Additional data validation was completed by the NAHMS staff 
after the data sets from each state were all combined.  All participants’ data were statistically 
weighted to reflect the population from which they were selected.  The weights included the 
inverse of the probability of being selected and adjustments for nonresponse (Dargatz and Hill, 
1996). 
Statistical analysis 
All data analyses were performed using Stata 10.1 (StataCorp, College Station, TX), 
which provides a unique platform (svy) for assessing survey data with weighted responses.  The 
outcome variable of interest for each herd was the rate of respiratory disease in calves between 
birth and weaning, hereafter referred to as BRDC rate.  Herd-level rates were defined using 
reported counts of calves treated with an antimicrobial for respiratory disease and total calf-days 
at risk from birth to weaning.  Calf-days at risk for each herd were initially determined using the 
reported number of calves born alive multiplied by the reported average number of days from 
birth to weaning.  Calf-days at risk were then adjusted based on any calf mortalities and 
respiratory morbidities occurring prior to weaning.  The reported count of calf mortalities for 
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three times periods (birth to 24 hours, 24 hours to three weeks, and three weeks to weaning) were 
contained in the data set.  Morbidity was not reported in these periods; only a total count for 
illness occurring pre-weaning.  All calf-days for calves dying within 24 hours were subtracted 
from the initial calf-days at risk estimate.  For calf mortalities within other time periods and for 
all pre-weaning morbidities, calves only contributed one half (mid-point) of their calf-days at 
risk from their respective time period. 
There were 804 survey responses initially considered as independent variables for this 
study.  Some variables (e.g., type of animal identification used) were not retained for analysis 
given lack of plausibility for potential associations with the outcome of interest.  Descriptive 
analyses including histograms and scatter plots were completed on each variable.  Categorical 
variables where one level represented more than 95% of the herds were excluded from further 
analysis.  Contingency tables were used to assess the similarities of variables among herds.  For 
variables with >95% of the herds answering similarly to multiple related questions, a single 
variable was created, to represent responses to these related questions.  For example, animals 
administered bovine viral diarrhea virus (BVDV) vaccine and animals administered infectious 
bovine rhinotracheitis (IBR) vaccine were included in one variable representing vaccination with 
both BVDV and IBR (versus those that vaccinated for only one or neither).  After these initial 
data evaluation steps, which included assessments of plausibility, descriptive statistics and 
correlations among variables, and combining some variables into single variables, 86 
independent variables were used for further analysis. 
Associations between BRDC rate and independent variables were evaluated in weighted 
analyses using negative binomial regression models with Taylor series linearized variance 
estimation and single sampling unit centered at the grand mean (Dargatz and Hill, 1996; Stata, 
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2007).  Each independent variable was initially assessed separately in bivariable models.  
Independent variables were retained for further analysis if the bivariable p value was ≤ 0.30.  
Continuous independent variables were assessed for the assumption of linearity by categorizing 
into quantiles.  If the quantiles were non-linear over each interval, the variable was entered into 
the model using the categorical coding.  To check for potential multicollinearity, associations 
among variables that were retained following the bivariable analysis (p ≤ 0.30) were assessed 
using chi-square and Spearman’s correlation for binary and nominal/ordinal variables, 
respectively.  In addition, collineariaty was assessed by adding one covariate at a time to the 
bivariable analyses of other possible collinear variables. 
Variables remaining following the bivariable analysis were entered into a multivariable 
negative binomial regression model and manual backward selection were used to select 
independent variables significantly associated (p ≤ 0.05) with the outcome.  In addition, herd size 
was assessed as a potentially important predictive variable and potential confounder.  Each 
variable not retained during the initial backward elimination process was later reoffered to the 
model to assess significance and to check for confounding.  Any variable, reoffered to the final 
model that was statistically significant or resulted in a coefficient change of ≥ 20% for any other 
variable was retained in the model.  This process continued until no variables reoffered to the 
model were eligible to be retained.  After the final model was determined, comparisons among 
levels within variables were made using adjusted Wald tests. 
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Results 
Study population 
There were 443 operations that had calves born alive during the study period and reported 
data on pre-weaning calf respiratory disease.  For the studied herds, the median number of beef 
cows on hand was 128 (range 2-5847) and the mean was 269.7 (standard deviation (SD) 467.2).  
The median percentage of the herd over 10 years of age was 10.6 (range 0-82.6) and the mean 
was 13.5 (SD 13.6).  Median percentage of cows under 5 years of age was 43.1 (range 0-100) 
and the mean was 42.9 (SD 21.6).  For our study herds, the median number of calves born alive 
was 125 (range 1 – 6,400).  For the calves born alive, the mean percentage of calves affected by 
respiratory disease was 3.0% (SD 7.1), and the mean days from birth to weaning was 207.2 (SD 
35.5) with a median of 210 (range 90 - 300).  The mean number of mortalities from birth to 24 
hours was 3.1 (SD 6.5) with a median of 1.0 (range 0 - 70).  The mean number of mortalities 
from 24 hours to 3 weeks of age was 3.3 (SD 7.9) and the median was 1 (range 0 -70), and for 3 
weeks of age until weaning the mean number of mortalities was 4.0 (SD 10.4) with a median of 2 
(range 0 - 125).  Mean number of calf-days at risk was 53, 260 (SD 95, 655) with a median of 
25, 905 (range 180 – 1,280,000).  Mean BRDC rate was 1.5 (SD 3.7) cases per 10,000 calf days 
and the median was 0.18 (range 0 – 75.0).  Figure 1 displays the distribution of herd BRDC rates. 
Analysis results 
 Of the variables assessed in the initial bivariable analyses, 21 were found to be 
associated (p ≤ 0.30) with the outcome variable (Table 1).  Crude incidence rate ratios (IRR) for 
these variables provided unadjusted estimates for the magnitude and direction of effects for 
factors affecting calf respiratory disease rates (Table 1).  In the bivariable analyses, several 
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variables of interest were found not to be associated (p > 0.30) with BRDC rates.  Herd size, 
divided in quartiles, was not associated with BRDC rate.  Herd demographics, as described by 
the proportion of cows in the herd under five years of age, was found not to be associated with 
BRDC rate.  Disease management variables, including how often the calving pen was used to 
house sick cows, vaccinating 22 day old to weaning-aged calves with a four-way viral vaccine 
that included infectious bovine rhinotracheitis (IBR), bovine viral diarrhea virus (BVDV), 
parainfluenza (PI-3), bovine respiratory syncytial virus (BRSV), consultation by a veterinarian 
on disease prevention, number of defined breeding seasons, and the separation of cow-calf pairs 
from pregnant cows also were not associated with BRDC rates.  General management practices 
including mean days from birth to dehorning, the use of creep feed, the use of artificial 
insemination and body-condition scoring also were not associated with the outcome variable. 
The final multivariable model included six independent variables that were significantly 
associated with herd-level BRDC rates (Table 2).  To assess the form of the model that best fit 
the data (Poisson or negative binomial), the dispersion parameter point estimate (α) and 95% 
confidence intervals were evaluated.  If the confidence interval did not include 0, the negative 
binomial regression model was deemed the most appropriate (Heeringa et al., 2010).  Although 
the reported average number of visits by outsiders was significantly associated with the outcome, 
the direction of effects varied and there were no differences between the referent category (zero 
visits by outsiders per month), and effects for herds reporting 1-2 visits (p = 0.256), 3-5 visits (p 
= 0.316), 6-30 visits (p = 0.147) or >30 visits (p = 0.668).  However, comparison between herds 
reporting 1-2 visits per month had higher BRDC rates compared to both 3-5 visits (p = 0.008) 
and 6-30 visits (p = 0.001).  Similarly BRDC rates were lower in herds recording 3-5 visits (p = 
0.020) and 6-30 visits (p = 0.001) compared to herds reporting >30 visits per month.  No 
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difference was found between 1-2 visits and >30 visits per month (p = 0.273).  Compared to 
single breed herds, two-breed cross (p = .005) and three-breed cross (p ≤ 0.001) herds had higher 
BRDC rates.  When compared to single breed herds, composite herds tended to have higher 
BRDC rates (p = 0.051).  Additionally, herds reporting the cow-calf operation was a secondary 
source (p = 0.015) of income had lower BRDC rates compared to primary source income herds.  
No difference was found between other source of income herds and primary source (p = 0.087) 
income herds or secondary income herds (p = 0.522). 
Discussion  
Using survey data representative of a large percentage of the U.S. cow-calf industry, we 
were able to generate unique information on management practices associated with pre-weaning 
BRDC rates.  In the final model, six variables were found to be associated with pre-weaning 
BRDC rates (Table 2).  These effects may be indicative of pathogen exposure levels within the 
herd, genetic or breed components to the disease syndrome, or may simply represent general 
management characteristics of certain cow-calf operations that affect rates of BRDC in pre-
weaned calves.  However, since we cannot assess the temporal relationships among these 
associations relative to onset of BRDC and given the cross-sectional design of our study, it is not 
appropriate to assume causal relationships.  The associations that we observed will require 
further evaluation into mechanisms for associations and potential disease mitigation 
opportunities, however, we have provided a unique assessment of potential risk factors for pre-
weaning BRDC in U.S. cow-calf herds that may be useful to profile or evaluate herds that could 
have higher BRDC rates. 
The mean cumulative risk of pre-weaned calf respiratory disease (3.0%) in our data was 
higher than that reported in one previous U.S. study (Wittum et al., 1994a) , but slightly lower 
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than another (Dewell, 2006).  One reason our mean percentage may have been higher than the 
0.5% reported by Wittum et al. is that they used a shorter period of time at risk (45 days) in their 
analysis (Wittum et al., 1994a).  The approximate days to weaning in the Dewell et al. study was 
200 days, which is comparable to our study; however, their risk estimate (4.6%) was based on a 
much smaller number of calves located in a single herd (Dewell, 2006).  Combined, these studies 
indicate that while pre-weaned BRDC risk is relatively low, it still may vary among different 
subsets of the national population.  Neither of the previous studies reported a BRDC incidence 
rate; thus Figure 1 displays unique data for U.S. cow-calf herds.   
The multivariable model of data from the survey population identified six management 
practices that were significant indicators of pre-weaning BRDC rate.  Operations that reported 
feeding antibiotics to unweaned calves to prevent respiratory disease had higher BRDC rates 
than those that did not; however, it is possible that this association is demonstrating reverse 
causation.  Because of the cross sectional design of this study, we do not know the historical 
BRDC experience in our study herds.  Herds may have begun feeding antibiotics in response to a 
recent or current BRDC outbreak, or feeding antibiotics may have been used for prevention in 
the survey year in response to previous year’s BRDC experiences.  Little research investigating 
the benefit of feeding antibiotics to prevent BRDC in pre-weaned calves has been published, but 
the practice is thought to be beneficial for post-weaned calves in some instances (Duff and 
Galyean, 2007).  Although we report the term ―prevention‖ as per the wording of the survey 
question, this may actually have been an antibiotic used for disease control since very few feed 
grade antibiotics are labeled for BRDC prevention and producers may consider prevention and 
control as equivalent.  Care must be exercised when evaluating the association between feeding 
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antibiotics and BRDC rate because of the possibility of reverse causation and the potential for 
this observed association to be due to other unmeasured factors. 
Rates of BRDC were lower for herds importing bred heifers, but importing weaned steers 
had a positive association with BRDC rate.  Producers that market bred heifers are likely to 
practice complete health programs because of the high value of breeding stock and germ plasm 
(Chenoweth and Sanderson, 2001).  These complete health programs may include vaccination or 
other preventive health measures, and managing genetics to affect risk factors such as dystocia, 
and udder and teat conformation, which have been associated with pre-weaned BRDC (Wittum 
et al., 1994a; Stokka, 2010).  It is possible that lower BRDC rates could be observed when herds 
marketing bred heifers concentrate on managing risk factors such as dystocia and udder 
conformation, which results in lower BRDC rates among herds that import this class of animal.  
Exposure to BRDC pathogens by contact with other populations, especially populations derived 
from multiple source herds, is believed to be a pre-weaning BRDC risk factor (Stokka, 2010).  It 
is possible that steer-purchasing also occurs through marketing channels where exposure to 
multiple pathogens is likely (Edwards, 2010).  The higher BRDC rates among herds importing 
steers could be due to pre-weaned calves being exposed to different BRDC pathogens or 
increased pathogen concentrations.  The temporal relationships between importation of bred 
heifers or steers and exposure to unweaned calves cannot be assessed with our data, but our 
results suggest that importing some classes of cattle could potentially impact, either negatively or 
positively, the BRDC rates for pre-weaned calves in cow-calf operations. 
Although few studies have documented its importance, biosecurity has been cited as an 
important management practice for pre-weaning BRDC control as it may reduce BRDC 
pathogen introduction and transmission to calves (Callan and Garry, 2002).  Pathogen 
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transmission can occur not only from animal to animal contact, but also from environmental or 
fomite contamination; therefore, controlling entrance to a cow-calf facility by outsiders may be a 
logical biosecurity practice (Callan and Garry, 2002).  Although the categorical variable 
representing the number of visits to the herd by outsiders was significant in our final model, we 
found no difference in pair-wise comparisons among herds that had zero visits per month by 
outsiders and those reporting one or more visitors per month.  It is possible that most visits do 
not involve contact with either outside animals or herd animals, but are instead non-livestock 
associated visits.  Although our data set would not allow us to assess the respondents’ biosecurity 
practices, it is also possible that respondents who allow outside visitors are cognizant of 
biosecurity as a disease control method and have effective biosecurity programs in place.  In 
comparisons among herds that had at least one visit per month, we found that herds with 1-2 
visits per month or >30 visits per month had higher BRDC rates compared to herds with 3-5 or 
6-30 visits per month.  Perhaps these effects indicate that herds with few visitors are less 
concerned with biosecurity than herds with moderate numbers of visitors.  These results also 
may indicate that large numbers of visits may overwhelm some biosecurity programs making 
them less effective than when implemented in herds with moderate numbers of visits.  The 
overall variability in effects among different levels of the variable representing the reported 
number of herd visits and the lack of specificity in defining types of visitors (e.g., employees, 
veterinarians, cattle buyers), combined with the cross-sectional nature of the data, make it 
extremely difficult to determine potential mechanisms for observed associations.  Further, when 
evaluating the association between outsider visitors and BRDC from our data set, caution is 
warranted because of the possibility that number of visits is a proxy for other unmeasured 
factors. 
 149 
Our multivariable model demonstrated that breed management may play a role in pre-
weaning BRDC rates (Table 2).  We found operations with two-way crosses, three-way crosses 
or composites had higher BRDC rates compared to single-breed herds, which is in contrast with 
results from a study where BRDC incidence was greater among single breed pre-weaned calves 
compared to two-way, three-way or composite calves (Snowder et al., 2005).  However, their 
study was completed on a large U.S. federal research operation with similar management 
practices for both single and multiple breed groups.  It is possible the single breed operations in 
our study were primarily purebred operations and enhanced disease prevention, or that more 
intensive treatment regimens were practiced given the perceived added value of purebred calves.  
Additionally, in our survey a definition for crossbred or composite was not provided; therefore, 
there may have been a difference in the breed makeup between our study population and the 
Snowder et al. study.  Because of the national scope of our study, it is unlikely that similar 
genetics were contained between the single-breed herds.  It is more likely that other management 
practices, unique to single or multiple breed herds, which can affect BRDC rates were present. 
Respondents that reported the operation was not the primary source of income but a 
supplemental source of income had lower BRDC rates.  Primary income source herds derive 
most of their income from the sale of calves (Wikse et al., 1994).  Because of the potential added 
importance of calf-sales in these herds, it is possible that an increased BRDC recognition 
intensity occurred resulting in more pre-weaned calves being treated for respiratory disease.  In 
our study population, primary income also was associated with greater herd size (data not 
shown).  Increased population size also may be associated with greater within herd exposure to 
BRDC pathogens, which is considered to be a risk factor for pre-weaning BRDC (Stokka, 2010).  
Additionally, a lack of labor quantity has been associated with increased pre-weaning BRDC 
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(Stokka, 2010), and labor deficiencies could be more common in primary income source herds.  
Because primary income source herds may have different pathogen exposure levels or disease 
recognition and control strategies, and are likely managed much differently than herds 
considered for supplemental income or other (hobby) purposes, income category may be a proxy 
for relationships among several risk factors that affect BRDC rates.   
Although the survey design and implementation should result in data effectively 
representing a large proportion of U.S. cow-calf herds, the external and internal validity of our 
study may be affected by several study limitations.  Because the survey design was complex, we 
used a weighted analysis of the sample population to potentially provide representation of the 
target population (Levy and Lemeshow, 2008; Heeringa et al., 2010).  We recognize that the 
assumptions required when using non-response weighting, if incorrect, may result in biased 
estimates of effects.  However, if the effects are unbiased, the weighted analysis allows for better 
external validity.  The participants volunteered to participate in the survey; therefore, a self-
selection bias may have been present.  In evaluating our final model, we compared it to an 
unweighted model (data not shown) and found relatively similar estimates of effects.  Internal 
validity may have been affected by the accuracy of our statistical models.  Unfortunately, 
limitations in available survey analysis software for weighted analyses prevent extensive 
evaluations of model fit (Heeringa et al., 2010).  However, we demonstrated that a negative 
binomial distribution was clearly more appropriate for our data than a Poisson distribution.  The 
additional variability may have been due to absence of hierarchical variables.   
For these national survey data, there was no uniform case definition for BRDC; reported 
were the number of calves treated with antimicrobials for respiratory disease.  Because the study 
population included many cow-calf operations throughout the U.S., the case definition and 
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disease recognition skills among participants likely differed.  The potential misclassification in 
our study may or may not have been differential with respect to risk factors of interest.  Because 
the outcome variable was the number of pre-weaned calves treated for respiratory disease and 
not the number of first BRDC treatments, some calves may have been counted more than once.  
In addition, due to the retrospective nature of the survey (operators were asked to recall events 
that occurred over the course of the previous year), recall bias may have affected both the 
number of BRDC events that occurred and the management practices that were present.  
Similarly, because the days at risk were calculated considering mortalities that occurred within 
specific time frames, some timing misspecification may have occurred.  Combined with potential 
inaccuracies in the reported average weaning days, these data may have led to differential or 
non-differential misspecification of the rate exposure (calf-days at risk). 
Conclusion 
Several cow-calf management practices were associated with herd-level pre-weaning 
BRDC rates in a survey of U.S. cow-calf herds.  Feeding antibiotics to pre-weaned calves was 
positively associated with BRDC rates, but it is possible that this practice was a response to, 
rather than a cause of BRDC events.  The effects of importing cattle from outside sources were 
found to be significantly associated with BRDC rates, but the direction of effects was dependent 
on the class of animal imported.  Surprisingly, when compared to herds reporting no outside 
visitors to herds with at least one visitor per month no difference in BRDC rates were found. 
However, among herds that reported outside visitors, the number of visits differentially affected 
the herd level BRDC rates.  Additionally, breed management practices and the economic purpose 
of the cow-calf operation were found to be associated with pre-weaning BRDC rates.  Due to the 
cross-sectional nature of our survey data, we cannot determine whether any of the associated 
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management practices preceded or followed BRDC events.  However, enhancing our 
understanding of these risk factors may help in identifying future disease mitigation 
opportunities and provides unique profiles of U.S. cow-calf herds that are associated with 
increase rates of BRDC in pre-weaned calves.  
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Table 5-1 Results of bivariable negative binomial regression analyses demonstrating 
management practices that were associated
a
 with the rate of pre-weaned calf respiratory 
disease in U.S. cow-calf herds 
Variable Response N IRR
b 
95% 
Confidence 
Interval (IRR) 
Vaccinate 22 day old to weaned calves for 
Mannheimia/Pasteurella 
No 293   
Yes 149 0.55 0.30, 1.01 
Vaccinate cows with four way viral 
vaccine (IBR, BVD, PI3, BRSV) 
No 260   
Yes 182 1.61 0.68, 3.80 
Unweaned calves fed antibiotics to prevent 
respiratory disease 
No 408   
Yes 35 2.65 0.89, 7.92 
Number of times calves vaccinated for 
respiratory disease from birth to weaning
c 
0 67   
1 111 2.82 1.04, 7.69 
2 175 2.79 1.09, 7.18 
≥3 52 0.99 0.36, 2.76 
Import unweaned calves with dams No 418   
Yes 25 2.99 1.00, 8.93 
Import bred heifers No 402   
Yes 41 0.32 0.13, 0.77 
Import weaned steers No 412   
Yes 31 2.83 0.82, 9.74 
During an average month, the number of 
visits to the operation made by outside 
visitors
d 
0 33   
1-2 79 2.02 0.37, 11.05 
3-5 92 0.49 0.10, 2.43 
6-30 114 0.39 0.08, 1.82 
>30 116 1.03 0.22, 4.83 
Best describes genetic make-up of calves  Single breed 122   
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Composite 32 2.32 1.08, 4.99 
2 Breed X 196 3.09 1.37, 6.97 
3 Breed X 93 4.23 1.70, 10.53 
At least one live calf with horns was born 
this year 
No 234   
Yes 209 1.92 0.84, 4.36 
Mean weaning weight of replacements (kg) <228 130   
229-250 37 0.76 0.27, 2.15 
>250-273 126 2.11 0.71, 6.33 
>273 43 1.00 0.40, 2.51 
Average days from birth to weaning <180 132   
181-210 162 1.51 0.64, 3.56 
211-230 40 2.23 0.41, 12.02 
231-315 109 0.53 0.23, 1.18 
The same people buy the operation’s 
calves each year 
No 209   
Yes 232 1.78 0.83, 3.84 
The cow-calf operation is a primary, 
supplemental or other source of income  
Primary 209   
Supplemental 209 0.68 0.26, 1.80 
Other 25 0.31 0.08, 1.19 
Percent of operator’s total hours worked 
(on and off operation) is devoted to the 
cow-calf operation 
<25 113   
26-50 115 0.79 0.32, 1.94 
51-99 78 2.43 0.69, 8.55 
100 137 0.70 0.29, 1.69 
Use estrus synchronization No 349   
Yes 94 1.51 1.08, 2.13 
Use pregnancy ultrasound No 395   
Yes 48 1.35 0.82, 2.32 
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Use pelvic measurement No 381   
Yes 62 3.46 1.11, 10.76 
Hours cows allowed in labor before 
intervention is initiated 
≤2 261   
>2 141 0.57 0.25, 1.31 
One or more cows treated for any disease 
except respiratory disease 
No 243   
Yes 196 1.58 0.69, 3.65 
One or more cows treated for respiratory 
disease 
No 373   
Yes 66 1.98 0.61, 6.42 
a
p ≤ 0.30  
b
IRR : incidence rate ratio 
c
Vaccinating with one or more of the following : IBR, BVDV, PI3, BRSV, Mannheimia 
haemolytica, Pasteurella multocida, Histophilus somni 
d 
Visitors included : employees, veterinarians, neighbors, nutritionists, commercial haulers, 
etc.  
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Table 5-2 Results of multivariable negative binomial regression model demonstrating 
management practices associated with the rate of pre-weaned calf respiratory disease in 
U.S. cow-calf herds 
Variable p
 
Level β S.E. (β) IRRa 
95% 
Confidence 
Interval 
(IRR) 
Intercept   -8.89 0.59   
Unweaned calves fed 
antibiotics to prevent 
respiratory disease 
0.008 No Referent    
 
Yes 1.24 0.46 3.46 1.39, 8.60 
Import bred heifers 0.013 No Referent    
  Yes -0.93 0.37 0.40 0.19, 0.82 
Import weaned steers 0.022 No Referent 
   
  Yes 0.96 0.42 2.62 1.15, 5.97 
During an average month, 
the number of visits to the 
operation made by outside 
visitors
b 
0.001
 
0 Referent    
 
1-2 0.72 0.63 2.06 0.59, 7.13 
 
3-5 -0.56 0.55 0.57 0.19, 1.70 
 
6-30 -0.78 0.53 0.46 0.16, 1.31 
 
>30  0.23 0.52 1.26 0.45, 3.51 
Best describes genetic 
makeup of calves 
0.001
 
Single breed Referent 
   
 Composite 0.82 0.42 2.27 1.00, 5.16 
 
2 Breed Cross 
0.86 0.31 2.36 1.30, 4.29 
 
3 Breed Cross 
1.39 0.37 4.00 1.93, 8.31 
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The cow-calf operation is a 
primary, supplemental or 
other source of income (i.e. 
pleasure) 
0.029
 
Primary Referent    
 Supplemental -0.74 0.31 0.48 0.26, 0.87 
 Other -1.17 0.68 0.31 0.08, 1.18 
a 
IRR : incidence rate ratio 
b 
Visitors included : employees, veterinarians, neighbors, nutritionists, commercial haulers, and 
others. 
Dispersion parameter (α) estimate 3.39 (95% Confidence interval 2.53, 4.54) 
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CHAPTER 6 - Conclusion 
Bovine respiratory disease complex (BRDC) is a multifactorial disease common in both 
pre- and post-weaning calf populations.  This disease syndrome continues to plague the beef 
industry, annually costing hundreds of millions of dollars, despite many years of study and 
development of multiple preventive health products and programs.  That BRDC remains 
important to the beef industry after many years of research reinforces the complexity of this 
disease syndrome and the difficulty in effectively reducing impacts of a complex disease.  A 
multifaceted epidemiologic research approach, taking into account all facets of the epidemiologic 
triad, including calf, pathogen, and management, is necessary to prevent and reduce the health 
and economic effects of this complex disease syndrome. 
Fundamental to the control of BRDC are multiple component preventive health 
programs.  Programs are often designed using research from multiple studies demonstrating the 
effectiveness of a single component (e.g., a single type of vaccine).  I hypothesized that different 
component combinations (e.g., vaccine-parasiticide combinations) may have variable 
effectiveness.  Because calves are usually administered programs consisting of multiple 
preventative health measures and not single components, I designed a study investigating 
potential differences in calf health and performance between multiple component programs.  The 
programs in my study differed in both the types of components and their mode of administration.  
One program consisted of all injectable components and the other utilized topical or oral 
components and only one low-dose injectable (subcutaneous) product.  My work showed a lower 
percentage of calves (47.8%) in the all-injectable program experienced BRDC morbidity 
compared to the calves in the one-injectable program (59.7%).  This research provides evidence 
that the effectiveness of BRDC prevention opportunities do differ between programs.  
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Additionally, by assessing only non-morbid calves, I found the all-injectable program calves 
(1.23 kg) gained more daily weight compared to the one-injectable group (1.16 kg).  My results 
indicated that differences in calf aversion to program administration did occur.  A lower 
percentage of calves in the one-injectable program (39.8%) vocalized compared to 47.8% of the 
calves in the all-injectable group.  Vocalization is believed to be associated with animal welfare; 
thus,my research may indicate potential welfare differences between programs.  In addition, calf 
activity as measured by pedometers differed throughout the early feeding period, with the one- 
injectable program calves taking fewer steps in each 24 hour period.  This is important because it 
provides evidence that a carry-over of aversion to initial administration may occur, or that 
multiple injection effects are not short-term.  Behavior as measured by the percentage of time 
spent lying down was higher for the one-injectable program calves on certain days.  This group 
also had higher BRDC morbidity risk.  I have also shown (Chapter 3) that calves spent less time 
lying down post-Mannheimia haemolytica inoculation.  Findings contained in my two research 
projects provide evidence that monitoring posture may be an important method for BRDC 
recognition.  My research provided information to the beef industry that differences do exist 
between preventive health programs as expressed through health, performance and behavior.  
No BRDC preventive health program has been shown to be completely effective; 
therefore, the disease continues to occur.  It is believed the success of the treatment for BRDC 
depends on how early during the course of disease that the treatment is initiated.  Unfortunately, 
disease recognition is difficult, largely because calves are prey animals and are able to mask 
clinical illness.  Additive to this difficulty is the requirement of calf-care-givers to observe large 
groups of calves and subjectively assess the clinical state of each animal.  I found that commonly 
employed BRDC recognition tools, such as physical examinations, were unable to discern health 
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from disease state.  Additionally, I found that blood metabolites were unable to distinguish health 
from disease.  However, I also noted changes in the amount of daily time that calves spent lying 
down and standing.  The importance of this is unknown, but the results suggest that investigating 
postural changes in calves for use as diagnostic tool is warranted.  I also found that calf activity, 
as measured by pedometers, was able distinguish health from disease.  My research identified 
calf activity as a practical method for assessing BRDC disease state and I was able to show that 
some commonly used techniques, such as physical examinations and blood component 
parameters are not useful BRDC recognition tools. 
Through the many years of BRDC research, the list of associated pathogens has changed.  
The class Mollicutes, and more specifically M. bovis, are just one of many newly identified 
BRDC pathogens.  Because M. bovis’ role in BRDC has just recently been discovered, little 
epidemiologic research has been completed.  Thus, data from my study are critical to our 
understanding of this organism.  I found that Mollicutes is ubiquitous and dynamic in some 
weaned calf populations.  Although I found no association between nasal prevalence and BRDC 
morbidity and mortality, prevalence was associated with calf weight gain.  This provides 
important information suggesting that when Mollicutes organisms are isolated from the upper 
airway, calf performance may be reduced.  I also provided evidence that some calves are 
exposed to M. bovis before arrival to stocker units, and that seroconversion during the early 
feeding period is common.  My findings suggest that exposure to M. bovis may have already 
occurred at the time of arrival to the feedlot.  The seroconversion results are important for 
veterinarians and producers when designing vaccination programs, because it indicates that even 
highly stressed calves can mount immune responses to M. bovis during the early feeding period.  
Additionally, I found that those calves that seroconverted had gained 0.35 kg/day compared to 
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0.49 kg/day for those calves that did not seroconvert.  That I found no difference in health 
outcomes between seroconversion status but a difference in performance provides evidence that 
exposure and immune reaction to this organism may have negative production impacts.  I 
provide important evidence that Mollicutes and M. bovis, even if not associated with calf health, 
can affect production within some calf populations. 
Identifying BRDC risk factors is as important as demonstrating differences in health 
programs, identifying accurate BRDC recognition tools, and determining the prevalence and 
impacts of new BRDC-associated organisms.  Until my final research project, BRDC risk factors 
had not been described for pre-weaned beef calves in U.S. cow-calf operations.  By using a data 
set from a survey of U.S. cow-calf production systems, I identified several management practices 
as risk factors for BRDC.  I found that feeding antibiotics to pre-weaned calves was associated 
with higher BRDC rates.  My study would not allow us to discern if feeding antibiotics was for 
prevention or control, and I suggest that this effect may be a measure of the response to BRDC 
rather than a factor leading to BRDC.  My research also showed that importing specific classes 
of animals may affect BRDC rates, but the direction and magnitude of these effects is dependent 
on the class of animals imported.  These results provide evidence that special precautions may be 
warranted when importing some classes of animals.  I provided evidence that for herds reporting 
at least one outside visitor to the operations, moderate numbers of visitors was associated with 
lower BRDC rates compared to very few or many.  These findings may suggest that operations 
with a moderate number of visitors may practice effective biosecurity, but many monthly visitors 
adversely affect some biosecurity programs.  Single breed herds were found to have lower 
BRDC rates compared to two and three breed herds.  This is important because it may indicate 
that single breed herd health programs contain general management practices that reduce BRDC.  
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Additionally, the economic reason for the existence of the cow-calf operation was associated 
with the herd BRDC rate.  It is plausible that greater BRDC detection intensity may be present in 
herds that are the primary source of income compared to supplemental source of income.  Due to 
the cross-sectional nature of mysurvey data, it cannot be determined whether any of the 
associated management practices preceded or followed BRDC events.  However, enhancing our 
understanding of these risk factors may help in identifying future disease mitigation 
opportunities and provides unique profiles of U.S. cow-calf herds that are associated with 
increase rates of BRDC in pre-weaned calves.  
My research has brought forth unique information concerning pre-weaning and post-
weaning BRDC.  I have provided evidence that differences in health, performance and behavior 
do exist between some health programs; thus, field trials utilizing randomized program (rather 
than product) assignments for identifying differences between programs is justified.  
Additionally, I identified calf activity and posture as accurate indicators of BRDC.  I also have 
illustrated Mollicutes and M. bovis may be important organisms associated with the performance 
of post-weaned calves.  Lastly, I have provided the first assessment of management practices as 
risk factors for pre-weaning BRDC in U.S. cow-calf herds. 
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